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Summary
The aim of this project was to use immunological techniques to determine the 
subcellular distribution of the a4S2 subtype of neuronal nicotinic acetylcholine 
receptor (nAChR) in the mammalian brain. Three approaches were taken:-
1) Immunoelectron microscopy of isolated presynaptic terminals (synaptosomes)
2) An attempt to immunoisolate synaptosomes bearing the a4S2 subtype, leading 
to synaptosome characterization studies to determine neurotransmitter 
synthesizing enzyme content.
3) Pharmacological and immunological characterization of subcellular fractions.
Monoclonal antibodies directed against the extracellular domain of detergent 
solubilized o4£2 were donated by J. Lindstrom and polyclonal sera directed 
against the cytoplasmic region between transmembrane regions M3 and M4 of 
various subunit subtypes were donated by S. Rogers.
The results indicate the viability of all three approaches, although an extensive 
immunoelectron microscopy study would be required, because of the low a4&2 
concentration. Immunoelectron microscopy and immunoisolation experiments 
were compromised by an unanticipated immunological recognition problem and 
so could not be pursued to completion. A pharmacological and immunological 
characterization of subcellular fractions reinforced previous studies indicating that 
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Chapter 1 Introduction
1.1 The chemical synapse
2
In the human brain there are approximately 1000 different cell types including 1011 
neurons. Every neuron has, on average, 1000s of connections with other neurons, 
muscle cells or secretory cells. The classic picture of the neuron and intraneuronal 
signal propagation is summarized in figure 1.1. The modem model of propagation 
is slightly modified, to account for signal propagation in all neuronal regions, by 
including the movement of other ions especially Ca2+ and C1‘ (reviews: Armstrong, 
1992; Catterall, 1992; Hille, 1992; Neher, 1992; Sakmann, 1992; and Stevens, 
1993). Some intemeuronal connections are electrical (Bennet et ai, 1991; 
Makowski et al, 1977,1984), but the vast majority are made via chemical synapses.
The ultrastructure of the chemical synapse was determined by electron microscopy 
(1953, Sjostrand; review: Jones, 1975), the classic description of synaptic structure 
and function is summarized in figure 1.2. Transmission at chemical synapses is 
significantly slower than at electrical synapses, but they have several advantages 
(Hall and Sanes, 1993), they:-
i) permit signal amplification and so avoid attenuation problems.
ii) allow easy conversion between excitatory and inhibitory signals.
iii) provide multiple regulation levels.
iv) allow multiple responses by the interplay of transmitter and receptor types.
v) fulfil the minimum requirements of regulation and feedback to be individually 
regarded as the fundamental units of information processing and storage (Hebb, 
1949).




Deitres first described the neuron in 1865. It consists of multiple branching 
dendrites and a single axon converging on a nucleated soma. Ramo'n y Cajal 
demonstrated that neurons are discrete units through which information flows 
unidirectionally. A signal propagates as described by the ionic hypothesis 
(Hodgkin, Huxley and Katz, 1949; Hodgkin and Huxley, 1952) from the 
postsynaptic junction on multiple branching dendrites and the soma (input), down 
the axon (long range transmission, up to lm) to presynaptic terminals (output). 
The term synapse was originally introduced by Sherrington in 1897 (historical 
review: Changeux, 1983).
Figure 1.2 The chemical synapse
4
Axon









Figure 1.2 is not to scale. The chemical synapse functions (chemical transmitter hypothesis, 1935, 
Dale) by the transmission of a chemical signal from synaptic terminal (500nm diameter) across the 
synaptic cleft (12nm) to the postsynaptic surface. The neuroactive substances are stored in and 
released from synaptic vesicles (De Robertis and Bennett, 1955), each vesicle represents one 
quantum (quantal release hypothesis, Del Castillo and Katz, 1954) for random (miniature end-plate 
potentials, mepps: Fatt and Katz, 1950,1952) or calcium induced release (calcium hypothesis, 1969, 
Katz). Small synaptic vesicles (SSV, uniform diameter, 50nm) contain classical small molecule 
neurotransmitters (Siidhof and Jahn, 1991), large dense-core vesicles (LDCV, heterogeneous 
diameter, around lOOnm) contain neuromodulatory peptides and proteins and bioamines (Sossin et 
al, 1989). Neurotransmitters interact with receptor molecules on the post-synaptic cell causing 
membrane depolarization (excitatory) or hyperpolarization (inhibitory) (Eccles, 1963). An action 
potential is initiated in the post-synaptic cell as a result of temporal and spacial summation synaptic 
responses. Synaptosomes are formed by "pinching off" presynaptic terminals at the neck. They often 
contain mitochondria (mit) and so are metabolically active. The functional role of presynaptic 
receptors is explored in the text.
There are over 100 neuroactive substances involved in interneuronal 
communication, they include the classical neurotransmitters and a variety of 
substances which m odulate the response to or the release  of these 
neurotransmitters (figure 1.2): a small selection neuroactive substances are 
released at any particular synapse (Jessel and Kandel, 1993;McGeer et al, 1987). 
There are 2 types of vesicles present at nerve terminals with different modes of 
storage and release (Kelly, 1993), both bud from the trans Golgi apparatus within 
the cell body and are transported along the axon to the nerve terminals:-
a) The SSVs are filled (McMahon and Nicholls, 1991) at the terminal to lOOmM 
concentrations (approximately) of either acetylcholine, glutamate, y-aminobutyric 
acid (GABA), glycine or one of the biogenic amines. When an action potential 
reaches the terminal voltage-gated Ca2+ channels open in addition to the Na+ 
channels (Fox et al, 1987; Nowycky et al, 1985; review McMahon and Nicholls,
1991). The resulting Ca2+ influx raises the intracellular Ca2+ concentration to 200- 
300/xM in microdomains in the vicinity of neurotransmitter release sites (Llinds 
et al, 1992), which dramatically increases the probability of neurotransmitter 
release above the basal level (mepps review: Stevens 1993). The Ca2+ induced 
release is very rapid, within 1ms of Ca2+ influx there is a 1ms neurotransmitter 
efflux (Lim et al, 1990; Lindau et al, 1992), which empties 10% of the docked 
vesicle pool present in the active zones (Cohen et al, 1991; Smith and Augustine, 
1988), ie 0.1% of the total vesicle pool. After neurotransmitter release SSVs can 
be recycled via (nerve terminal) endosomes and/or rapidly refilled with fresh 
neurotransmitter at the terminal (Siidhof and Jahn, 1991). (Neurotransmitter 
release reviews:- Aimers and Tse, 1990; Kelly, 1993; McMahon and Nicholls, 
1991; Sihra and Nichols, 1993; Siidhof and Jahn, 1991). The mechanism for
6calcium independent neurotransmitter release is unclear, it may merely involve 
the release of intracellular calcium stores (Adam-Vizi, 1992). 
b) The LDCVs are less common than SSVs and cannot be refilled at nerve 
terminals, but must return to the Golgi (Sossin et al, 1989). The Ca2+-induced 
exocytosis of LDCVs is slower (50ms) and occurs at different sites (Pow and 
Morris, 1989; Thureson-Klein, 1983; Thureson-Klein and Klein, 1990) to release 
from SSVs, probably via an independent release mechanism (Jessel and Kandel, 
1993; Kelly, 1993).
Before the breakdown and/or re-uptake of neuroactive substances (Iversen, 1979) 
they might interact with receptors on the pre- or the post synaptic membranes. 
Presynaptic receptors are typically metabotropic (Bourne and Nicoll, 1993). They 
regulate the action potential modulation of Ca2+ influx and neurotransmitter 
release, in response to transmitter released by the terminal itself (autoreceptors) 
or other terminals (heteroreceptors).
Receptors fall into two categories :-
a) Metabotropic receptors (Ross, 1989) are coupled via GTP-Binding (G-) 
proteins to effectors, which enzymically produce intracellular second messengers. 
The metabotropic receptors are a large class, they include families of receptors, 
each of which slowly respond (ie persist seconds or minutes) to one the small 
molecule neurotransmitters (eg the muscarinic acetylcholine receptor family 
respond to acetylcholine [ACh]) either to open or close ion channels or to 
regulate and modify cellular proteins in coordinated responses (reviews: Bourne 
and Nicoll, 1993; DeVries and Baylor, 1993; He and Rosenfeld, 1991; Ross, 1989).
b) Ionotropic receptors are ligand-gated ion channels (LGIC) which span the 
plasma membrane, when the relevant small molecule neurotransmitter binds to 
the extracellular recognition sites long range conformational changes cause the 
rapid opening of a central pore (see nicotinic acetylcholine receptors [nAChR], 
section 1.2,1.3,1.4). The ion flux through this pore is transient before closure and 
LGICs produce rapid synaptic potentials lasting only milliseconds (Sakmann, 
1992). Like metabotropic receptors, a family of LGICs are expressed to recognize 
each of the small molecule neurotransmitters, the pharmacology and functional 
behaviour of each receptor subtype varies, providing a wide range of responses 
to different conditions (sections 1.2,1.3). The LGICs are divided on the basis of 
sequence identity and structural similarity into 2 superfamilies
i) the glutamate receptors [Gasic and Hollmann, 1992; Sommer and Seeburg,
1992]: NMD A (N-methyl-D-aspartic acid), AMPA (o'-amino-3-hydroxy-5-methyl-4- 
isoxazole propionic acid) and kainate classes
ii) nAChR (section 1.3),serotonin/5-HT (5-hydroxytryptamine), GABA (Wisden 
and Seeburg, 1992) and glycine (Betz, 1992) receptors
There is little sequence similarity, but some structural similarity between the 2 
superfamilies (Unwin 1993a). The LGICs are also compared with the porin 
channel, which is non-selective to ions, and the voltage gated channels, which are 
far more ion selective than LGICs (Jessel and Kandel, 1993). The LGICs are 
charge specific, they can be: either cation selective (depolarizing, tending to an 
excitatory synaptic potential), eg ACh, 5-HT and glutamate receptors; or anion 
selective (hyperpolarizing, tending to an inhibitory synaptic potential), eg glycine 
and GABAa channels (Sakmann 1992; Unwin, 1993a).
81.2 The composition and structure of nAChRs
The nAChRs are the best characterized family of LGICs for a variety of historical 
reasons
a) the high concentration of a neuromuscular form of nAChRs in the electric 
organs of the electric fish Torpedo, Narcine and Electrophorus electricus, which 
allowed their purification during the early 1970’s (Changeux, 1981; Conti-Tronconi 
and Raftery, 1982),
b) the abundance of the neuromuscular form of nAChR in mammalian muscle 
relative to the neuronal forms found in the brain (Changeux, 1981; Karlin 1990),
c) the early discovery of natural neurotoxins, especially the snake toxins such as 
a-Bungarotoxin from Bungarus multicinctus, which were used as a pharmacological 
probes (Lee, 1979; Wonnacott, 1987b) and affinity ligands (Norman et al, 1982; 
Wonnacott et al, 1982),
d) the autoimmune disease myasthenia gravis, which is characterized by the 
production of antibodies which recognize the muscle nAChR (Erlanger et al, 
1984; Vincent, 1980). The antibodies produced in this disease initiated the 
immunological investigation of the nAChRs (Lindstrom, 1984; Lindstrom et al, 
1987,1991). Neuronal nAChR levels are abnormal in important diseases including 
Alzheimer’s and Parkinson’s disease (Aubert et al, 1992; Giacobini, 1992; Kellar 
and Wonnacott, 1990; Lange et al, 1991; Perry et al, 1987).
e) nicotine (figure 1.3), the agonist which defines the family, is the major active 
component amongst the 1000s of tobacco smoke ingredients: it causes a variety 
of psychoactive effects (Balfour, 1982; Clarke, 1987; Wonnacott et al, 1990b) 
including addiction (Benowitz, 1988; Pommerleau, 1984). The drug is very
Figure 1.3 Nicotine
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Nicotine is the agonist which defines the nicotinic acetylcholine receptors. The 
molecular structure is shown in figure 1.3.Note the chiral centre, there are + and 
- isomers, the latter has far greater psychoactive and pharmacological potency 
(see references to smoking and addiction in the text). Produced using Hyperchem 
for Windows - Autodesk.
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popular, at present tobacco is consumed by one third of the population of most 
western countries and extensively worldwide, prompting considerable and 
continuous interest in its effects upon the brain and the body (Bock and Marsh, 
1990; Clark, 1991; Lippiello et al, 1992).
In 1980 Raftery et al published the results of N-terminal amino acid sequence 
analysis of each Torpedo subunit, the corresponding oligonucleotide probes were 
used to clone and sequence the entire subunit genes (Ballivet et al, 1982; Noda 
et al, 1982, 1983a; Sumikawa et al, 1982) initiating extensive cross hybridization, 
cloning and immunopurification studies, which have reported nAChR subunit 
families in several species (Deneris etal, 1991; Lindstrom et al, 1987; Luetje et al, 
1990a; Role, 1992; Sargent, 1993). There are 5 homologous (Noda et al, 1983b) 
subunit subtypes (a l, SI, y, <5, e), which are expressed in the 2 neuromuscular 
forms of nAChRs
i) a l 2Sly<5, extrasynaptically or at developing synapses and
ii) a l 2£ le 6 ,a t  mature synaptic junctions (Hall and Sanes, 1993)
The neuronal nAChRs, which have been discovered, are composed either entirely 
of a subunits (rat:-a2 to oil; chick:- a2 to oiS) or of a  subunits and S subunits (£2 
to £4) (Deneris et al, 1991; Sargent, 1993). The subunits are homologous (Bossy 
et al, 1988; Cockcroft et al, 1992; Deneris et al, 1991; Sargent, 1993), but there is 
greater sequence similarity within subunit classes than between subunit classes. 
The oi subunits are distinguished by a pair of consecutive cysteines at 192 and 193 
(!Torpedo amino acid numbering), which are in the vicinity of the ligand binding 
site (Kao et al, 1984). Other affinity labelling experiments indicate that the acetyl
group binds close to the cysteine pair on the a subunits (Galzi et al, 1991a), 
where the quaternary ammonium binds is unclear (Unwin, 1993a), but it may well 
be to a negative subsite formed at least partly by acidic residues on the adjacent 
subunit (Unwin, 1993a). Galzi et al (1991a) demonstrated that there are at least 
two acetylcholine binding sites per receptor and the associated a  subunits are not 
adjacent. The £ subunits were originally defined by the ability of £2 to substitute 
for SI in functional receptors (Deneris et al, 1988). The S subunits may influence 
numerous receptor properties (Cachelin and Jaggi, 1991; Papke and Heinemann, 
1991). The a4£2 neuronal nAChR subtype has been shown to be a pentameric 
(Anand et al, 1991; Cooper etal, 1991) hetero-oligomer, and the muscle form also 
appears to be pentameric (above), but there is no evidence that any other 
neuronal nAChR is pentameric, although this extrapolation is frequently 
suggested. The subunit composition of neuronal nAChRs varies:
a) A single a subunit subtype may be expressed, eg oocyte expression combined 
with whole cell recording studies confirm that a l  (Couturier et al, 1990a), and 
perhaps a4 (Deneris etal, 1991) can be expressed as functional multimeric homo­
oligomers,
b) A pair of subunits, one a and one £ subunit subtype may be co-expressed, eg 
a.2, a.3, a4 have been co-expressed in pairwise combinations with £2 and £4 
subunits as functional multimeric hetero-oligomers ie a2£2, a3£2, o4£2, a2£4, 
ce3£4, a4£4 (Ballivet et al, 1988; Boulter et al, 1987; Couturier et al, 1990b; 
Deneris et al, 1988; Duvoisin et al, 1989; Wada et al, 1988; review Deneris et al,
1991). There is some evidence that receptors with different stoichiometries can 
sometimes be found or expressed, eg the a4£2 subtype, which was characterized 
in early experiments seemed to be composed of 2:3 o4:£2 subunits (Anand etal,
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1991; Cooper et al, 1991), but there is some evidence that a q4 3£22 can be 
expressed, which has different conductance characteristics (Papke et al, 1989).
A pair of a subunits subtypes may be co-expressed. Immunoprecipitation 
experiments indicate a3a5 and a4a5 combinations can be expressed in vivo 
(Conroy etal, 1992), and antisense oligonucleotide deletion experiments indicate 
the in vivo coassembly of a3al (Listerud et al, 1991) and c/7a8 (Schoepfer et al, 
1990) combinations.
c) More than 2 subunit subtypes can be expressed, providing some as are 
included, eg the in vivo expression of single multimeric hetero-oligomers 
containing:- o?3, a5 and £4 (Vemallis et al, 1993); and a3, o4 and o?5 (Conroy et 
al, 1992) have been demonstrated by immunoprecipitation experiments.
Each subtype combination has distinctive pharmacological and conductance 
characteristics (MacAllan et al, 1988; Luetje et al, 1990b; Deneris et al, 1991;
Sargent, 1993) which are being evaluated (eg Amar et al, 1993). Despite the
bewildering array of functionally expressed receptors, co-expression seems neither 
random nor non-specific: there are many subunit subtype combinations which do 
not produce functional receptors (Deneris et al, 1991) and a single neuron may
express more than one receptor combination, yet maintain receptor segregation
(Vemallis et al, 1993).
The 3-dimensional appearance of the acetylcholine receptor is increasingly being 
resolved (now 9A: Unwin, 1993b) by electron microscopy of semicrystalline arrays 
of the Torpedo electric organ form (Heuser and Salpeter, 1979). This resolution
is inadequate to solve the nAChR structure, but the information gained does 
contribute to the experimental verification of theoretical topographical models 
(Unwin, 1993a). Hydropathy plots (Kyte and Doolittle, 1982) indicate that all 
nAChR subunits, and indeed all LGICs, have 4 significant hydrophobic stretches 
which are thought to span the plasma membrane, from the extracellular N- 
terminal end they are named M1-M4 (reviews: Changeux et al, 1992b; Connolly, 
1989; Galzi et al, 1991b; Guy and Hucho, 1987; Unwin, 1993a). Various methods 
have been employed to establish topography, the present consensus favours the 
model displayed in figure 1.4 for each subunit of the entire receptor.
The transmembrane region can be analyzed in greater detail. There is increasing 
evidence (Ortells and Lunt, 1993, in preparation) that the membrane spanning 
regions M l, M3 and M4 are not a-helical, Unwin (1993a) suggests they form a 
continuous rim of S-sheet as has been found in the solved structures of 2 
pentameric toxin complexes (Sixma et al, 1991; Stein et al, 1992). There is 
considerable evidence to indicate that the major contributor to the pore lining is 
the M2 region. Imoto et al (1986) used single-channel conductance measurements 
(Neher etal, 1978; Neher and Sakmann, 1976) of receptors composed of chimeric 
subunits to demonstrate that the M2 region determined channel conductance. 
Labelled channel blockers penetrate the open pore and bind to M2 residues 
(Galzi et al, 1990; Giraudat et al, 1986; Hucho et al, 1986; Leonard et al, 1988; 
Revah et al, 1990). Site-directed mutagenesis of the M2 region can affect:- the 
binding of channel blockers (Changeux et al, 1992a; Chamet et al, 1990; Leonard 
et al, 1988), channel conductance (Imoto et al, 1988; Villarroel et al, 1991; 
Villarroel and Sakmann, 1992), channel selectivity (Galzi et al, 1992) and






Figure 1.4 displays the 4-helix folding model (Noda et al, 1983; Devillers-Thie' ry 
et al, 1983; Claudio et al, 1983), now favoured (Galzi et al, 1991; Changeux et al, 
1992; Unwin, 1993) over a variety of models suggested in the 1980’s (Popot and 
Changeux, 1984; Ratman et al, 1986a; McCrea et al, 1987). The acetylcholine 
(ACh) binding site, the glycosylation (Glv) sites (Popot and Changeux, 1984) and 
the main immunogenic region (Lindstrom, 1984;Ratnam etal ,  1986b) are located 
in the extracellular N-terminal region. The polypeptide spans the membrane at 
regions M1-M4. Phosphorylation (P) sites (Huganir etal,  1986; Swope etal,  1992) 
and the amphipathic region (Dwyer, 1988; Roth et al, 1987) are located in the 
M3-M4 cytoplasmic loop, the C-terminus is extracellular (McCrea et al, 1987).
pharmacological properties, eg channel desensitization (Bertrand et al, 1992; 
Revah etal, 1991). The majority of these experiments indicate that the secondary 
structure of the M2 region is a-helical (Changeux et al, 1992a, b; Galzi et al, 
1991b; Unwin, 1993a) and ion flux is controlled by the rings of amino acids which 
face the lumen (Changeux et al, 1992b; Chamet et al, 1990; Galzi et al, 1991a, b, 
1992; Imoto et al, 1988; Konno et al, 1991; Pedersen et al, 1992; Villarroel and 
Sakmann, 1992). Figure 1.5 displays a possible arrangement for the membrane 
spanning region of the receptor. The control of channel opening is not yet 
understood (Changeux et al, 1992b; Galzi et al, 1991b; Unwin, 1993a), but it 
seems to involve the highly conserved Ml region (Lo et al, 1991).
1.3 Pharmacology and modulation of the nAChR
Ligands bind to receptors and induce (agonist) or block (antagonist and channel 
blocker) or modulate (below) a functional response. Each new functional nAChR 
combination is pharmacologically characterized (see subunit composition, section 
1.2), and there is a continuous effort to find and characterize new ligands (eg 
methyllycaconitine: Jennings etal, 1986; MacAllan et al, 1988; Ward et al, 1990), 
and ligand derivatives (eg anatoxin-a derivatives: Wonnacott et al, 1992). Ligand 
binding (review: Lunt, 1987; Yamamura etal, 1985) can exploit subtle differences 
between subunit subtypes to distinguish receptor combinations (Clarke, 1992; 
Deneris et al, 1991; Luetje et al, 1990b; MacAllan et al, 1988; Wonnacott, 1987). 
The receptor combinations responsible for high affinity [3H]-nicotine binding are 
of particular interest, because of the wealth of localization and pharmacological
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Figure 1.5 Diagrammatic representation of the distribution of the 
membrane spanning hydrophobic regions of the nAChR
Figure 1.5 is a diagrammatic representation demonstrating a possible distribution 
of the hydrophobic regions M1-M4 as they span the membrane, based on Unwin 
(1993a). The M2 region is probably a-helical and pore lining, the M4 region 
seems to be facing the lipid and M l, M3 and M4 are of undetermined secondary 
structure. The 2 a  subunits are not adjacent. Kuhse et al (1993) review the 
assembly of pentameric LGICs.
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(ie competitive binding, etc) data using this ligand (section 1.4). The a42£23 is 
mainly, if not wholly (>90%), responsible for high affinity [3H]-nicotine and the 
high affinity [3H]-cytisine binding (Flores et al, 1992; Pabreza et al, 1991; 
Nakayama et al, 1991; Whiting et al, 1987a, b; Whiting and Lindstrom, 1986a, 
1987, 1988). Two isoforms of the rat o4 are expressed (o4-l and 0:4-2) due to 
splicing variation during transcription, however all evidence to date indicates that 
the two forms of o4£2 are identical in terms of distribution, pharmacological 
properties, functional responses and immunological detection with the antibodies 
used in this project, (Connolly et al, 1992).
Receptor modulation and regulation may be homospecific (self regulation) or 
heterospecific (trans-regulation by other receptors) and can also be divided into 
receptor turnover (Hollenberg, 1985a) and receptor modification (Hollenberg, 
1985b). Examples of receptor modification include:-
a) Prolonged agonist exposure results in reversible receptor desensitization (Katz 
and Thesleff, 1957), first to an intermediate desensitized state (I), then over a 
longer time period to a fully desensitized state (D) (see Changeux et al, 1992b; 
Changeux and Revah, 1987).
b) Certain hormonal steroids, eg progesterone, appear to bind to nAChRs and 
reversibly modify the receptor to inhibit ACh evoked responses, this modulation 
does not involve channel blocking, desensitization or competitive inhibition 
(Bertrand et al, 1991; Valera et al, 1992).
c) Calcium ions bind to some neuronal nAChRs at an extracellular site and at 
physiological concentrations potentiate ACh evoked ion flux (Mulle et al, 1992b; 
Vemino et al, 1992). Some neuronal nAChRs are permeable to calcium (Mulle
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et al, 1992a; Vemino et al, 1992) and this allows the intracellular modulation 
which calcium ions can initiate (Mulle et al, 1992a), possibly including 
neurotransmitter release (Wonnacott et al, 1990a) and receptor regulation 
(DeLorme and McGee, 1988; Mulle et al, 1992a).
d) Several agents, eg Substance P (Margiotta and Berg, 1986; Simmons et al, 
1990) are known heterospecifically to modulate receptor activity by changing its 
tendency to desensitization via second messenger systems (Changeux, 1981). Often 
nAChR phosphorylation is changed: desensitization increases with increasing 
phosphorylation of the M3-M4 transmembrane section (Huganir and Greengard, 
1990; Steinbach and Zemple, 1987; Swope et al, 1992).
Examples of regulation of receptor expression include
a) Metabotropic receptor regulation of receptor expression via second messenger 
systems (Bourne and Nicoll, 1993; DeVries and Baylor, 1993; He and Rosenfeld, 
1991; Ross, 1989).
b) The atypical agonist-induced upregulation of the o4£2 receptor which is 
observed in some brain regions after chronic exposure (Flores etal, 1992; Hagino 
and Lee, 1985; Kellar et al, 1989; Marks et al, 1983,1986; Martino-Barrows and 
Kellar, 1987; Pauly et al, 1991; Sanderson et al, 1993). The high affinity agonist 
binding to the desensitized form of the receptor (Changeux et al, 1992b; Changeux 
and Revah, 1987) may be the trigger (Schwartz and Kellar, 1985; Wonnacott,
1990) for this upregulation. The functional significance of upregulation remains 
a contentious issue, some groups suggest that chronic agonist exposure causes the 
numbers of functional receptors to fall (Hillard and Pounds, 1993; Hulihan-Giblin 
et al, 1990; Lapchak et al, 1989; Lukas, 1991; Marks et al, 1985), whilst others
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show an upregulation of functional response (Clarke et al, 1988; Fung, 1989; Ksir 
etal, 1987; Rowell and Wonnacott, 1990; Wonnacott et al, 1990a). These results 
may reflect differences in:-
i) experimental protocol (eg mode of agonist delivery)
ii) brain region
iii) agonist type
iv) receptor type, ie other receptors may (Harsing et al, 1992; Stolerman et al,
1992) or may not (Grady et al, 1992) contribute to the functional response.
At present, it is difficult to resolve the issue, because no available technique can 
independently confirm the functional activity of the a4£2 receptor population in 
a particular tissue (reviews: Drasdo, 1993; Sanderson, 1993). 
c) Other chemicals, which are normally present in the brain (eg neuronal growth 
factor: Rogers et al, 1992; Whiting et al, 1987c), or are introduced by consumption 
(eg ethanol: Yoshida et al, 1982), regulate nAChR expression.
1.4 Immunology and localization of nAChRs
For historical reasons (section 1.2), immunological probes were raised against 
nAChRs before any other LGIC. Affinity and immunoaffinity purification of 
detergent solubilized nAChRs allowed the production and screening of 
immunological probes (Lindstrom, 1984; Lindstrom et al, 1987, 1991). This 
approach proved very powerful and immunological cross-reaction allowed 
antibodies to be raised against different receptor subunits from a variety of 
species (Lindstrom et al, 1987, 1991). Epitope mapping was achieved using
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immunological protection techniques (Tzartos etal, 1981;Tzartos and Lindstrom, 
1980) and peptide fragment analysis (Maelicke et al, 1989). Anti-idiotypic 
antibodies have been raised and show anti-nAChR binding (Lippiello etal, 1991), 
which seems to include a4£2 recognition (Fluhler et al, 1992). More recently, as 
subunits have been sequenced, it has been possible to raise antibodies against 
specific receptor regions: the M3-M4 intracellular region is popular, because it is 
relatively accessible and has little sequence similarity between subunit subtypes 
(Flores et al, 1992; Hill et al, 1993; Rogers et al, 1991b). Anti-nAChR antibodies 
have been used to immunoisolate receptors, which can then be pharmacologically 
(Flores et al, 1992; Whiting and Lindstrom, 1986a), immunologically (Whiting et 
al, 1987b) and structurally (Maelicke et al, 1989; Whiting and Lindstrom, 1986b,
c) characterized.
Some anti-nAChR antibodies have been used for immunohistochemical studies 
of brain slices to localize the regional distribution of receptor subunits subtypes: 
the antibodies were fluorescence labelled (Fluhler et al, 1992; Lippiello et al,
1991), radiolabelled (Swanson et al, 1987), enzymically labelled (Deutch et al, 
1987; Hill et al, 1993) and colloidal gold labelled (Hill et al, 1993). These 
experiments have been paralleled by mRNA hybridization (Daubas et al, 1990; 
Morris et al, 1990; Wada et al, 1989, 1990) and radioligand binding (eg 
acetylcholine, nicotine and a-bungarotoxin: Clarke et al, 1985) to brain slices. 
Radioligand binding provides pharmacological information which can be used to 
localize those receptor isoforms which can be distinguished (section 1.3), this 
information contrasts with that from the former two techniques:- the distribution 
of subunit subtypes only gives limited information about the distribution of
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receptor isoforms, because so many receptor combinations can be expressed by 
common or neighbouring neurons (section 1.3). The distribution of high affinity 
[3H]-nicotine binding is very interesting, because it may reflect a single receptor 
isoform (o4£2, see section 1.3) and there is a wealth of historical information in 
a variety of species (Wonnacott, 1987a), eg high affinity [3H]-nicotine binding 
assays have been performed upon preparations of different human brain regions 
(Benwell and Balfour, 1985a), comparing smokers with non-smokers (Benwell et 
al, 1988).
The subcellular localization of nAChRs has been investigated by a variety of 
approaches :-
a) Immunostaining and mRNA hybridization techniques yield direct localization 
data:-
i) Some LGICs have been localized by histochemistry and immunoelectron 
microscopy of brain slices (Dechesne et al, 1990; Rogers et al, 1991a; Somogyi et 
al, 1989). In 1987 Swanson eta l,used 125I labelled monoclonal antibody (mAb) 270 
to examine the distribution of the £2 subunit in tissue slices at the light 
microscopy level, a virtually identical distribution described by Wada et al, (1989) 
using the more sensitive histochemical mRNA hybridization technique. These 
techniques were of insufficient to examine subcellular distribution, but sometimes 
the regional distribution of a receptor can be used to deduce its subcellular 
localization (Swanson et al, 1987). Recently, Hill et al (1993) performed 
immunoelectron microscopy studies upon tissue slices and obtained very similar 
results for the regional distribution of the £2 subunit. Hill et al (1993) raised 
antibodies to the M3-M4 region of the £2 subunit and then used two
immunological detection m ethods: peroxidase-linked nickel-enhanced 
[3,3’ ,4,4’tetraaminobiphenyl]-tetrahydrochloride (3,3’-Diaminobenzidine, [DAB]) 
precipitation and silver-amplified immunogold detection; the latter technique is 
less sensitive, because immunogold labelling is less efficient, but localization can 
be more refined, because discrete particles are detected instead of a diffuse stain 
(see appendix A.3). At the subcellular level, both techniques revealed extensive 
cytoplasmic 62 staining representing reserve, redundant or abortive expression; 
however no 62 was detected in the Golgi and very little was found in the vicinity 
of synapses using both pre and postembedding procedures. This result may reflect 
detection problems or possibly non-synaptic localization (Sargent et al, 1989; 
Umbriaco et al, 1991). Hill et al (1993) did find some evidence for some 
postsynaptic 62 expression in cortical neurophil dendrites, but no presynaptic 
terminal expression. These experiments are inconclusive with respect to a462 
localization, 62 is expressed in other receptor subtypes and the results can be 
interpreted as showing pre- or post- or non-synaptic localization.
ii) The immunological staining of cultured neurons has been used to give nAChR 
localization information (Lippiello et al, 1991; Stollberg and Berg, 1987). These 
experiments have not resolved the issue of o462 localization, in some cases (eg 
Lippiello eta l, 1991) they produce a localization profile for a particular cell line, 
but even this information must be evaluated - the Langone/Bjercke antibodies 
used by Lippiello eta l {1991) do recognize the a462 subtype, but the recognition 
is not necessarily exclusive to this nAChR subtype.
iii) The distribution of nAChRs on subcellular particles has rarely been 
investigated by electron microscopy: Lentz and Chester (1977) reported the 
catalysis by peroxidase conjugated of-bungarotoxin of DAB deposition onto
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postsynaptic densities associated with synaptosomes; Ratnam et al (1986a) 
demonstrated electron microscopy of immunogold stained postsynaptic vesicles 
formed by homogenization of neuromuscular junctions. Preliminary experiments, 
performed in our laboratory by Thome (1989, person, comm.) using immunogold 
electron microscopy to examine the distribution of the a4S2 subtype in subcellular 
particles, were compromised by a high non-specific signal.
b) Preliminary experiments, performed in our laboratory, seemed to show the 
immunoisolation of subcellular particles (synaptosomes) bearing the a4£2 
receptor; these synaptosomes were characterized for neurotransmitter content 
(Abstracts: Irons e ta l, 1988,1989). The results indicated some o4£2 localization 
to presynaptic terminals, however there was considerable experimental variation 
(Wonnacott person, comm.).
c) Ligand binding to subcellular fractions can localize receptor subtypes, if the 
ligand can distinguish the subtype. This approach has been used to examine o4£2 
localization by virtue of its high affinity [3H]-nicotine binding. Early binding ligand 
studies to subcellular fractions indicated some a4£2 were presynaptic (Benwell 
and Balfour, 1985b; Rapier eta l, 1990; Yoshida and Imura, 1979). This result was 
recently reinforced by Thome eta l (1991) and Bames e ta l (1992) who examined 
pH]-nicotine binding to subcellular fractions prepared on Percoll gradients which 
offer superior fractionation of synaptosomal material (Dunkley et al, 1987,1988), 
however the results of [3H]-nicotine binding studies to Percoll fractions may have 
been compromised by the specific binding of [3H]-nicotine to Percoll (Wilkie and 
Wonnacott, 1991).
d) Functional assays can be used to detect and localize nAChRs. Nicotinic ligands 
have been shown to induce neurotransmitter release from synaptosomes prepared
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by subcellular fractionation (Rapier et al, 1988,1990; Rowell and Winkler, 1984; 
Wonnacott et al, 1989, 1990a). This is interpreted by the authors as confirming 
presynaptic nAChR localization and indicating that their role is to evoke or to 
modulate neurotransmitter release. It is possible that the nicotine acts on other 
channels to cause release, but the authors argued that the range of 
neurotransmitters, which are released in response to nicotinic agonists, and the 
accumulating pharmacological data characterizing release, strongly indicates that 
presynaptic a4£2 nAChRs are responsible (Drasdo, 1993; Rapier et al, 1990; 
Sanderson, 1993; Wonnacott et al, 1989). Patch clamp analysis indicates functional 
o4£2 nAChRs can be found postsynaptically on the soma (Mulle and Changeux, 
1990) and dendrites (Aracava et al, 1987) of neurons.
e) Lesion experiments can be used to derive localization information by observing 
the resulting changes in receptor concentration in brain regions which contain 
different parts of the damaged neuron. Some lesion experiments show 
postsynaptic o4S2 localization (Schwartz et al, 1984) others show presynaptic a4£2 
localization (Clarke et al, 1986; Clarke and Pert, 1985; Schwartz et al, 1984), this 
indicates that the receptor is found in different locations in different neurons, 
perhaps performing different functional roles (Papke, 1993).
f) A significant proportion of the nAChRs, which bind [3H]-nicotine that are lost 
during Alzheimer’s disease seem to be located presynaptically (Aubert etal, 1992; 
Giacobini, 1992; Kellar and Wonnacott, 1990)
It has been suggested that presynaptic a4&2 represent as much as 30% of the 
total a4£2 receptor population in some brain regions (Wonnacott, 1987a), this 
would indicate a significant role in synaptic modulation.
1.5 Synaptic modulation
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The chemical synapse has multiple and dependent levels of regulatory control
a) many neurotransmitters are available (McGeer et al, 1987), each is recognized 
by a family of receptors consisting of several receptors subtypes, composed of 
distinct subunit combinations, with distinct pharmacological and perhaps 
functional profiles,
b) the neurotransmitter interacts with pre- or post synaptic receptors, which can 
be metabotropic or ionotropic, thus gradual and rapid changes can be made to 
either cell,
c) neuromodulators and hormones can regulate receptor responses (section 1.3),
d) combinations of neurotransmitters and neuromodulators can be released at the 
same synapse resulting in a composite response (O’Donohue et al, 1985),
e) the number of quanta released can be facilitated or depressed (Zucker, 1989),
eg by changes in Ca2+ concentration,
f) the number of functional receptors can be altered, either by expression 
(permanent) or desensitization (temporary), (section 1.3). This is probably an 
important factor because the number of receptors can be low, some workers 
(Edwards et al, 1990; Larkman et al, 1991) report evidence from mammalian 
central nervous system (CNS) that the release of one neurotransmitter quantum 
(1 vesicle) can be sufficient to saturate all postsynaptic receptor sites (Stevens,
1993),
g) developmental changes in the synapse can result in changes in receptor 
expression (Goodman and Shatz, 1993) and even in the use of different
neurotransmitters (Landis, 1980; Patterson and Nawa, 1993),
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h) retrograde signals can result in the modulation of the presynaptic terminal by 
the post-synaptic cell, eg nitrous oxide is a retrograde messenger which causes 
long term potentiation (facilitation of release) in the presynaptic terminal (Jessel 
and Kandel, 1993; Stevens, 1993),
i) synaptic plasticity (Goodman and Shatz, 1993; Hall and Sanes, 1993) involves 
the precise organization of synaptic proteins by the bidirectional flow of 
information across the synapse (Hall and Sanes, 1993; Jessel and Kandel, 1993). 
This refinement and remodelling of synaptic connections continues throughout life 
(Edelman, 1993), reflecting the ability of the brain to adapt to experience 
(Patterson and Nawa, 1993).
Classically neuronal circuitry has been elucidated in simple neuronal systems such 
as Aplysia (Abrams et al, 1991) or, more recently, in model systems of low 
complexity where input can be quantitatively controlled and where the functional 
context of synaptic operations is clearly defined, eg in the visual and olfactory 
systems (review: DeVries and Baylor, 1993). It is a greater challenge to 
understand the interactions between neurons in other brain regions, which can 
involve 1000s or even 10,000s of synaptic connections (Edelman, 1993)! An 




If the effects of nicotine upon the brain are to be elucidated, it is fundamentally 
important to define the functional role of nAChRs within complicated neural 
circuits. An essential aspect of nicotinic neurotransmission is receptor location; 
the precision of models for nicotinic responses will increase if receptor subtypes 
can be localized and their distribution correlated with neurotransmitters and other 
receptors. It was the aim of this project to develop the techniques used for 
preliminary experiments in our laboratory (section 1.4 aiii, b, c) to dissect the 
functional role of an nAChR isoform by examining its subcellular distribution, and 
by immunopurifying and characterizing subcellular particles which bore the 
receptor. The a4S2 subtype was chosen, because of:-
i) its distinct pharmacological profile,
ii) the wealth of information, generally and within our group, about this isoform.
iii) the controversy surrounding the locations and roles of this isoform.
The project was divided into 3 experimental aims:-
a) To use physical separation techniques to reinforce the subcellular distribution 
of the a4£2 isoform.
b) To use immunoaffinity techniques to immunopurify subcellular particles 
bearing the a4£2 isoform.
c) To develop immunoelectron microscopy techniques to examine subcellular 
particles, from brain preparations and ultimately from immunopurified subcellular 
particles.




High speed centrifugation was performed with a Beckman L5-50B Ultracentrifuge 
(Beckman Instruments), at 4°C using pre-cooled Beckman rotors: either a SW50.1 
swing-out rotor holding 6 full Beckman Ultraclear centrifuge tubes (13x51mm, 
5.2ml), or a SW28 swing-out rotor holding 6 full Beckman Ultraclear centrifuge 
tubes (25x89mm, 40ml), or, when these volumes were inappropriate, a Ti50 fixed 
angle rotor holding samples (0.5-6ml) in Polycarbonate tubes (Beckman). 
Medium speed centrifugation was performed with a Sorvall RC-5B Refrigerated 
Superspeed centrifuge (Du Pont Instruments, Du Pont [UK] Ltd, Stevenage, 
Hertfordshire), at 4°C using pre-cooled fixed angle Sorvall rotors: either a GSA 
rotor (6x250ml Sorval tubes), or a SA600 rotor (12x50ml Sorvall tubes), or a SM 
24 rotor (outer ring - 16x14ml Sorvall tubes).
Low speed centrifugation of small volume samples was performed with a MSE 
Micro Centaur microfuge and a Anderman Eppendorf Centrifuge (5415) varifuge, 
if required, the entire centrifuge pre-cooled to 4°C for 4 hours before use. 
Samples were placed in Eppendorf microtest tubes (306/0308, BDH, Lutterworth, 
Leicestershire).
Colorimetry
When possible, samples were placed in 96 well microtitre plates (Titretek 
multidish [flat bottom] Nunc: Life Technologies Gibco Ltd, Paisley) and their 
optical density measured using a Titretek multiscan MCC EFLAB (ICN flow,
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High Wycombe, Bucks). When a change of optical density was being measured 
or the relevent wavelength was not in the titretek repertoire, samples were placed 
in plastic cuvettes and measured with a Pye Unicam SP6-450 spectrophotometer 
(Pye Unicam Ltd, Cambridge) equipped with an electronic recorder.
Electron Microscopy
The resin was cured in Gelatin capsules (0.3ml A0487, Biorad: Fisons) or 
Eppendorf microtest tubes or a Small flat embedding mould (Biorad A0520) 
using a Mini/696/A1 incubator (Genlab, Widnes, UK). Glass knives for sectioning 
were produced on an LKB Knifemaker (LKB-Pharmacia 7801A) and LKB Trufs 
(Biorad: Fisons A0584) were attached with wax. Sections were cut using a 
Reichert OMU 3 Ultramicrotome and mounted on nickel or copper grids 
(Biorad). Plastic film was cut using a Diamond Scriber (Biorad: Fisons A0564). 
Carbon coating was performed under vacuum in a Speedyvac Coating Unit 12E6 
(Edwards High Vacuum Ltd). Light microscopy was performed at xlOO by oil 
immersion microscopy (light microscope - Carl Zeiss Jena Ltd, CZ Scientific 
Instruments Ltd). Transmission Electron microscopy was performed using a 1200 
EX JEOL electron microscope (JEOL, Watchmead, Herts). Photographs for 
analysis were made from developed film from the 1200 by projection onto 
photographic paper using a DeVere 504 Projector (Varicon) regulated by an 
Electronic timer (Rayco instruments Ltd).
Filtration
Filtration in ligand binding assays was performed using a Brandel Cell Harvester 
M 24R (Brandel: Semat, Herts) under a vacuum, of approximately 15 mm Hg,
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provided by an Edwards 5 two stage pump (Severn Science Ltd, Thomberry, 
Bristol). All other filtration was performed using a Buchner filter (Fisons).
Mixing and tissue dispersion
Tissues were homogenized using a glass-Teflon homogeniser, total clearance 
0.31mm, attached to a varicontrol motor, (Citenco F.H.P. motors).
Preparations were mixed using: a Whirlimixer (Fisons, Loughborough) when 
speed was important and tissue damage was not important; a Pasteur pipette or 
Gilson pipette for more gentle, less rapid mixing; or a homogeniser (as above) 
when specimen disruption was the primary concern.
Preparations were shaken using: a Luckham R100 Rotatest Shaker (Luckham Ltd: 
Denley Instruments Ltd, Billingshurst Sussex) for routine agitation; an empty 
water bath was used for gentle horizontal shaking of nitrocellulose sheets, etc; a 
home-made end-over-end shaker was used for very gentle agitation, eg for the 
attachment of material to beads or for the preparation of material for electron 
microscopy.
Magnetic separation
The isolation of magnetic beads was achieved using a Dynal MPC-1 magnetic 
particle concentrator (Dynal, New Ferry, Wirral).
Polyacrylamide gel electrophoresis and western transfer
The Phast system (Pharmacia [GB] Ltd, Hounslow, Middlesex) was used to
perform PAGE, transfer onto nitrocellulose was achieved using the add-on
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transfer unit. The Mighty Small II Minigel system (SE 250 Hoefer Scientific 
Instruments) was also used to perform PAGE, transfer onto nitrocellulose was 
achieved using the TE series Transphor electrophoresis unit (Hoefer).
Preparation of solutions
a) The Osmolarity of solutions was measured using a freezing point osmometer 
(Camlab Ltd, Roebling).
b) Radioligands and (-) nicotine were dispensed using a Drummond 10/d micro­
dispenser.
c) Percoll gradients were layered using a Gilson Minipuls 2 Peristaltic pump 
(Gilson: Anachem, Luton) with a fine bore 25Gxl5/16 inch Sabre needle 
(Gillette UK Ltd, Isleworth, Middlesex, UK)
Radioactivity detection
a) A 1600 TR, Tri-Carb Liquid Scintillation analyzer (Packard Instrument 
Company: Canberra) was used to measure Tritium.
b) A 1277 Gammamaster automatic gamma counter (Wallac: LKB-Pharmacia, 
Milton Keynes) was used to measure 125I.
c) 125I labelled material was detected by autoradiography using Tritium sensitive 





Electrophoresis sample buffer (prepared fresh) contains: O.IMTris, O.IMbicine, 
10% w/v sucrose, 2% w/v SDS, 5% v/v S-mercaptoethanol, 0.05% w/v
Bromophenol blue.
PBS - lOmM Phosphate Buffered Saline (prepared fresh) contains: 8mM 
potassium dihydrogen phosphate (KH2P 0 4), 2mM dipotassium hydrogen 
phosphate (K2HP04.3H20), 150mM sodium chloride (NaCl). pH adjusted to 7.4 
Tris/HEPES (stored at -20°C, or < 5days at 4°C) contains: 118mM sodium 
chloride (NaCl), 4.8mM potassium chloride (KC1), 2.5mM calcium chloride 
(CaCl2), 20mM N-[2-Hydroxyethyl] piperazine-N-[2-ethane sulfonic acid] 
(HEPES), 200mM Tris, O.lmM Phenylmethylsulfonyl fluoride (PMSF), 0.01% 
sodium azide. pH adjusted to 7.4
Electron microscopy reagents
Epoxyresin (Epoxyresin Kit TK1, medium hardness Araldite CY 212 resin from 
TAAB Laboratories Eq Ltd.) cured by heat cure (48 h 60°C). LR White resin 
(LR White resin medium hardness L012, TAAB Laboratories Eq Ltd) cured by 
cold cure (24h, -15°C) using the accelerator or by heat cure (24h, 55°C). 
Colloidal gold labelled antibodies and Avidin - see immunological reagents. 
Reynolds lead citrate was prepared as follows. Lead citrate (2.66g) was mixed 
with sodium citrate (3.52g) in 60ml water and incubated with gentle agitation at 
room temperature for 30 min. The pH of the staining solution was raised to pH
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12.0by the addition of 1M NaOH (8ml) and water (to a final volume of 100ml). 
The mixture may be kept at 4 °C for 6 months but should be filtered before use.
Immunological reagents and stains 
[^Ij-Avidin see radiochemicals
Lindstrom antibodies and Rogers antibodies refer to Table 2.1. Stored at -20°C 
in 10ii\ aliquots.
Colloidal gold probes, stored at 4°C:-
a) Auroprobe TM EM Goat-(anti-Rat) G10: anti-rat IgG probes conjugated to 
lOnm diameter gold particles. (Amersham)
b) Goat Anti-rat IgG (whole molecule) gold conjugate 5nm (Sigma G2397)
c) Streptavidin Albumin conjugated to 10 nm Colloidal gold labeled from 
Streptomyces avidinii (Sigma S4275)
Peroxidase linked probes, stored at 4°C:-
a) Extravidin peroxidase conjugate (Sigma Chemical Co Ltd, Poole, Dorset, E- 
2511)
b) Goat-(anti-Rat IgG [whole molecule]) peroxidase conjugate (Sigma A-9037)
c) Rabbit-(anti-Rat IgG [whole molecule]) peroxidase conjugate (Sigma A-5795)
d) Vectastain Elite ABC Kit, Standard (Vector PK 6100)
Linker proteins, stored at 4°C:-
a) Goat-(Anti-rat IgG [whole molecule]) (Sigma R5005)
b) Protein A Extracellular from Staphylococcus aureus (Sigma P6031)
c) Protein G from Group C Streptococcus sp. (Sigma P9659)
Protein blocking, stored at 4°C:-
a) Goat serum (Sigma)
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Table 2.1 The antibodies used for the project
Antibodies donated by J. Lindstrom. Raised in rats against detergent solubilized 









270 1 .5 1 .6 62 chick IgG2a
290 40 26.9 62 rat IgG1
297 40 0.3 62 rat not IgM
299 115 0.3 a4 rat not IgM
Polyclonal sera donated by S.Rogers. Raised in rabbits against rat nAChR fusion 
proteins. Henceforth collectively refered to as Rogers sera:
antiserum 5009 4842
vs a4 62
immunocytochemistry 1 : 500 - 1 :1 000 1:1500 - 1:3000
immunohistochemistry ---- 1:2000 - 1:3000
immunoprecipitation 1 :800 1 :500 - 1:1000
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b) Vectastain Avidin D/biotin blocking Kit (Vector laboratories, Bretton, 
Peterborough, England SP 2001)
c) Marvel dried skimmed milk (Chivers and Sons Ltd, Coolock, Dublin), prepared 
fresh.
Stains
a) 5-aminosalicylic acid (5-Amino-2-hydroxybenzoic acid, [5AS] (Sigma A6178)
b) 3,3’-Diaminobenzidine ([3,3’,4,4’tetraaminobiphenyl]-tetrahydrochloride, 
[DAB]) Sigma D5637
c) paranitrophenyl phosphate (p-nitrophenyl phosphate, disodium salt, pnpp) 
(Sigma 104-0)
d) PAGE blue 83 (BDH 44246)
e) Ponceau S Red (Sigma P7170)
Photographic materials
The 1200 EX uses Black and white negative film, Kodak Plux-Xpan, (5-PXP 200, 
Eastman Kodak Co. Rochester, N.Y.,USA), which was developed using Ilford 
Ufofix fixer and Ilford Perceptol developer (Ilford Ltd: CIBA-GEIGY). Ilford RC 
De luxe Multigrade II (MG.1M 24x30.5cm, Ilford) photographic paper was 
developed with Ilford Multigrade paper developer (Ilford) and fixed with Ilford 
Hypan fixer (Ilford).
Hyperfilm [3H] High Performance autoradiography film (RPN 535, Amersham) 
Preparation of discontinuous gradients
Gradients were made using freshly prepared solutions using double distilled water 
and equipment which had been washed thoroughly to remove all trace of
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detergent. All gradients were prepared using chilled solutions (4°C), where the 
pH had been adjusted to 7.4. In all cases the sample was initially suspended in 
0.32M sucrose (pH 7.4).
0.8/1.2M sucrose gradients were freshly prepared in either 5.2ml or 40ml 
Beckman Ultra-Clear centrifuge tubes, the volumes used were appropriate to fill 
the tubes. A pasteur pipette was used to layer gradients comprising of 1 volume 
of sample, on 2 volumes of 0.8M sucrose, on 2 volumes of 1.2M sucrose. 
0.8/1.0/1.2M sucrose gradients were freshly prepared in 5.2ml Beckman Ultra- 
Clear centrifuge tubes, the volumes used were appropriate to fill the tube. All 4 
sucrose solutions, including the sample solution, contained 50/xM calcium chloride 
CaCl2.2H20 . A pasteur pipette was used to layer gradients comprising of 1 volume 
of sample, on 1 volume of 0.8M sucrose, on 1 volume of 1.0M sucrose, on 1 
volume of 1.2M sucrose solution.
Percoll gradients were prepared in 14ml Sorvall centrifuge tube and comprised 
of equal (2ml) volumes of:- sample (0%), on 3%, on 10%, on 15%, on 23% v/v 
Percoll suspensions in 0.32M sucrose. Percoll was filtered using a Millipore AP 
15 prefilter to remove aggregates. Percoll suspensions were prepared in 0.32M 
sucrose and the pH adjusted to 7.4. All suspensions were layered using a Gilson 
Peristaltic pump (running speed lml/min) set up with a Sabre fine bore needle. 
Gradients were allowed to settle for at least one hour before sample application, 
they could be stored at 4°C for up to 24 h.
Radiochemicals
[125I]-Bolton Hunter labelled Avidin (CG92520, New England Nuclear [NEN] 
research products, Du Pont [UK]). Thawed, diluted (10% v/v) with Phosphate
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Buffered Saline (PBS) containing (0.1% w/v) Bovine Serum Albumin [BSA] and 
stored at -20°C in 200/xl aliquots for storage. Specific activity 157 /iCi/jzg, 
concentration 92.4 /xCi/ml, Ty2 is 60 days. The [125I]-Avidin was stable and usable 
for 4 weeks, but for maximal activity it was used within 10 days of the preparation 
(89% original activity).
[3H]-cytisine:- cytisine HC1 [3,5-3H(N) cytisine] approximately 30 (15-40)Ci/mmol, 
30/xM in 90% ethanol (Net-1054, NEN), stored at -20°C.
[3H]-nicotine:- (-)-N-methyl-3H-nicotine approximately 75 (60-87)Ci/mmol, 15/xM 
in 90% ethanol (Net-827, NEN), stored at -20°C in 100/d aliquots in a ten fold 
molar excess of S-mercaptoethanol (Romm et al, 1990)
Solid supports:- filters, gels and plates
Supports, stored at 4°C:-
a) Agarose-Avidin D (Vector A2010)
b) cyanogen bromide activated Sepharose 6MB (Sigma C9267)
c) tosylactivated Dynabeads M-450 (Dynal (UK) Ltd, New Ferry, Wirral, UK 
14003/14004)
d) Dynabeads M280 Streptavidin (Dynal 112.05/112.06)
e) Dynabeads M450 Sheep anti-rat IgG (11007/11008)
f) Pansorbin cells Staphylococcus aureus based immunoadsorbents (Calbiochem- 
Novabiochem [UK] Ltd, Highfields Science Park, Nottingham, UK.) 
Polyacrylamide electrophoresis (Phast system), stored at 4°C:-
a) Phast Gel: SDS Buffer Strips, (Pharmacia, 17-0516-01)
b) Phast Gel: Gradient Gel 10-15%, (Pharmacia, 17-0540-01)
c) Phast Gel: Sample Applicator 8/1, (Pharmacia, 18-1618-01)
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Polyacrylamide electrophoresis (Mighty Small II):-
a) 10% Polyacrylamide gel (running gel). 0.1M Tris (hydroxymethyl) amino 
methane [Tris], 0.1M N,N-bis(2 hydroxyethyl) glycine [Bicine], 10% w/v 
acrylamide, 0.27% w/v bis acrylamide, 0.1% w/v sodium dodecyl sulphate [SDS], 
0.1% v/v N ,N ,N \N ’Tetramethyl ethylenediamine [TEMED], after mixing add 
0.09% w/v ammonium persulphate. A few drops of 50 % v/v ethanol was layered 
onto the surface of the gel after pouring to improve gel shape. Gels may be 
stored before use in a humid atmosphere at 4°C for up to 5 days.
b) 2.5% Polyacrylamide gel (stacking gel). 0.1M Tris, 0.1M bicine, 2.5% w/v 
acrylamide, 0.067% w/v bis acrylamide, 0.1% w/v SDS, 0.2% v/v TEMED, after 
mixing add 0.03% w/v ammonium persulphate. Stacking gels were always freshly 
prepared.
Filters
a) Gelman GFA/E Glassfibre filters
b) Nitrocellulose filter BA 85 Membrane Filters (0.45/xm) (Schleicher and 
Schuell)
c) Millipore AP 15 filter (Millipore UK Ltd, Watford, Herts)
Miscellaneous
Optiphase "safe"scintillant (LKB Scintillation Products). "Superpolyethylene vial" 
standard (20ml) scintillation vial (Packard). Lp4 tubes (Luckham). Glycopeptidase 
F (EC 3.2.2.18)from Flavobacterium meningosepticum (Sigma G9769), stored at 
4°C. Collagenase from Boehringer Mannheim (103 586), freshly prepared before 
use. All other chemicals brought from Sigma, Fisons or BDH as appropriate.
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Chapter 3 The characterization of subcellnlar 
fractions by ligand binding and by immnnostaining 
techniques other than immunnelectrnn microscopy
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3.1 Introduction
This section describes experiments which were performed to reinforce the findings 
of para lle l attem pts at im m unoelectron m icroscopy (section  4) and 
immunoisolation (section 5) of nerve terminals bearing the nAChRs. These 
experiments are divided into two approaches:-
a) The subcellular localization of nAChRs was investigated by examining 
subcellular fractions using ligand binding and a combined approach of ligand 
binding and receptor immunoprecipitation.
b) The immunological recognition of the a4£2 receptor subtype was investigated 
by a variety of biochemical techniques.
3.1.1 Subcellular localization
The o4£2 nAChR subtype is mainly or wholly responsible for high affinity [3H]- 
nicotine or [3H]-cytisine binding (section 1.3). Various investigations have 
demonstrated that part of the o4£2 population is located at presynaptic terminals 
(section 1.4). Previous [3H]-nicotine binding studies to subcellular fractions have 
shown that the o;4£2 isoform is enriched in synaptosomal fractions (see sections 
3.2.2and 3.2.4).
The measurement of [3H]-nicotine or [3H]-cytisine binding can be problematic 
(Romano and Goldstein 1980). It is not within the scope of this thesis to present 
a detailed description of the problems and the best approaches to this assay, 
because a good system had been established in the laboratory before this work
began (MacAllan et al, 1988), but the limited characterization which was 
performed is described in section 3.3.1. The [3H]-cytisine binding experiments 
described in sections 3.3.3 and 3.3.4 were designed to develop methods to 
measure o4S2 concentrations in SI-Percoll fractions, as described by Thome et 
al (1991) and by Bames et al (1992), whilst circumventing the binding of [3H]- 
nicotine to Percoll (Wonnacott and Wilkie, 1991), which might compromise 
results. The use of Western blotting to localize the glutamate receptor GluRl to 
the post synaptic density preparation (Rogers et al, 1991a) initiated two lines of 
research. Section 3.12 describes Western blotting attempts. Section 3.32 describes 
an attempt to use [3H]-nicotine binding experiments to determine the proportion 
of a4£2 which can be measured at synaptic junctional complexes (SJC). Note 
sections 3.3.2and 3.3.4describe preliminary localization experiments which were 
performed at the end of the project. In both cases some improvements were 
possible, which might increase the accuracy of results (sections 3.4.2and 3.4.3), 
but no change in the qualitative picture of receptor localization was expected.
3.1.2 Immunological recognition
Whiting and Lindstrom (1987, 1988) reported immunoblot experiments with the 
Lindstrom mAbs used in this project:- immunopurified receptors were separated 
by PAGE, transferred by Western transfer onto nitrocellulose and immunostained 
using the mAbs detected by 125I-labelled goat (anti-rat IgG) antibodies. The 
experiments discussed in section 3.3.5.2 were performed to determine if the 
sensitivity of the Western blot system was sufficient to allow the analysis of 
preparations without immunopurification. Rogers et al (1991a) demonstrated that 
such an analysis can provide a semi-quantitative procedure to examine the
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localization of receptors. Dot blot controls were performed to confirm the 
detection of nitrocellulose-bound primary probes by labelled secondary probes. 
The experiments discussed in section 3.3.6were partly performed with the same 
objective, ie to determine if ELISA was sensitive enough to allow the analysis of 
preparations without immunopurification. Neither Western blot nor ELISA were 
sensitive enough to be used for receptor analysis without immunopurification.
Immunoelectron microscopy is a labour intensive procedure and so controls are 
often performed to ensure that immunostaining is possible before an extensive 
study is performed. One of the primary aims of the project was to attempt to 
immunostain synaptosomes bearing the nAChR. The normal control prior to 
immunoelectron microscopy is to immunostain a preparation for light microscopy 
(eg Hill et al, 1993), however all component parts of a synaptosome preparation 
are too small to be visible using light microscopy, and so any specific 
immunostaining could not be identified or quantified. Light microscopy of an 
immunostained tissue block (Swanson et al, 1987) was a poor control for 
immunostaining synaptosomes, because the immunostaining conditions are 
different. Sections 3.3.6and 3.3.7describe the development of immunostaining 
controls which would allow the quantification of specific nAChR recognition. The 
development of immunostaining controls was performed at the same time as the 
preliminary immunoelectron microscopy experiments described in section 4, they 
reinforce the results described in sections 4 and 5, which indicate that nAChR 




The methods described in this chapter are divided into tissue preparation 
(sections 3.2.1 to 3.2.4)and detection (section 3.2.5to 3.2.10)procedures.
Tissue preparation procedures
Unless otherwise stated, throughout all procedures described in section 3.2.1 to 
3.2.4: all tissue preparation was performed at 4°C using chilled solutions and 
equipment; all vessels were washed carefully in distilled water to remove all trace 
of detergents; all pellet resuspension was performed by homogenization.
3.2.1 Homogenization and summary of tissue preparations
Male Sprague-Dawley rats (age 4-6 wk, mass 200-250g) were obtained from a 
breeding colony maintained at the University of Bath. They were killed by cervical 
dislocation and the whole brain minus cerebellum (mass approx. 1.2g) rapidly 
removed. Brain dissection to obtain cortex (mass approx 0.75g) was performed on 
ice, whilst soaking in homogenizing buffer containing sucrose (0.32M), EDTA 
[Diaminoethane tetra-acetic acid disodium salt] (5mM), PMSF (O.lmM), pH7.4. 
To minimize postmortem changes, brain tissue (cortex or whole brain minus 
cerebellum) was rapidly placed into homogenizing buffer (10% w/v) and 
homogenized at the earliest opportunity, using 2x6 up/down strokes of a 
homogenizer at 200 rpm. Figure 3.1 outlines all the tissue preparations made from 
the homogenate by differential centrifugation.
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Figure 3.1 summarizes the tissue preparations and the uses to which they were 
put. For greater details of preparative procedures see figures 3.2,3.3,3.4 and 5.1.
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3.2.2 Svnaptosome isolation by subcellular fractionation using 
sucrose gradients
Brain homogenate was fractionated using a 2-step sucrose density gradient (figure 
3.2), essentially as described by Rapier et al (1988). Briefly, the homogenate was 
layered onto a 0.8/1.2M sucrose gradient (section 2.2) and after centrifugation 
(100,000g,60 min, Beckman, swing out rotor), the fractions were collected from 
sucrose interfaces using a Pasteur pipette. The synaptosome preparation from the 
0.8/12  interface (Hb) contains a considerably higher concentration of high affinity 
[3H]-nicotine binding sites than the other 2 fractions (Rapier et al, 1990).
Alternatively, differential centrifugation of the brain homogenate yields a P2 
plasma membrane preparation (Gray and Whittaker, 1962; Rapier etal, 1990), as 
follows (figure 3.2). Centrifugation (Sorval) of the homogenate at l,000g,for 10 
min, yielded a supernatant fraction (SI) and a pellet (PI). This pellet was 
resuspended in fresh homogenizing buffer (5ml/g original wet weight) and the 
supernatant fraction from centrifugation of the resuspended PI (l,000g, 10 min) 
was pooled with the SI. Centrifugation (17,000g, 30 min) of pooled SI yielded a 
supernatant fraction (S2) and a pellet (P2). This pellet was resuspended in fresh 
homogenizing buffer (2.5ml/g original wet weight). The P2 plasma membrane 
preparation could then be fractionated (Beckman, swing-out rotor, 100,000g,60 
min) using a 2-step (0.8/1.2M) sucrose density gradient (Gray and Whittaker, 
1962) using the same procedure as described above for Hb (figure 3.2). The P2b 
preparation consists of approximately 50% v/v synaptosomes (Whittaker, 1969) 
and contains a considerably higher concentration of high affinity [3H]-nicotine 
binding sites than the other 2 fractions (Yoshida and Imura, 1979).
Figure 3.2 The isolation of svnaptosome preparations using 
sucrose gradients
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Figure 3.2 summarizes the production of the Hb (Rapier et al, 1990) and P2b 
(Gray and Whittaker, 1962) synaptosome preparations using sucrose density 
gradients.
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3.2.3 The preparation of synaptic junctional complexes
The production of synaptic junctional complexes from the P2b synaptosome 
preparation (figure 3.3) was based on the procedures described by Cotman and 
Taylor (1972), and by Rao and Steward (1991). The P2b preparation was gently 
shaken with four volumes of lOmM PBS, then after centrifugation (17,000g, 30 
min, Sorval) the synaptosomes in the P2b pellet were lysed. The pellet was twice 
resuspended in 0.1 mM HEPES (1% w/v) and left for 15 min before 
centrifugation (23,000g, 15 min). The pellet was washed by centrifugation with 
0 .16M sucrose, 50/xM calcium chloride (CaCl2), ie the pellet was resuspended (1% 
w/v, 0.16M sucrose/CaCl2) and immediately precipitated by centrifugation 
(23,000g, 15 min). The pellet was resuspended (1% w/v) in a warmed sodium 
phosphate  bu ffer (3 0 °C , 40mM , pH 7.6) which co n ta ined  0.5 mM 
iodonitrotetrazolium violet and 20 mM succinate and incubated at 30 °C for 20 
min. This treatment reduces the density of mitochondria so that they do not 
precipitate during centrifugation (10,000g, 7 min). The pellet was washed twice 
by centrifugation (10,000g, 7 min) with 0.16 M sucrose, 50/xM CaCl2 (1% w/v) and 
resuspended (approx 4ml/g rat brain) in 0.32M sucrose, 50/xM CaCl2. This 
mixture was layered onto a 3-step sucrose density gradient (0.8/1.0/1.2M). After 
centrifugation (75,500g,90 min, Beckman, swing-out rotor) the material from the 
1.0/1.2 interface was collected. This fraction represents the synaptic plasma 
membranes (SPM), it was mixed with three volumes of 50/xM CaCl2. The pellet 
from centrifugation (10,000g, 10 min) of this mixture was resuspended using a 
pasteur pipette in 2mM bicine, 2mM EDTA, 0.4% Triton X-100 (1.5ml/g rat 
brain) and left for 10 minutes at room temperature. The mixture (1 volume) was 
layered onto 1.0M sucrose, 50/zM CaCl2 (4 volumes) for centrifugation (68,000g,
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Figure 3.3 summarizes the production of synaptic junctional complexes (SJCs) 
from P2b preparations, based on the protocol described by Cotman and Taylor 
(1972), and by Rao and Steward (1991).
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60 min, Beckman, swing-out rotor). The pellet consisted of synaptic junctional 
complexes (SJC), and the extract floating on the sucrose represented the non-SJC 
component of SPM.
3.2.4 Subcellular fractionation using Percoll gradients
An alternative fractionation technique involves only 2 rapid medium-speed 
centrifugation steps (figure 3.4): the SI Percoll procedure (Dunkley et al, 1987, 
1988; Harrison et al, 1988) is a non-equilibrium method which separates particles 
on the basis of size and density. Rat neural tissue (cortex or whole brain minus 
cerebellum) was homogenized in fresh 0.32M sucrose (pH 7.4). Homogenate 
centrifugation (Sorval, l,000g, 10 min) yielded the supernatant SI which was 
layered onto chilled discontinuous 4-step Percoll gradients (section 2.2). 
Centrifugation (5 min, 32,500g) yielded 4 interfacial fractions and a pellet. All 5 
fractions contain synaptosomes, but fractions F1,F2 and F5 contain synaptosomes 
of low viability (Harrison etal, 1988) and considerable non-synaptosomal material 
(Dunkley et al, 1988), whilst the F4 fraction is especially rich in synaptosomes 
(56% v/v, very strict criteria, Dunkley et al, 1988) of high viability (Harrison et 
al, 1988). The concentration of high affinity [3H]-nicotine binding sites increases 
down the gradient, ie increases from fractions FI to F5 (Barnes et al, 1992; 
Thome et al, 1991).
Detergent extracts of each Percoll fraction (figure 3.4) were made before 
quantification of high affinity nicotine binding sites; the supernatants from 
detergent extraction were assayed either by immunoprecipitation (section 3.2.10) 
or by filtration (section 3.2.6).Before detergent extraction fractions were washed
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Figure 3.4 summarizes the procedure for the subcellular fraction of the SI 
preparation using Percoll gradients (Dunkley et al, 1987, 1988; Harrison et al, 
1988).
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once, by centrifugation, with 20 volumes of Tris/HEPES buffer (26,000g,30min). 
The pellets were resuspended using a pasteur pipette in 1 volume of Tris/HEPES 
containing 0.5 % v/v Triton X-100, then incubated for 2 h, under gentle agitation. 




Two methods were used to measure protein concentration.
3.2.5.1 The Lowrv method
Protein estimation was performed essentially as described by Lowry et al (1951) 
using BSA as a protein standard. A constant and minimal buffer concentration 
was maintained in all tubes including standards and blanks, to avoid interference 
effects from buffer components. All samples were measured, in duplicate, at two 
dilutions, in the protein concentration range 0-300 /xg/ml.
Fresh copper complex solution (1ml) containing: NaOH (0.1M), sodium carbonate 
(2% w/v Na2C 03), copper sulphate (0.01% w/v CuS04.5H20), sodium tartrate 
(0.02% w/v [CH0HC00Na]2.2H20) was vortex mixed with diluted samples 
(200/d) in LP4 tubes. After a 10 min incubation at room temperature, each 
sample was vortex mixed with Folins-Ciocalteau reagent (100/d). After a further 
40 min incubation, aliquots (2x200/d) of each sample were transferred to 
microtitre plates for optical density measurement, at 690nm, using a titretek
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multiscan reader.
The procedure for the estimation of protein in samples which contained 
detergents was identical, except the copper complex solution also contained 1% 
w/v SDS (Markwell et al, 1978).
3.2.5.2 Protein approximation bv PAGE analysis of dilution series
A crude approximation of protein concentration was made by analyzing several 
dilution series of a sample using PAGE (section 3.3.5.1).This technique is not 
affected by the composition of the sample buffer, or the presence of other 
proteins unless they are composed of polypeptides of the same molecular weight. 
It was used when a Lowry estimation was not possible, eg to measure antibodies 
in an unknown buffer, which contained stabilizing proteins. The vanishing point 
where a particular polypeptide was at a concentration which was just undetectable 
was assumed to be constant for that polypeptide. A series of serial dilutions were 
used to "home in" on the vanishing point dilutions of polypeptide components of 
a protein. Pure protein preparations (no stabilizing proteins) of known protein 
concentration (estimated by Lowry) were used as standards.
3.2.6 Ligand binding assays
The detection of nAChRs using the filtration assay was based on the procedure 
first described by Romano and Goldstein (1980). The assay was performed, 
essentially as described previously by our laboratory (MacAllan et al, 1988), 
except samples were suspended in Tris/HEPES buffer (see section 2.2) to reduce 
non-specific binding (Romm et al, 1990). When binding assays were performed on
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detergent solubilized receptors care was taken to use Tris/HEPES buffer 
containing 0.25% v/v Triton X-100, unless otherwise stated. Total and non­
specific high affinity binding were measured in triplicate.
Tritiated nicotine binding proceeded as follows:-
Samples (6x0.5 ml, 0.5-1.0 mg protein/ ml) were placed in LP4 tubes. Water (10/xl) 
was added to measure total binding, or (-) nicotine free base (10/zl, final assay 
concentration ImM) was added to measure non-specific binding. All tubes were 
vortex mixed. The [3H]-nicotine (10/xl, final assay concentration 20nM) was added 
to each tube and all tubes were vortex mixed. The tubes covered and incubated 
for 30 min at room temperature, then for 2 h at 4°C. Samples were rapidly 
filtered under vacuum (4°C) using a Brandel cell harvester (Lippiello and 
Fernandes, 1986), through a double thickness of GFA/E filters which had been 
pre-soaked (18hr, 4°C) in PBS containing polyethleneimine (PEI: 0.3% v/v) and 
azide (0.05% w/v), and washed with PBS/azide (2x4ml, 4°C). The PEI exposure 
had 2 effects:- it reduces the non-specific binding (Lippiello and Fernandes, 1988; 
Schwartz et al, 1982) of [3H]-nicotine and radiolabelled impurities (Romm et al, 
1990) to the glass fibre filters (Romano and Goldstein, 1980) and it allows the 
adsorption of detergent solubilized nAChRs by ion exchange (Bruns et al, 1983; 
Lunt, 1987). The total filtration and washing time was less than 30 seconds. Filters 
were placed in scintillation vials. Scintillation fluid (5ml) was added and, after 4h, 
the vials were vortex mixed. The level of Tritium was measured with controls in 
the 1600 TR.
Tritiated cytisine binding was performed in the same way as nicotine binding
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(Pabreza etal, 1991), except:- [3H]-cytisine (10/d, final assay concentration 2.5nM) 
was added instead of [3H]-nicotine; tubes were incubated for 2h at room 
temperature.
3.2.7 Polyacrylamide gel electrophoresis
3.2.7.1 Electrophoresis procedures
PAGE was performed as described by Laemmli (1970). Two electrophoresis 
systems were used:-
a) Electrophoresis using the Phast system was mainly used for protein estimation 
(section 3.3.5.1).As recommended, samples were incubated (lOmin, 100°C,50% 
v/v) in sample buffer (section 2.2),before electrophoresis (30min, lOmA/gel) on 
precast running gels (10-15% gradient) with buffer strips. Western transfer 
(Renart et al, 1979) onto nitrocellulose was achieved using the transfer attachment 
(15 min, 20 mA/gel).
b) The Minigel system was used for immunoelectrophoresis experiments, as 
described by Peers etal, 1993. Samples were incubated in sample buffer, as above, 
and then the reduced SDS-bound samples were applied (20/d) to a 1.5mm 10% 
running gel (section 2.2), with 2.5% stacking gel (section 2.2). Electrophoresis 
using a running buffer containing Tris (0.1M), bicine (0.1M), SDS (0.1% w/v) 
proceeded at 10 mA/gel until samples had passed through the 2.5%-10% gel 
interface (approx 10 min) and then with a current of 35mA/gel for a further lh
(60 min, 35 mA per gel). Western transfer onto nitrocellulose was performed
(constant 80V, lh) in transfer buffer containing Tris (2.5mM), Glycine (19.2mM),
methanol (20% v/v).
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3.2.7.2 Protein visualization after PAGE
All incubations described in this section were performed at room temperature, 
under gentle agitation.
Protein was visualized in gels, as directed, by staining (2 h) with PAGE blue 83 
(0.2% w/v in 50% v/v methanol, 10% v/v acetic acid) and then destaining (24 h) 
with 20% v/v methanol, 10% v/v acetic acid. Stained gels could be kept for 
months in water, or dried for storage.
Protein was visualized on nitrocellulose sheets, as directed, by staining (10 min) 
with Ponceau S Red (10% v/v Ponceau S Red concentrate) and then destaining 
until the contrast was optimal (1-20 min) with water, or with 5% v/v acetic acid. 
The stain faded less rapidly after the nitrocellulose was removed from water. 
Stained nitrocellulose could be stored for several days (preferably in the dark, 
preferably at 4°C), but generally transfers were photographed and then 
immunostained. The PBS/Tween buffer (lOmM PBS, 0.1% v/ v Tween 20, pH 7.4) 
rapidly removed the Ponceau S Red stain from nitrocellulose sheets.
3.2.7.3 Immunoblotting after PAGE
Immunostaining proceeded, with only minor modifications, as described in Peers 
et al, 1993. Unless otherwise stated, all incubations were performed at room 
temperature, under gentle agitation. The PBS/Tween buffer was lOmM PBS 
containing 0.1% v/v Tween 20, pH 7.4.
Some nitrocellulose transfers were blocked, before incubation with the primary
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probe. According to Vector stain literature, blocking is generally not required 
when biotinylated antibodies are used as primary probes. Some transfers were 
blocked using the Avidin/biotin blocking kit, as directed. Briefly, transfers were 
incubated for 15 min with Avidin in PBS/Tween; washed twice for 5 min with 
PBS/Tween; incubated for 15 min with biotin in PBS/Tween; and finally washed 
thrice for lOmin in PBS/Tween. None of the alternative blocking conditions 
described in the Vector stain literature are discussed in this thesis. When 
unlabelled antibodies was used as primary probes, transfers were usually protein 
blocked, by incubation (60 min) in PBS/Tween containing Marvel skimmed milk 
(5% w/v) and then washed twice with PBS/Tween (5 min).
Transfers were incubated for 18 h with primary antibody in PBS/ Tween, then they 
were washed twice with PBS/Tween (15 min). The transfers were incubated (4h) 
with the secondary probe, at the recommended concentration, in PBS/Tween and 
finally washed thrice with PBS/Tween (15 min), then once with PBS (15 min) 
before visualisation. The visualisation method depended on secondary probe, 
three secondary probes were used:-
a) Peroxidase conjugated anti-rat IgG antibodies are generally recommended to 
be used at 0.02% v/v. Peroxidase stained proteins were visualized by the 
precipitation of the insoluble product of peroxidase catalyzed DAB oxidation. 
Transfers were incubated in PBS containing 0.6% v/v H20 2, 0.1% w/v DAB. The 
optimal contrast between specific and non-specific staining was usually achieved 
after 10-150 sec incubation. The reaction was stopped by washing the transfers 
thoroughly in water.
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The sensitivity of DAB staining could be enhanced ten-fold using the nickel 
enhancement procedure (De Bias and Cherwinski, 1983). Transfers were 
incubated for 10 min in a prestaining solution which consisted of lOmM PBS 
containing 0.1% w/v DAB, 0.03% w/v ammonium nickel (II) sulphate 
[(NH4)2Ni(S04)2.6H20] and 0.03% w/v cobalt (II) chloride [CoClJ), and then (10 
min). Then the transfers were incubated for 10 min in a staining solution, 
consisting of prestaining solution plus 0.6% v/v H20 2. Both prestaining and 
staining solutions were freshly prepared then filtered though 0.45 /im 
nitrocellulose to remove undissolved DAB. Colour development was stopped by 
washing the transfers in water.
b) Peroxidase conjugated Avidin was used near the recommended concentration 
(0.1% v/v). Peroxidase stained proteins were visualized using nickel-enhanced 
oxidative DAB precipitation, as described above. Further enhancement was 
achieved by successive exposures (up to 3 sandwiches) to biotinylated goat (anti- 
Avidin) antibodies and peroxidase conjugated Avidin (Vector stain literature).
c) 125I labelled Avidin was used near 0.1 % v/v. Immunostained protein bands were 
visualized by autoradiography (2 weeks, using Tritium sensitive film).
3.2.8 Enzvme-Iinked immunosorbent assay (ELISA) analysis
Samples were resuspended to 10 /xg protein /ml in carbonate buffer (50mM 
sodium carbonate, 0.01% v/v Thiomersal, pH 9.6) and dispensed (250/xl) into 
titretech plates. After 18 h incubation (4°C) plate wells were thrice washed gently 
with PBS/Tween (PBS, 0.1% v/v Tween 20, pH 7.4). The wells were blocked for 
1 h in PBS/Tween at room temperature, and thrice washed with PBS/Tween. 
Relevant wells were filled (250/xl) with PBS/Tween with or without primary
antibody cocktail (0.4% v/v) containing: 270 (titre 1.6nM, detects 200fmol 
nAChR); 290 (titre 27nM, detects 3380fmol nAChR); 297 (titre 0.3nM, detects 
38fmol nAChR); 299 (titre 0.3nM, detects 38fmol nAChR). After a 4h incubation 
plate wells were thrice washed with PBS/Tween and filled (250/xl) with 
PBS/Tween containing the secondary antibody (0.02% v/v). After a 4h incubation 
plate wells were washed thrice with PBS/Tween, then twice with PBS. The 
peroxidase was quantified colorimetrically (450 nm) by measuring the oxidation 
of Tetramethyl benzidine. Sodium acetate/citrate buffer (250/xl of 50mM: 0.68% 
w/v sodium acetate, 0.0315% w/v citric acid) containing Tetramethyl benzidine 
[400/xM, TMB], DMSO (1% v/v), H20 2 (0.005% v/v), pH 6.0, was added to each 
well, oxidation was stopped after 30min by the addition of 1.0M Sulphuric acid 
[50/xl H2SOJ.
3.2.9 Immunostaining material in free suspension
Specimens (P2b preparation) were immunostained in solution using a procedure 
developed from ELISA and prefixation immunostaining, two probes were used:-
a) mAbs recognized by peroxidase conjugated anti-rat IgG
b) biotinylated mAbs recognized by radiolabelled Avidin (cf section 3.2.7.3)
Samples were washed by dilution to 2% v/v with PBS, centrifugation (l,000g,7 
min, Sorval) and gentle resuspension using a pasteur pipette. When samples were 
blocked, the procedure described for nitrocellulose in section 3.2.7.3was used. 
The sample was resuspended in PBS containing primary antibody probe cocktail 
(0.4% v/v) containing: 2 fil of 270 (titre 1.6nM, detects 1.6pmol nAChR); 2 /xl of 
290 (titre 27nM, detects 27pmol nAChR); 2 [i\ of 297 (titre 0.3nM, detects
0.3pmol nAChR); 2 /xl of 299 (titre 0.3nM, detects 0.3pmol nAChR). After 18h 
incubation (4°C) under gentle agitation samples were twice washed (15 min) with 
PBS. The samples were resuspended with PBS containing the secondary probe 
(0.02% v/v for peroxidase conjugate, 1% v/v for radiolabelled Avidin) before a 
4h incubation (room temperature). Samples were washed with PBS a recorded 
number of times and the concentration of secondary probe measured. The 
peroxidase content of a pellet was quantified colorimetrically (450 nm) in a 
Titretek multiscan reader by measuring the oxidation of 5AS. The pellet was 
resuspended (10% v/v) in PBS containing 0.2% w/v 5AS and 0.6% v/v H20 2, pH 
7.4. After 30 min (room temperature) the reaction was stopped by the addition 
of 1/10 volume 1M NaOH. The radiolabelled Avidin content of a pellet was 
quantified using a gamma counter.
3.2.10 Immunoprecipitation of detergent solubilized nAChR 
using the Rogers sera
An immunoprecipitation protocol was used to measure the concentration of 
detergent solubilized nAChR. This method, summarized below, was described by 
Flores et al (1992), with further practical details provided by S.Rogers (person, 
comm.). Tissue preparation was prepared or resuspended (sections 3.2.1,3.2.2and 
3.2.4)to approximately 20mg protein/ml in a Tris/salts/Triton buffer containing 
Tris (50mM), sodium chloride (120mM), potassium chloride (5mM), magnesium 
chloride (ImM), calcium chloride (2.5mM), Triton X-100 (0.5%v/v), pH 7.0. 
Unless otherwise stated, all incubations proceeded under gentle agitation provided 
by an end-over-end shaker. After a 2h incubation (4°C), and then centrifugation 
(48,000g, 30 min, Beckman), the detergent solubilized material (supernatant) was
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diluted (to 0.25% v/v Triton) with a Tris/salts buffer which was identical to 
Tris/salts/Triton, but without Triton, pH 7.0.The solubilized nAChR preparation 
was dispensed into Eppendorf microfuge tubes (6 x 1ml) to which primary probe 
(0.125% v/v) was added. The radiolabelled ligand ± cold ligand were added (as 
section 3.2.6): ie [3H]-cytisine plus water was added to determine total binding; 
[3H]-cytisine and (-)-nicotine were added to determine non-specific binding. The 
material was incubated either at room temperature (2 h) or at 4°C (18 h) and 
then stripped (Shantz and Palmer, 1983) Pansorbin cells (10% v/v) were added. 
Pansorbin cells were stripped immediately prior to use, they were dispensed, in 
a uniform suspension, into Eppendorf microfuge tubes, centrifuged (lOmin, 
10,000g, microfuge), the pelleted cells were resuspended (10% w/v) in stripping 
buffer containing Tris (50mM), NaCl (150mM), S-mercaptoethanol (10% v/v), 
SDS (3% w/v), pH 7.2, and incubated at 95°C (30 min). Centrifugation, 
resuspension and incubation were repeated once. After centrifugation of the 
stripped cell suspension (10 min, 10,000g) the pellet was resuspended in one 
volume of the Tris/salts buffer. The mixture of stripped Pansorbin cells and 
antibody exposed material was incubated for 1 h (room temperature). The 
Pansorbin cell bound nAChR was immunoprecipitated by centrifugation in a vari- 
microfuge (10 sec, lOOOg). The supernatant from each tube was rapidly removed 
by aspiration and the surface of each pellet gently washed once, by the rapid 
addition and then removal by aspiration of 1ml lOmM Tris containing ImM 
EDTA, pH 7.5. The total time for centrifugation and washing of any sample was 
less than one minute. Each pellet was solubilized in 0.1M NaOH (100/zl) 
containing sodium deoxycholate (3% w/v) and mixed, in a scintillation vial, with 
5ml scintillant. Tritium levels were measured with the 1600 TR.
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3.3 Results
3.3.1 Optimization of the r3Hl-nicotine binding assay
The method for measurement of [3H]-nicotine binding, described by Mac Allan et 
al (1988), was improved by using the Tris/HEPES buffer instead of 50mM 
Phosphate buffer during ligand incubation (Romm et al, 1990). As anticipated this 
buffer change reduced non-specific binding (figure 3.5),but caused no change in 
specific binding when attempts were made to detect [3H]-nicotine binding to 
Triton X-100 detergent extracts of P2 membranes.
The results of performing the filtration assay upon buffer blanks is displayed in 
figure 3.6:-
a) at high Triton concentrations (>0.5%  v/v Triton) there is a tendency for the 
values of both total and non-specific binding to rise, this result was frequently 
observed attempts were made to measure ligand binding at high Triton 
concentrations (Smillie, unpublished observations), the rise in measured binding 
correlates with a noticeable retardation in the passage of the blanks through the 
filter.
b) at Triton concentrations of 0.25% Triton or below the level of non-specific is 
similar to the level of non-specific binding to tissue preparations (figure 3.6)
c) there is considerable variation between replicate experiments, even though 
each measurement is made in triplicate, this means if n is low or if specific 
binding is low, the potential errors in specific binding measurement can be large: 
eg 100 cpm (see figure 3.6) is equivalent to around 2.5 fmol [3H]-nicotine!
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Figure 3.5 The effect of buffer composition upon T3H1- 
nicotine binding
Buffer composition has an effect upon [3H]-nicotine binding, figure 3.5 compares the effect of 2 
buffers upon:-
a) Total and non-specific binding to a detergent extract of P2 membranes.
Protein concentration = 1 mg/ml, Triton concentration = 0 .05%  v/v.
b) Specific binding to detergent extracts of P2 membranes as derived from the (a) according to the 
formula:- Total binding = Specific binding -I- Non-specific binding
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The two buffers were:-
1) Phosphate buffer (50mM, pH 7.4), n =  3, standard error of the mean, SEM shown
2) Tris/HEPES buffer, n =  4, SEM shown
Specific binding using the phosphate buffer and the Tris/HEPES buffer was not significantly 
different at the 0.05 level (t-test, t=0.71,P=0.510)
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Figure 3.6 Apparent binding to buffer blanks
Figure 3 .6 displays the levels of total and non-specific ligand binding to buffer blanks, consisting of
Tris/HEPES buffer containing Triton X-100 at various concentrations, binding was measured in
triplicate (n = 1) by the filtration assay. These graphs demonstrate the variation in binding
measurements and also the effect of Triton X-100.
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There seemed to be a tendency to detect a small level of apparent specific binding:-
a) mean specific [3H]-nicotine binding for all 5 blanks of graph (a) = 37.4 (SEM = 22)
b) mean specific [3H]-cytisine binding for all 5 blanks of graph (b) =  16.4 (SEM = 8.9)
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The binding of [3H]-cytisine (Pabreza et al, 1991) using the same conditions, 
except for incubation times and temperature (section 3.2.6)is also shown in figure 
3.6. The comments (a), (b) and (c) above can also be applied to [3H]-cytisine 
binding except the level of radioactivity is lower. (36 cpm was equivalent to 
around 1.4fmol [3H]-cytisine).
Some effects upon [3H]-nicotine binding of the storage (4°C) of the extracts and 
of the Tris/HEPES buffer are displayed in figure 3.7:-
a) As the Tris/HEPES buffer ages beyond about 10 days the level of detectable 
specific binding falls. The buffer was stored at 4°C and used within 7 days of 
preparation. Parallel studies (M.W. Stephens, within the laboratory) indicated that 
buffer could be stored indefinitely at -30°C,and, after thawing, it could be treated 
as if freshly prepared.
b) When detergent extracts of P2 membranes were stored by freezing at -30 °C 
all specific activity was lost, however the loss of specific activity was far more 
gradual when stored at 4°C. It was apparent that there was negligible loss of 
activity during the first 48-72h of storage at 4°C, when fresh Tris/HEPES buffer 
was used; detergent extracts were always freshly prepared and generally were not 
incubated for more than 24h.
The binding of [3H]-nicotine to detergent extracts of P2 membranes by filtration 
under constant Triton concentration was found to be proportional to protein 
concentration, up to 3.5mg/ml protein (figure 3.8). The problems of handling very 
concentrated protein solutions prior to the dilution step placed an upper practical 
limit for extract concentration of around 2mg/ml protein during filtration in
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Figure 3.7 The effect of storage upon r3H1-nicotine binding to a
detergent extract of P2 membranes
Figures 3.7. a (total and non-specific binding) and 3.7.b (specific binding) summarize the effect on 
[3H]-nicotine binding filtration assays of increasing buffer age and increasing preparation age.
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Tris/HEPES buffer was prepared and stored at 4°C, in the dark. As the buffer aged, 3 detergent 
extracts of P2 membranes were prepared, these were also stored at 4°C, in the dark. The level of 
[3H]-nicotine binding to extracts at 0.05% v/v Triton, and protein concentration = lmg/ml was 
measured using the original buffer at various times after preparation. The extract marked "Frozen" 
was prepared with fresh buffer; stored at -30°C, in the dark, for 7d; and then assayed using fresh 
buffer. The ligand binding to all samples was measured in triplicate. Each preparation was 
represented with a different symbol. For each point displayed, n = l.
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Figure 3.8 The effect of protein concentration upon r3H1-nicotine 
binding to detergent extracts of P2 membranes at 
constant Triton concentration
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The pooled results of 3 dilution experiments at constant Triton concentration 
(0.1% v/v) are shown in figure 3.8. The specific binding was calculated from 
triplicate measurement of total and of non-specific binding. Each dilution series 
was represented with a different symbol, for each point n = 1.
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immunoisolation experiments. This is a convenient protein concentration, because 
nicotine binding in the absence of Triton is proportional to protein concentration 
up to 2mg/ml protein (Lippiello and Fernandes, 1988; Mac Allan et al, 1988; 
Wonnacott, person, comm.; Smillie unpublished observations).
3.3.2 Ligand binding to synaptic junctional complexes
Synaptic plasma membranes (SPM) were prepared from brain tissue (6 rat brains, 
8.5g)and then solubilized and fractionated to yield synaptic junctional complexes 
(SJC: 0.7mg)and solubilized synaptic plasma membranes (SPM-SJC: 0.6mg)were 
prepared in about 36 h (section 3.2.3) and assayed for nicotine binding (section 
3.2.6). These preliminary experiments indicated that high affinity [3H]-nicotine 
binding sites were not enriched in SJCs or the solubilised SPM-SJC preparations 
(figure 3.9).Calculations show that 1 rat brain (1.2g) produces 8mg P2b (720fmol 
nAChR) which produces 0.12mg SJC (20.5fmol nAChR) and O.lmg SPM-SJC 
(20fmol nAChR). Each of these 2 receptor populations represent about 2.8% of 
the high affinity [3H]-nicotine binding nAChRs measured in P2b preparations. 
These results should be interpreted with some caution, because the protein 
concentration and ligand binding (cpm) were low, but they show that high affinity 
[3H]-nicotine binding sites are present at the synaptic junction (SJC) and away 
from the synaptic junction (SJC-SPM) in synaptosomes. It was not considered a 
worthwhile use of resources to pursue these experiments further, a precise 
determination of the nAChR content of SJC or SPM would be difficult to achieve 
and the additional information gained would be negligible.
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Figure 3.9 The binding of r3Hl-nicotine to synaptic junctional 















Figure 3.9.a displays the results of experiments to determine specific binding of
[3H]-nicotine to SJC (n=4) and SPM (n=2) in cpm. SEMs shown.










Figure 3.9.bdisplays the results of experiments to determine specific binding of
[3H]-nicotine to SJC (n=4) and SPM (n=2) in fmol/mg protein. SEMs shown.
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3.3.3 Subcellular localisation using discontinuous density 
Percoll gradients; optimization of conditions
An examination of the distribution of nAChR subtypes which bind [3H]-nicotine
at high affinity was compromised in previous experiments by the presence of
Percoll: Percoll binds [3H]-nicotine in a manner which mimics specific binding to
the receptor (Wonnacott and Wilkie, 1991). This observation was confirmed by 
measuring [3H]-nicotine and [3H]-cytisine binding by filtration (section 3.2.6) to 
buffer blanks containing Percoll (figure 3.10).The specific binding of [3H]-nicotine 
(2009 fmol/ml Percoll) is far greater than the specific binding of [3H]-cytisine (216 
fmol/ml Percoll) to Percoll: both represent unacceptably high levels. The value 
of for specific [3H]-nicotine binding is similar to the value of for specific 
[3H]-cytisine binding (Lippiello and Fernandes, 1986, 1888; Pabreza et al, 1991; 
further references in section 1.3). The concentration of the a4£2 isoform in 
Percoll fractions was measured using [3H]-cytisine binding, because its binding is 
less compromised by the presence of Percoll. The degree of ligand binding to 
Percoll seemed largely unaffected by freezing or short term storage (4°C) of the 
filtered Percoll solution.
Three approaches were taken try to minimize the effect of Percoll upon [3H]- 
cytisine binding:-
a) Repeated washing by centrifugation. P2 membranes were extensively 
centrifugally washed before the measurement by [3H]-cytisine binding. Percoll 
forms a very dense gelatinous precipitate during high speed centrifugation, which 
is harder to resuspend than tissue pellets. It was possible to remove all/most of 
the Percoll, this was confirmed by binding assay (figure 3.11, preparation 1),
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Figure 3.10.ashows [3H]-cytisine binding and figure 3.10.bshows [3H]-nicotine binding to:-
1) 50:50Tris/HEPES:sucrose, n = 3
2) 50:50Tris/HEPES:23% Percoll in sucrose, n= 4 . Fresh Percoll.
3) 50:50Tris/HEPES:23% Percoll in sucrose, n = 2. Percoll suspension frozen after preparation.
4) 50:50Tris/HEPES:23% Percoll in sucrose, n= 2 . Percoll suspension stored for 3d, at 4°C , after
preparation.
5) 50:50 Tris/HEPES:23% Percoll in sucrose, n =  2. Percoll suspension stored for 4d, at 4°C.
6) 50:50Tris/HEPES:23% Percoll in sucrose, n = 2 . Percoll suspension stored for 5d, at 4°C.
SEMs shown. Mean specific binding to Percoll suspension:-
a) 216 fmol [3H]-cytisine/ml of original (ie 100%) Percoll suspension
b) 2009 fmol [3H]-nicotine/ml of original Percoll suspension
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Figure 3.11 The binding of T3 HI-cytisine to P2 preparations in 
the presence and absence of Percoll
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Controls were performed to determine if methods could be established, which minimized the effect 
of Percoll upon [3H]-cytisine binding. In figure 3.11.a two types of preparation are displayed:- P2 
preparation containing Percoll ( ), P2 preparation containing no Percoll ( Cdi ). This figure
compares 3 assays:-
1) Filtration of heavily washed P2 membranes. n =  3 .0.5ml samples.
2) Filtration of the detergent extracts, n = 4 .0.5ml samples.
3) Immunoprecipitation of the nAChR from detergent extracts using Rogers antisera and Pansorbin 
cells. n= 4 . 1.0ml samples.
Note, in these experiments care was taken to match the protein concentration of Percoll/no Percoll 
pairs, however figure 3.11.a displays raw data, which has not been corrected for protein 











Figure 3 .ll.bdisplays the same data as figure 3.11.a,except specific binding is expressed in terms 
of fmol/mg of protein, corrected for detergent concentration in the case of measurement approach 
(2). Statistical analysis (t-test of all pairs) indicates (not shown) that there is no difference at the 
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Figure 3 .ll.cdisplays the relationship between [3FI]-cytisine binding to pairs of P2 membranes 
containing and not containing Percoll, ie for each experiment in each approach to binding the value 
of: P2 preparation containing Percoll x 100%
P2 preparation not containing Percoll 
is determined. Statistical analysis (t-test of all pairs) indicates (not shown) that there is no difference 
at the 0.05 level between (1), (2) and (3). SEMs shown.
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however the resuspension of tissue pellets was very difficult without the parallel 
resuspension of Percoll pellets. This approach was unsatisfactory, because any 
potential Percoll resuspension would become a significant factor when examining 
samples containing low protein concentrations.
b) Filtration of detergent extracts. The problems of pellet resuspension were 
avoided by performing a detergent extraction upon P2 membranes (± Percoll). No 
washing was required because all the Percoll and non-solubilized material formed 
a pellet during centrifugation, the filtration assay was performed upon the 
solubilized material (figure 3.11, preparation 2). The effects of Triton upon the 
filtration assay were reduced by dilution of extracts (0.5% v/v to 0.25% v/v 
Triton), however the variance associated with low specific binding using the 
filtration assay to preparations could not be avoided, protein concentration was 
lowered (yield 28%) by extraction and Triton concentrations were relatively high.
c) Immunoprecipitation of detergent extracts. Immunoprecipitation (using 
antibodies against ot4 and £2 donated by S. Rogers) of detergent solubilized 
nAChRs which had been exposed to [3H]-cytisine (see section 3.2.10) was found 
to be unaffected by the presence of Percoll in the original preparation (figure 
3.11, preparation 3). Specific binding of [3H]-cytisine, measured by the 
precipitation assay (section 3.2.10), approaches the level of binding to 
preparations in the absence of Triton by the filtration assay indicating that this 
approach to measuring [3H]-cytisine binding was unaffected by Triton. Non­
specific binding was far higher (10 times: lOOOcpm cf lOOcpm) than non-specific 
binding measured in filtration assays and so this approach was less accurate than
(b), especially at low protein concentrations, because of the relatively high non­
specific to specific binding ratio (Lunt, 1987; Yamamura et al, 1985)!
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In summary, the best approach to measuring nAChR in Percoll fractions was the 
filtration (b) of detergent extracts. The immunoprecipitation assay (c) is not as 
accurate as the filtration of detergent extract assay (b), however the results of this 
assay do reinforce the proposition that the nAChR isoform which is measured is 
the a4S2 subtype.
3.3.4 Subcellular localisation using discontinuous density 
Percoll gradients: Examination of Percoll gradients
The SI fraction prepared from rat brain cortex was separated using discontinuous 
density Percoll gradients (section 3.2.4). Figure 3.12 displays the protein 
distribution infractions from Percoll gradients. Figure 3.13displays the results of 
[3H]-cytisine binding to fractions from Percoll gradients, measured by the filtration 
assay. No washing was performed after resuspension to 11 ml. Figure 3.14displays 
the results of [3H]-cytisine binding to detergent extracts of fractions from Percoll 
gradients (section 3.2.4),measured by the immunoprecipitation assay. The protein 
recovery during detergent extraction was approximately 28% in all fractions. The 
specific binding to F5 cannot be negative as indicated. The recovery of [3H]- 
cytisine binding proteins was unexpectedly high considering the overall level of 
protein recovery. Figure 3.15 displays the results of [3H]-cytisine binding to 
detergent extracts of fractions from Percoll gradients (section 3.2.4),measured by 
the filtration assay. The protein recovery during detergent extraction was 
approximately 28% in all fractions. The preparations were concentrated 4 fold 
before extraction. These experiments indicate that nAChRs are concentrated in 
fractions F4 and F5, but the bulk of nAChRs were found in fraction F2. These 
results are interpreted and related to previous studies in section 3.4.3.
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Figure 3.12 The distribution of protein down a discontinuous 
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Figure 3.12.a shows the protein concentration of SI (applied volume 20ml) and 
of the fractions (resuspension volume 11ml) from Percoll gradients (10 parallel 






Figure 3.12.bdisplays total protein recovery (where SI was 100%):- FI (15.7%), 
F2 (37.3%), F3 (22.2%), F4 (5.1%), F5 (3.0%), so the overall protein recovery 
was 83.4%.
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Figure 3.13 The distribution of [3Hl-cvtisine binding down a 
discontinuous density Percoll gradient measured 
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Figure 3.13. a displays the total specific binding of the SI applied to Percoll gradients and of the 
resulting fractions. n = l  throughout.
Figure 3.13.bshould display the recovery of ligand binding proteins (where SI was 100%):- FI 
(16.5%), F2 (67.9%), F3 (33.4%), F4 (15.5%), F5 (11.1%), so the apparent total recovery of "ligand 
binding protein" was 144.4%! Clearly a pie chart is not meaningful.
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Figure 3 .13 .cdisplays apparent concentration of specific [3H]-cytisine binding proteins per mg of
total protein present. n = l  throughout.
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Figure 3.14 The distribution of r3Hl-cvtisine binding down the 
discontinuous density Percoll gradient measured 












Figure 3.14. a displays the total specific binding of the SI applied to Percoll gradients and of the 
resulting fractions as determined by the immunoprecipitation assay using Rogers anti-sera and 
Pansorbin cells. n = l  throughout.
Figure 3 .14.bdisplays the recovery of ligand binding proteins (where SI was 100% ):-FI (1.7%), F2 
(35.2%), F3 (18.6%), F4 (7.2%), F5 (-1.1 %), so the apparent total recovery of ligand binding protein
was 62.7%
20
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Figure 3.14.cdisplays apparent concentration of specific [3Hl-cytisine binding proteins per mg of
total protein present. n =  l throughout.
79
Figure 3.15 The distribution of r3H1-cytisine binding down the 
discontinuous density Percoll gradient, detergent 
extracts measured using the filtration assay
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Figure 3.15.a displays the total specific binding to detergent extracts of the SI applied to Percoll 
gradients and of the resulting fractions. n = 5 throughout, SEMs shown.
Figure 3.15.bdisplays the recovery of ligand binding proteins (where SI was 100%):- FI (14.8%), 
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Figure 3 .15 .cdisplays apparent concentration of specific [3H]-cytisine binding proteins per mg of
total protein present. n = 5  throughout, SEMs shown.
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3.3.5 Polyacrylamide gel electrophoresis and immunoblotting
PAGE was used in two ways:-
a) To estimate the concentration of proteins,
b) To immunostain nAChRs.
3.3.5.1 Protein concentration
The concentration of one protein type (IgG), in samples which did not contain 
polypeptides with the same mobility on the PAGE gels (eg BSA), was estimated 
by running a serial dilution of the sample down a polyacrylamide gel (section 
3.2.5.2).Plate 29 demonstrates the use of this method to estimate the protein 
concentration of a Lindstrom monoclonal antibody. The protein concentration of 
Lindstrom monoclonal antibodies is shown in table 2.1, the same technique was 
used to verify the concentration of biotinylated Lindstrom antibodies.
3.3.5.2 Immunostaining
The optimal protein concentration for PAGE differs with sample composition and 
gel size. An appropriate sample dilution had to be found, before proceeding with 
immunostaining. The optimal concentration of P2b samples (20/xl) using the 
minigel system as described in section 3.4.1 was found to be 1.5 mg protein/ml 
(plate 30), this concentration and volume was used for immunostaining trials. The 
concentration of the o4S2 in P2b samples was 45 finol/mg protein (section 4.4.1.1, 
5.3.4.1),thus each lane contains 1.4fmol (or 0.34 ng) of nAChR.
Antibody biotinylation and preliminary immunostaining work, using biotinylated
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Lindstrom antibodies, detected using the Vector stain system was performed, 
under my supervision, by C.Billington (1992, unpublished: fourth year project 
report). The subunits of immunopurified nAChR were detected by immunoblot 
analysis using biotinylated Lindstrom mAbs detected by the peroxidase-conjugated 
Avidin (Billington, 1992, unpublished).
The results of immunostaining experiments using Lindstrom antibodies for the 
direct recognition of nAChR in P2b preparations, without preliminary receptor 
purification, are summarized in plates 31, 32 and 33. These plates show Western 
transfers of lanes from PAGE of P2b in parallel with dot-blot controls (figure 
3.16) using the three approaches to immunostaining with Lindstrom antibodies 
(section 3.2.7.3).Dot blot controls provided the following information: -
a) The biotinylated mAbs and the mAbs were recognized by the peroxidase 
conjugated anti-rat IgG antibodies.
b) The biotinylated mAbs were recognized by the peroxidase conjugated Avidin 
and by 125I-Avidin, but neither recognized mAb cocktails which had not been 
biotinylated.
c) There was a low level non-specific tissue recognition by all secondary probes 
which increased with secondary probe concentration, however the majority of the 
dot coloration seen in the photographic plates was due to the slight colour of the 
P2 preparation itself.
d) Goat anti-(rat IgG) antibodies were not recognized under any of the conditions 
investigated.
Immunoblotting PAGE transfers was not sensitive enough to detect the a4 or £2
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Figure 3.16 The layout of dot blot controls
Dot blot controls were placed at the top of each nitrocellulose strip representing 
one well from PAGE experiments. The strips were then immunostained.
Figure 3.16a shows the layout for plates 31 and 32,
Figure 3.16b shows the layout for plate 33
Controls
A biotinylated mAb cocktail (5/xl)
B P2 membranes (5/il)
C Goat (anti-rat IgG) antibody (5/xl)
D mAb cocktail (5/zl of 1/20)
a ) b)
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subunits in the P2b preparation. There was some non-specific staining, for 
example when secondary probes were used in excess, but the following 
observations indicated the absence of specific staining:-
a) the banding pattern after immunostaining was the same in the presence and 
absence of primary probe (plate 34)
b) the banding pattern after immunostaining was the same regardless of which 
Lindstrom antibody was used as primary probe (plate 35, 36 and 37)
c) the molecular mass of the bands which were visible after immunostaining did 
not correspond to the molecular mass of the a4 (79kD) or the £2 (51kD) subunits 
detected by immunoblotting immunopurified receptors (Whiting et al, 1987c; 
Whiting and Lindstrom, 1987).
These experiments were performed in triplicate and a variety of enhancement and 
blocking conditions were tried for each approach (only a representative example 
is shown), but each of the three approaches to immunostaining nAChRs directly 
in tissue preparations using Lindstrom mAbs were unsuccessful.
3.3.6 Indirect nAChR detection by ELISA
An attempt was made to use ELISA to detect nAChRs in synaptosome 
preparations. Figure 3.17 displays a representative experiment: mAb detection was 
demonstrated (no washing), but the non-specific signal (controls) was high and 
there was no detectable specific nAChR signal (rat IgG in washed samples). 
Calculation indicated that if specific recognition had occurred, it probably would 
not have been detectable using this approach to ELISA: using the recommended 
protein concentration for samples (10/xg/ml), each microtitre well contained
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Synaptosome preparations (P2b) were exposed to PBS ± mAb (0.4% v/v cocktail) 
then washed a recorded number of times. Samples were taken before each wash 
and the level of rat IgG measured by ELISA (5AS oxidation, 30 min). SEMs 
shown, n =4. Statistical analysis (t-test) of ELISA measurements indicated: 
after no washes ± mAb exposure samples differ at the 0.05 level (t=30), 
after 1 wash ± mAb exposure samples differ at the 0.05 level (t=3), but do not 
differ at 0.025, and after 4 washes ± mAb exposure samples do not differ at the 
0.05 level.
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approximately 0.07 fmol (17 pg) of nAChR. If one assumes each receptor was 
recognized by two antibody molecules, then the detection of this specific staining 
would cause an increase of 0.0025 Absorbance units per ELISA well, ie 1% of the 
non-specific staining. Experiments were performed to reduce the level of non­
specific staining, they are not shown. The level of non-specific staining was 
reduced in these experiments, but the variation between samples was 
considerable. The use of ELISA was not pursued, because this approach was 
judged to be too insensitive to measure nAChRs from synaptosome preparations 
without prior immunopurification (section 3.4.5), but it initiated the use of 
potentially more sensitive immunostaining approaches described in section 3.3.7.
3.3.7 Immunostaining tissue in free suspension
Synaptosomes were immunostained in free suspension using a procedure based 
on ELISA and prefixation immunogold staining (section 3.2.9). This technique 
had 3 advantages over ELISA:-
a) There was a lower probability of non-specific staining, because of there was no 
matrix which might adsorb proteins.
b) More sample, containing more nAChR, can be immunostained increasing the 
probability of detection.
c) Large volumes of washing vehicle can be used increasing washing efficiency.
Whilst its advantage over prefixation immunogold staining related to the nature 
of the secondary probe :-
a) Probe dissociation was very unlikely (Hayat, 1989a, b; Williams, 1977b)
b) Detection was easy on a macroscopic scale.
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Two types of secondary probe were used in attempts directly to immunostain 
nAChR in a tissue preparation in free suspension (section 3.2.9).
When peroxidase conjugated anti-rat IgG antibodies were used to immunostain 
tissue in free suspension, anomalous results were found. Figure 3.18a shows how 
the level of 5AS oxidation caused by controls (ie no mAb exposure) rises with 
samples taken from each successive wash after exposure to the secondary probe. 
The same trend was seen in samples which had been exposed to mAbs (Figure 
3.18b). No specific staining was apparent in these experiments. Section 3.4.6 
describes why this approach was unreliable, initiating the use of an alternative 
secondary probe (125I-Avidin).
The use of 125I-Avidin as a secondary probe for immunostaining avoided the false- 
signal problem encountered using the peroxidase conjugated anti-rat IgG 
antibodies as a secondary probe. In both control and cocktail exposed 
preparations some non-specific staining was measured (about 0.1 fmol of 125I- 
Avidin per mg of protein). With each wash, between exposure to secondary probe 
and measurement, the level of non-specific staining fell equally in both 
preparations (figure 3.19). However, despite the potential sensitivity of this 
approach, no specific staining was measured in tissue preparations which had 
been exposed to a biotinylated monoclonal cocktail relative to control (no 
monoclonal exposure) preparations. Section 3.4.7describes the interpretation of 
this result.
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Figure 3.18 Immunostaining tissue in free suspension using
peroxidase conjugated probes to detect mAbs
a
] 2 3 4 5
Num ber  of w a sh e s  be fore  sampl ing
Figure 3.18. a displays immunostaining results for control P2b preparations, which 
had not been exposed to mAb cocktails prior to washing (lOOOg, lOmin, diluted 
2%v/v with PBS) and mAb detection (as section 3.2.9).n= 3 , SEMs shown.
b
o. 2
Num be r  of w a sh es  be fore  sampl ing
Figure 3.18.bdisplays immunostaining results for mAb exposed P2b preparations 
(washing 500g), n = l .
Figure 3.19 Immunostaining tissue in free suspension using a 
125I-Avidin probe to detect mAb binding
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P2b preparations were exposed to PBS ± mAb (0.4% v/v cocktail), then to 125I- 
Avidin (section 3.2.9).Note 1% v/v 125I-Avidin was 250 x 1017 mol 125I-Avidin/mg 
protein in the P2b preparation. The preparation was washed by centrifugation 
(l,000g, lOmin, preparation 2 %v/v in PBS) a recorded number of times, 3 
samples were taken before each wash. The pellets from centrifugation of the 
samples (l,000g,5min, microfuge) were placed in a Gamma Counter to measure 
125I content. SEM shown, n=2.  Statistical analysis (t-test) indicate for a given 
number of washes the level of 125I-Avidin binding to mAb exposed and control are 
not different at the 0.05 level.
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3.4 Discussion
3.4.1 Characterization of r3Hl-nicotine binding assay
The accuracy in determining specific binding is improved by reducing the non­
specific relative to specific binding (Romano and Goldstein 1980), eg by using a 
different buffer (Romm et al, 1990) as described in section 3.3.1.Ligand binding 
to buffer blanks (section 3.3.1),containing less than 0.5% v/v Triton, was constant 
demonstrating that non-specific binding is mainly due to the association of the 
radioligand or of radiolabelled contaminants in the radioligand (Romm et al,
1990) with the filter (Romano and Goldstein 1980; Schwartz et al, 1982). The 
variation in total and non-specific binding to buffer blanks where no specific 
binding was expected (figure 3.6) was probably attributable to random fluctuation 
in filtration conditions, which cannot be made more consistent, because the 
vacuum for each filter varies and the viscosity of the filtered solutions also varies. 
If the Triton concentration is high (0.5% v/v) the filtration time is over 40 sec 
and there is a tendency for other filters to be dried relative to the high Triton 
filter and ligand dissociation is increased (Lippiello and Fernandes, 1986,1988).
The storage parameters for both detergent extracts and Tris/HEPES buffer were 
established (section 3.3.1).The deterioration of specific binding with buffer age 
probably reflected bacterial or chemical breakdown of buffer components, 
because freezing resolved the problem. Deterioration was not explored further, 
because an adequate approach had been established.
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3.4.2 Analysis of synaptic junctional complexes and svnaptic 
plasma membranes
Both SJC and the detergent solubilized (SPM-SJC) contained high affinity [3H]- 
nicotine binding proteins in approximately equal amounts, perhaps reflecting 
heteroreceptors and autoreceptors respectively (figure 3.20; section 1.1).In these 
preliminary experiments, the protein concentration and the level of [3H]-nicotine 
binding was low and errors were fairly high, but clearly a significant proportion 
of the o4£2 nAChRs were not present in the synaptic cleft. Other evidence 
reinforces this conclusion. The detergent extraction procedure would remove the 
dense SJCs by precipitation during centrifugation (Taylor and Cotman, 1972) and 
this confirms that at least 28% of the o4£2 were not present at the SJC, 
furthermore the distribution of SJC prepared from Percoll fractions overlaps with, 
but does not mirror, [3H]-nicotine binding (table 3.1; section 3.4.3). The a4£2s 
were not enriched in either preparation relative to P2b preparations and 
approximately 12% of synaptosomes have attached postsynaptic densities (eg 
Dunkley et al, 1988). It seems that a4£2 in the synaptic cleft represent a relatively 
small fraction of the total o4£2 nAChR population. It is interesting to note that 
Baude etal (1993) localized the metabotropic glutamate receptor mGluRla using 
immunogold electron microscopy to a perisynaptic position, ie the receptors 
formed a ring around the synaptic junction. It is likely that the role of this 
metabotropic receptor is synaptic modulation, ie the same role proposed for the 
the presynaptic o;4£2 nAChR (section 1.4). However, immunolocalization of 
nAChRs present in the synaptic junction and cleft (SJC) might be sterically 
hindered by the cleft matrix, essentially as described in interpretation (b), section 
5.4.3.Matrix digestion would be problematic, because the nAChRs are sensitive
Figure 3.20 Receptor locations
heteroreceptor?
°<p cu o0 ©
autoreceptors
Postsynaptic receptors
Presynaptic receptors may be autoreceptors which respond to neurotransmitter 




The distribution of protein down Percoll gradients
A B C D
F1 1 5 . 7  ( 2 . 8 ) 2 1 . 9  ( 5 . 4 ) 7 . 0  ( 1 . 6 ) 2 . 3  ( 1 . 8 )
F2 3 7 . 3  ( 5 . 2 ) 3 3 . 0  ( 3 . 4 ) 2 6 . 3  ( 1 . 6 ) 1 2 . 3  ( 3 . 5 )
F3 2 2 . 2  ( 2 . 6 ) 1 2 . 2  ( 3 . 4 ) 1 4 . 0  ( 0 . 8 ) 1 4 . 8  ( 2 . 8 )
F4 5 . 1  ( 1 . 2 ) 8 . 0  ( 1 . 2 ) 8 . 2  ( 1 . 2 ) 1 0 . 3  ( 2 . 7 )
F5 3 . 0  ( 1 . 5 ) 6 . 7  ( 1 . 3 ) 4 . 5  ( 0 . 4 ) 3 . 9  ( 1 . 7 )
R eco v ery 8 3 . 4 81 . 8 3 5 . 6 —
The distribution of protein down Percoll gradients is compared to previous studies 
in Table 3.1, SEMs are shown in brackets. Column A shows the protein 
distribution infractions from Percoll gradients described in section 3.4.3 (n= 5). 
Column B shows the protein distribution in fractions from Percoll gradients 
described by Dunkley et al, 1988 (n=4). Column C shows the protein distribution 
in fractions from Percoll gradients described by Thome etal, 1991 (n= 6). Column 
D shows the proportion of synaptosomes which have attached post synaptic 
densities (PSDs) described by Dunkley et al, 1988 (n=4).
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to most proteases (Whiting and Lindstrom, 1986b, c). These experiments could 
have been pursued, eg employing a more sensitive protein assay and performing 
more replicates in order to reduce the standard error of the mean, but time 
constraints prevented a deeper study.
3,4.3 Subcellular localisation using discontinuous density 
Percoll gradients
The distribution of protein between Percoll fractions of SI prepared from rat 
cortex was similar to previous experiments (Table 3.1; Thome, 1990), the 
differences were probably due to minor differences in preparation, or interface 
removal, or variations in protein estimation and [3H]-ligand measurement. The 
variance in protein estimation and ligand binding are large in this and the 
previous studies (protein: Table 3.1; Thome, 1990. Ligand: Bames et al, 1992; 
Thome et al, 1991). The degree of extraction seemed constant (about 28% protein 
recovery) for all Percoll fractions.
When the filtration assay was performed on fractions without detergent extraction 
or extensive washing, the recovery of specific [3H]-cytisine binding was much 
greater than 100%. This demonstrates the specific [3H]-cytisine binding to Percoll, 
but no meaningfully interpretation of nAChR distribution can be made, because 
the Percoll concentration varies in different fractions! Note, previous studies 
(Bames et al, 1992; Thome et al, 1991) report elevated levels of recovery of 
specific [3H]-nicotine binding sites.
As anticipated (section 3.2.4), the standard error of the mean in non-specific
binding estimation using the immunoprecipitation assay (b) were larger than the 
low level of specific [3H]-cytisine binding: thus the potential errors in specific 
binding measurement were large. This assay gave good estimates, compared with 
the filtration assay, of specific binding to fractions F2, F3 and F4 which contain 
high protein or high nAChR concentrations; but very poor estimates of specific 
binding to fractions FI and F5, which contain low nAChR and low protein 
concentrations respectively. This approach does confirms that the filtration assay
(c) predominantly measures nAChR which bind [3H]-cytisine with high affinity and 
contain oi4 and/or £2 subunits (section 1.3). But, as anticipated in section 3.3.3, 
immunoprecipitation was inappropriate for a quantitative analysis of Percoll 
fractions.
Percoll fraction analysis using the filtration assay gave a picture for the subcellular 
distribution of specific [3H]-cytisine binding sites which was consistent with 
previous localization data (section 1.4). The majority of specific ligand binding 
sites (fmol) were detected in the F2 fraction: fractions F4 and F5 represents only 
23% of detectable binding sites. However, specific ligand binding (fmol/mg 
protein) was concentrated in fractions F4 and F5. Similar results were reported 
in previous studies, using different brain regions (Bames et al, 1992; Thome et al,
1991), which also show increasing specific [3H]-nicotine (fmol/mg protein) to 
fractions down the Percoll gradient (FI to F5). These results must be carefully 
interpreted to deduce the subcellular localization of the a4£2 isoform. The 
distribution of nAChRs and synaptosomal neurotransmitter content cannot be 
reliably linked using this technique. The distribution of certain neurotransmitters, 
eg noradrenaline (Harrison et al, 1988) and to a lesser extent acetylcholine
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(Thome etal, 1991), do mirror the distribution of the nAChR: the distribution of 
other neurotransmitters, eg dopamine (Harrison et al, 1988), do not. Despite 
apparent correlations there is a considerable distributional overlap, furthermore, 
the concentration of a4£2 is low and its dispersion unknown. It is entirely possible 
that this nAChR is widely dispersed, at low concentrations, over many subcellular 
particles, eg many synaptosomes, each with low nAChR concentration: 
alternatively or additionally the nAChRs may be concentrated to a very small 
subpopulation of subcellular particles, eg a small subpopulation of synaptosomes 
each with high nAChR concentration.
Similarly, analysis of each fraction indicates that moving down the gradient (FI 
to F5) there is an increase in the numbers of large (Dunkley et al, 1988), 
synaptosomes, which contain mitochondria (Dunkley et al, 1988) and are 
functionally and metabolically viable (Harrison et al, 1988): functional 
synaptosomes are most enriched in fraction F4. The most probable interpretation 
is that ligand binding to fractions F5 and especially F4 measures the concentration 
of presynaptic o4£2 nAChRs and the binding to other fractions measures the 
concentration of that isoform at other sites. But synaptosomes and other 
subcellular structures are found in all fractions from the Percoll gradient (Dunkley 
et al, 1988; Thome et al, 1991). It is conceivable, though improbable, that the 
correlation between a high concentration of specific ligand binding sites and 
enrichment of functional synaptosomes in fractions F3, F4 and F5 is coincidental 
and does not reflect presynaptic localization. The possibility that the cx4&2 which 
were detected in Percoll fractions were exclusively postsynaptic and merely 
associated with attached postsynaptic densities was rejected for 4 reasons:-
9 6
a) the distribution of PSDs falls in F4 and F5 (table 3.1)
b) section 3.4.2demonstrates that a significant proportion of the nAChRs are not 
associated with the PSD
c) the distribution of postsynaptic receptors, eg muscarinic AChRs in the 
hippocampus (Thome et al, 1991), show a completely different distribution, they 
are concentrated in FI and F2 and virtually absent from F4 and F5.
d) an exclusively postsynaptic distribution would contradict the results of lesion 
studies and neurotransmitter release studies which demonstrated presynaptic 
nAChRs (section 1.4)
These results strongly indicate, but do not conclusively demonstrate, that at least 
23% of o;4S2 receptors are located presynaptically, this compares favourably with 
previous studies (section 1.4;Wonnacott, 1987a). The presynaptic a4£2 receptors 
seem to be concentrated on large terminals which survive enrichment using the 
Percoll gradient. These experiments could have been pursued (as section 3.4.2), 
eg employing a more sensitive protein assay and performing more replicates in 
order to reduce errors, but time constraints prevented a deeper study.
3.4.4 PAGE and dot-blot analyses
The dot blot analyses confirmed that primary probe detection was successful and 
specific, using the relevant secondary probes, and that non-specific recognition 
occurred at high secondary probe concentrations.
The concentration of the a4£2 in each PAGE lane was 1.4 fmol or 0.34 ng 
(section 3.3.5.2).Although these approaches to immunoblotting can theoretically
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detect less than lOpg per lane (De Bias and Cherwinski, 1983; Towbin et al, 
1979), the mAbs are relatively poor immunoblotting probes (Lindstrom person, 
comm.). Successful immunoblot experiments reported by Whiting and Lindstrom 
(1987) used a 100-fold higher receptor concentration per lane (0.5-2.0pmol/lane), 
by examining immunopurified receptors with Lindstrom mAbs and 125I-labelled 
goat anti-rat IgG. Immunoblotting experiments were not pursued further: 
considerable information had been obtained, but it was clear that the system used 
would not be sensitive enough using the Lindstrom mAbs to detect a4 and £2 
subunits directly in tissue preparations.
3.4.5 ELISA detection of immunostaining
The ELISA attempts (section 3.3.6)demonstrated that the mAbs were recognized 
by the peroxidase conjugated anti-rat IgG antibody probes, but there was 
considerable non-specific staining by the peroxidase conjugated anti-rat IgG 
antibody probes. No specific recognition of the nAChR in P2b preparations by the 
mAbs could be measured using the peroxidase probe. More sensitive approaches 
to nAChR detection were not pursued, because of the high level of non-specific 
staining. It was recognized that ELISA was not sensitive enough to be used 
reliably to detect nAChRs in P2b preparations, and the only viable approach 
remains that taken by the Lindstrom group, ie the detection of immunopurified 
receptors (section 1.4). Unfortunately the detection of immunopurified receptors 
compromises nAChR quantification (section 3.1.1) and provides a poor control 
for immunostaining and immunoaffinity experiments (section 3.1.2).
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3.4.6 Immunostaining nAChRs in P2b preparations using mAbs 
and peroxidase conjugated anti-rat IgG antibodies
Figure 3.18 shows the level of 5AS oxidation per mg of protein, the oxidative 
power of samples rises with centrifugal washing, even if the level of 5 AS oxidation 
was measured relative to sample volume (a constant for all samples!). The 
increase in oxidative power of samples with preparation washing (section 3.3.7; 
figure 3.18) was due to the release of oxidative enzymes by mitochondrial damage 
during centrifugation (Alberts et al, 1983). This trend was found in mAb exposed 
and control samples taken during the washing of preparations. Even if specific 
binding had occurred its detection would have hindered by the fact that neither 
preparation had constant oxidative power. This approach to immunostaining 
nAChRs was clearly unreliable.
3.4.7 Immunostaining nAChRs in P2b preparations using 
biotinylated mAbs and 125I-Avidin
The potential sensitivity of 125I-Avidin detection of nAChR bound mAbs was far 
greater than detection using peroxidase-anti(rat-IgG) antibody conjugates (section 
3.4.6),see (d) below. This sensitivity, combined with the specificity of the Avidin- 
biotin reaction (appendix A.3), allowed an approach to immunostaining P2b 
preparations, which was very sensitive to any specific recognition of epitopes by 
the biotinylated monoclonal antibodies. No specific recognition of nAChRs 
containing the o4 or 152 subunit subtypes was detected (section 3.3.7)and it seems 
inconceivable that any specific binding would not have been detected using this 
method:-
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a) The recognition of the biotinylated mAbs by I25I-Avidin had been confirmed by 
dot blot analysis (section 3.4.4).
b) Some of the 125I-Avidin bound directly to the P2b preparations. This 125I-Avidin 
was gradually removed by washing, indicating low affinity attachment.
c) The level of 125I-Avidin binding was identical in mAb exposed and control (no 
mAb) tissues. When results were analyzed in pairs, such that samples ± mAb 
exposure were matched for each wash and for each experiment, the difference 
caused by mAb exposure was even less: there was no difference between samples 
± mAb exposure, using the t-test at the 0.05 level. This observation indicates that 
immunostaining to the P2b preparation was entirely non-specific.
d) The concentration nAChRs was approximately 45 fmol/mg protein. The level 
of non-specific binding was in the order of 0.1 fmol of 125I-Avidin per mg of 
protein and triplicate samples did not differ greatly (figure 3.19). The variation 
between measurements of 125I-Avidin in parallel experiments was small. During 
mAb exposure, the cocktail of primary probes had been present in excess (10’s of 
pmol mAb/mg protein), after washing the preparations had been exposed to 4 
fmol of labelled Avidin per mg protein (1 fmol 125I-Avidin measured 14,600 cpm).
A very similar approach to receptor recognition was reviewed by Lindstrom 
(1984). Detergent solubilized nAChRs were labelled using 125I-tagged probes and 
immunoprecipitated. A plausible approach to examining receptor recognition 
under different Triton concentrations might be to use the mAb/125I-Avidin system 
to immunostain nAChRs which had been detergent solubilized and then attached 
to Sepharose, using Rogers antisera. This approach was not taken for 4 reasons:-
a) the attachment of Rogers antisera to the M3-M4 region might cause long range
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conformational changes to the receptors, altering epitope availability
b) this approach involves Triton exposure then removal and so it is inappropriate 
for an examination of the effects of Triton concentration upon recognition.
c) Triton X-100 is difficult to remove from nAChRs (Lindstrom, 1985)
d) Triton X-100 is readily iodinated (Lindstrom, 1985).
The 125I-Avidin immunostaining experiments were performed, as controls, in 
parallel to immunoelectron microscopy experiments. Unlike the immunogold 
staining techniques, this approach to immunostaining is not vulnerable to 
extensive probe dissociation during centrifugation, because the 125I-Avidin has low 
density and high binding affinity. Unfortunately, the 125I-Avidin immunostaining 
demonstrates that none of the 4 Lindstrom mAbs recognize the nAChR in 10 mM 
PBS (pH 7.4), as suggested by immunoelectron microscopy (section 4) and 
immunoprecipitation (section 5) experiments.
Chapter 4 Tmmnnoelectron microscopy
4.1 Introduction
When immunolocalization experiments are performed to localize neurotransmitter 
receptors, the usual approach involves staining tissue blocks (appendix A. 1). The 
aim of the experiments described in section 4 was to immunostain subcellular 
particles (section 1.6). Synaptosome preparations were examined, because of the 
high concentration of high affinity [3H]-nicotine binding sites (Rapier et al, 1990; 
Yoshida and Imura, 1979; section 1.4; appendix A.4) and in order to relate to 
immunoprecipitation experiments (section 5). This study continued previous, 
unpublished work, performed in our laboratory by B. Thome, which had 
unfortunately been compromised by high levels of non-specific immunogold 
staining. Immunoelectron microscopy of synaptosomes was performed with 3 
initial aims:-
i) to assess the viability of immunostaining
ii) to evaluate the subcellular distribution of nAChRs
iii) to evaluate the viability of dual staining
The results of immunoelectron microscopy (section 4) and parallel experiments 
(sections 3 and 5) indicated that the Lindstrom mAbs did not recognize the 
nAChR isoform under physiological conditions, thus the latter two aims could not 
be pursued. The experiments described in section 4 relate to an assessment of the 
viability of immunostaining and preliminary, unsuccessful attempts to detect 
immunostaining.
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The optimal conditions for electron microscopy of synaptosomes were established 
in the late 1960’s (review: Jones, 1975 Chapter 3), but various conditions have 
been used for an immunoelectron microscopy of synaptosomes (eg Lentz and 
Chester, 1977; Richardson et al, 1984) and related structures (Ratman et al, 
1986a). Appendix A outlines the background to experimental decisions, 
summarizes the available methodological options, and describes the choice of 
initial preparative approach. Two representative approaches to immunostaining 
synaptosomes (P2b and Hb, see section 3.2.2) for nAChRs were evaluated and 
developmental variations to the basic protocols (section 4.2) performed with the 
aim of optimizing preparative conditions are described in section 4.3 (results)
a) Prefixation immunostaining. Specimens containing synaptosomes were 
immunologically stained for the a4 and the £2 subunit subtypes of nAChR, then 
prepared for examination with an electron microscope. This technique tends to 
produce excellent micrograph images, but it is most appropriate for freely 
accessible epitopes.
b) In postem bedding im m unostaining experim ents p reparations were 
immunostained after specimens had been prepared for electron microscopy, but 
prior to chemical staining, which allows specimen visualization. This technique 
produces micrographs of lower quality and only a fraction of epitopes are 
immunostained, so it is less sensitive, however it allows the detection of epitopes 
regardless of location, because there is immunological access to all parts of the 
cell.
If immunoelectron microscopy had been not been compromised by an unexpected 
failure of the antibodies to recognize the nAChR subtype, it could have been
expanded to help determine the functional role of the isoform. Immunoelectron 
microscopy could reveal the density and distribution of the isoform on subcellular 
particles in preparations from different brain regions and dual staining techniques 
could be used to examine the distribution of neurotransmitters and other 




4.2.1 Immunostaining and fixation of the sample
Hb and P2b synaptosome preparations prepared from whole rat brains (each 
minus cerebellum) were initially suspended (section 3.2.2) in sucrose from the 
0.8M/1.2M interface (pH 7.4, 4°C). Unless otherwise stated, all incubations 
described in this section: -
a) were performed at 4°C with chilled buffers and equivalent
b) proceeded using end-over-end rotation.
Synaptosome suspensions were diluted with three volumes of chilled PBS and, 
after centrifugation (23,000g, 30min, Sorval), resuspended (homogeniser) in 
chilled PBS which contained 5% w/v milk powder. After blocking (30 min) the 
preparation was washed by centrifugation with 20 volumes PBS (500g, 10 min, 
Sorval) and resuspension in 2ml PBS using a Gilson pipette. The synaptosome 
suspension was incubated (lh, room temperature) with the primary probe 
(Lindstrom antibodies), then washed by centrifugation (500g, 10 min). The 
synaptosome suspension was incubated (lh, room temperature) with the secondary 
probe (lOnm gold particle labelled Avidin). Synaptosome fixation using the dual 
fixation technique (Sabatini et al, 1963) proceeded in 2 stages:
a) Glutaraldehyde was added to the suspension (to 1% v/v), the mixture was 
incubated (lh, room temperature) then diluted with 20 volumes of PBS and 
fixation was terminated by centrifugation (10 min, 500g).
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b) The pellet was resuspended in 1 ml of 0.8% v/v osmium tetroxide in either 
0.32M sucrose or lOmM PBS (pH 7.4, 4°C). Osmium fixation (lh, room 
temperature) was arrested by centrifugation (500g, 10 sec, microfuge).
4.2.2 Embedding the sample
The specimen pellet was treated as a tissue block. It was washed twice by adding 
lml water and, after 10 min, removing the water by aspiration. The pellet was 
fully dehydrated (Hayat, 1989a) using a series of 15 min washes in acetone/water 
mixtures of progressively lower water content (30%, 30%, 50%, 50%, 70%, 70%, 
100% then 100% acetone). Embedding in epoxyresin (Glauert and Glauert, 1958) 
began with an overnight infusion of a 50:50 acetone:resin mix, followed by two 
overnight infusions with pure resin and finally the tissue was placed in fresh resin 
and cured (Marshall, 1980) by heating (60°C, 48 h) in an incubator.
4.2.3 Sectioning and positive staining the embedded sample
The resin block was cut to shape, with a razor, for sectioning of the sample area. 
A glass knife (Latta and Hartmann, 1950), prepared with an LKB knife maker, 
was used for sectioning specimens in an ultramicrotome (review: Hayat, 1989). 
Sections (0.5/mi) were cut for light microscopy to check cutting quality. They were 
heat fixed, stained borax (1% w/v) containing toluidine blue (1% w/v), and 
viewed under oil immersion at 100 fold magnification.
Sections (100-1 lOnm) were cut for electron microscopy using a fresh section of the 
knife, selected by interference colour (Peachey, 1958; Table 4.1), heat spread (to 
around 90nm) and collected on the dull side of a 300 square mesh grid (copper
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Consider the interactions of light with a thin section floating on water: -
a) some light will pass through the thin section,
b) some light will be reflected by the section as the light passes into it, ie at the 
upper (air/section) interface.
c) some light will be reflected by the section as the light passes out of it, ie at the 
lower (section/water) interface.
The reflected light from (b) and (c) will interfere and, as the wavelength of light 
and the thickness of the section determine the degree of constructive or 
destructive interference, the frequencies of light which can be seen will be 
determined by section thickness. To summarise the colour of a thin section 
indicates its thickness. Table 4.1 shows the relationship between colour and 
section thickness. Thus, an approximation of section thickness can easily be made, 
if the thickness must be more accurately determined then the interference pattern 
can be analyzed by spectroscopic measurements (Williams, 1977b).
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or nickel). The mounted sections were positively stained (Reid, 1974). Briefly, 
each grid was incubated section-side-downwards on a drop of uranyl acetate (2% 
w/v, see section 2.2) for 10 min in the dark, humid atmosphere (see Weakley, 
1981), then washed on 4 drops of water. Then, each grid was incubated on a drop 
of Reynolds lead citrate (0.24% lead citrate, section 2.2) for 10 min in a NaOH 
rich atmosphere (Reynolds, 1963), then washed on 4 drops of water. All grids 
were air dried.
Specimens were viewed under the electron microscope at 80 kV. Micrographs 
were taken at 2 magnifications (7.5k and 30k) onto photographic film. Negatives 
were projected onto, or used for contact-prints onto, photographic paper to give 
a final magnification of 30k.
4.2.4 Quantification of observations
Crude measures for the degree of damage to, and the abundance of, 
synaptosomes were used:-
a) The structures which could be characterized as synaptosomes in the analysis 
field were counted and divided into intact (ie outer membrane apparently not 
disrupted) and damaged categories. The degree of synaptosomal damage was 
assessed by estimating synaptosomal integrity, ie the percentage of undamaged, 
recognizable synaptosomes from the entire recognizable synaptosome population:- 
Intact synaptosomes, % = number of intact x 100%
number of detected synaptosomes 
This actually represents an over-estimate of synaptosomal integrity and an under­
estimate of the total synaptosomal damage, because it fails to include
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synaptosomes which were completely destroyed during preparation,
b) Mitochondria are easily characterized and robust structures: it is unlikely that 
many were damaged beyond recognition during specimen treatment and so their 
frequency in the tissue preparations was assumed to be constant. The abundance 
of synaptosome populations was determined relative to mitochondria. A measure 
of the abundance of a synaptosomal population were calculated by dividing the 
number of synaptosomes by the number of mitochondria in a field, 
synaptosome abundance = number of synaptosomes
total number of mitochondria 
In this way the abundance of intact, damaged or detectable (intact + damaged) 
synaptosome populations could be calculated for comparison.
Note, as synaptosomal damage during preparation increases, (a) becomes an 
increasingly poor measure of damage, because it fails to include destroyed 
synaptosomes, (b) becomes unreliable when preparative conditions cause 
m itochondrial damage. Qualitative evaluation, by visual inspection, of 
synaptosomal content and damage is important as it can incorporate the 
abundance of synaptosomal components.
The distribution of gold particles in micrographs was analyzed. A random 
distribution of gold staining is modelled by the Poisson distribution:- 
P(r)=e V /r !  (r= 0 ,1,2,3... p > 0)
where /x is the mean number of gold particles in all quadrats,
P(r) is the proportion of quadrats which contain 
r gold particles
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Quadrats of defined area or volume are examined, generally by placing a regular 
grid of quadrats over a micrograph and counting the contents of each by hand, for 
an accurate analysis of gold distribution a large number (hundreds) of small 
quadrats (containing a mean of 2-5 gold particles) would be required. If sufficient 
quadrats from a micrograph are examined then a chi-squared goodness of fit test 
can be applied to see if the actual frequency of quadrats containing r gold 
particles matches the theoretical frequency predicted by the model. The value of 
chi squared is calculated using the formula :-
( o b s e r v e d - e x p e c t e d  f r e q u e n c y ) 2
for all values where the expected frequency > 5. The expected frequencies of 
< 5 are pooled into groups, such that for each group the sum of expected 
frequencies > 5. The degrees of freedom in this case is equal to number of values 
for expected frequency, which are included in the calculation, minus 2. The t-test 
was used to compare the value of /z for quadrat populations under different 
conditions.
Gold staining is, of course, limited by the abundance of the antigen, which is 
examined. There was a relatively low concentration of the a4£2 subtype in the 
specimen. An estimation of a4£2 subtype abundance based upon [3H]-nicotine 
binding studies (section 1.3) was made from:-
a) the concentration of high affinity [3H]-nicotine binding sites (a4£2),
b) the dimensions of each analysis micrograph,
c) the protein concentration of pellets.
e x p e c t e d  f r e q u e n c y
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As follows
a) [3H]-nicotine binding experiments (section 3.2.6), performed upon P2b 
preparations, measured 90.3 ± 10.8 (SEM, n= 15, figure 5.11)fmol/mg protein 
(section 5.3.4.1),this concentration compares well with previous studies (Irons et 
al, 1989; Wonnacott, 1987a).
b) Section thickness can be estimated, with suitable, if moderate (Williams, 
1977b), accuracy from interference colour (Peachey, 1958). The dimensions of 
each analysis micrograph were 10.00x8.34x0.09 = 7.5 /xm3
c) the protein concentration of P2b pellets was measured using the Lowry 
procedure as 70 mg protein/ml of pellet.
On average, each analysis micrograph was expected to contain 28.5 high affinity 
[3H]-nicotine binding sites or 14 o4£2 receptors (Galzi et al, 1991a). Section 
4.4.1.1 discusses the interpretation of this estimate of o:4£2 receptor abundance.
When specific staining can be shown, stereological methods can be used to 
reconstruct three dimensional information. For a full discussion of these methods, 
refer to Williams (1977a, b) and Griffiths and Hoppeler (1986), note that 
autoradiographic methods are of relevance in this case.
Post fixation staining
4.2.5 Specimen embedding
The synaptosome preparations were resuspended in PBS (4°C, pH 7.4) as 
described in section 4.2.1. The suspension was washed once with PBS by 
centrifugation (500g, 10 min), resuspended in PBS (2ml) and transferred into 2
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Eppendorf tubes. Synaptosome suspensions were fixed either by glutaraldehyde/ 
osmium tetroxide dual fixation (section 4.2.1) or by mixed aldehyde fixation 
(Kamovsky, 1965), as follows. Paraformaldehyde (10% w/v) was dissolved in PBS 
at 60-70°C and NaOH (1M) added (to 4% v/v) until the suspension cleared. The 
suspension was fixed by incubation (lh, 4°C) in PBS containing 2% w/v 
paraformaldehyde, 0.1% v/v glutaraldehyde. Free aldehyde groups were removed 
by exposure (lh, 4°C) to ammonium chloride (0.1M in PBS).
The tissue was embedded in LR White resin as described by Hayat (1989a). 
Briefly, the water washed specimen was only partially dehydrated by a series of
15 min washes at -15 °C, in ethanol/water mixes of progressively lower water
content (70%, 80%, 95% then 100% ethanol). Embedding began by infiltrating 
the specimen with a 7:3 mixture LR White:ethanol (30 min, -15°C), then with 
pure resin (24 h, -20 °C). The tissue was transferred into fresh resin, placed into 
gelatin capsules and cured (24 h, 55 °C).
4.2.6 Sectioning and staining
The grid used to collect ultramicrotome sections was sometimes coated with 
piloform plastic, then sometimes further coated with a layer of carbon (review: 
Hayat, 1989a, chapter 6). Briefly, a clean glass slide was dipped into 0.5% 
piloform in chloroform, removed and kept in a saturated chloroform atmosphere 
(30 sec) and then air dried (more than 2 min). A section of plastic was scored out 
using a diamond pen and floated off the slide onto a surface of water. Grids were 
placed dull side towards the plastic. A piece of dampened grease-proof paper was 
placed over the plastic and when removed the grids remained sandwiched
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between plastic and paper. The plastic was coated with a 150nm (15 A) layer of 
carbon under vacuum. The plastic around grids was scored and the coated grids 
stored in a grid holder at room temperature. Sections were mounted on the 
carbon layer coating the piloform covering the dull side of the grid.
Mounted sections were immunogold stained (Faulk and Taylor, 1971), essentially 
as described by Vamdell and Polak (1984), immediately before uranyl acetate and 
lead citrate staining as described in section 4.2.3.2.Grids were placed section-side- 
downwards onto drops of PBS which contained protein block and /o r 
immunological probes. Incubations proceeded in a humid atmosphere at room 
temperature. Sections were blocked for 30 minutes, incubated for 1 h on a drop 
of PBS containing the block and primary probe (Lindstrom antibodies), then 
washed on 4 drops of PBS/block. Next, sections were incubated for 45 min on a 
drop of PBS containing the block and secondary probe (lOnm gold particle 
labelled goat anti-rat IgG), washed on 2 drops of PBS and washed on 2 drops of 
water. See results for details of the concentrations of the probes and block. NB, 
this technique can readily be adapted to double immunostaining procedures 
(Vamdell and Polak, 1984)
Micrographs were made and printed as described in section 4.2.3.2.The image 
clarity was improved when examining sections on carbon coated grids by using a 
higher operating voltage (120 kV).
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4.3 Results
4.3.1 Prefixation immunostaining: optimisation of conditions
Micrographs were examined at 30K, because it was difficult to see the subcellular 
components which were used to characterize synaptosomes or lOnm diameter gold 
particles at lower magnifications.
The quality of immunolocalisation results from a particular set of preparative 
conditions can be assessed by considering various criteria. The general effects of 
changes in preparative conditions are established (Appendix A). The relationship 
between preparative conditions and results criteria for prefixation immunostaining 
is summarized in Table 4.2. There are 2 important points
a) denaturation is not a problem and so harsh chemical treatments can be used 
after immunostaining,
b) mechanical disruption during centrifugation is potentially a major problem and 
must be minimized.
4.3.1.1 The choice of tissue suspension
The choice of synaptosome suspension was made empirically, based on the 
abundance of recognizable synaptosomes, because the effects of shear forces 
during preparation could not be predicted from previous work.
Plates 1 and 2 show micrographs of Hb and P2b respectively. The preparation 
differed from the protocol described in sections 4.2.1 to 4.2.4 (PBS buffer until
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mechanical disruption during 
centrifugation
- - + - - - - +
Buffer composition during 
immunostaining
- - u + + + - +
Triton X-100 usage during 
immunostaining
u - 9 + u u - +
Fixation regime - - + - + + - -
Dehydration - - - - - + - -
Resin type - - - - - + + -
Table 4.2 summarises which conditions during specimen treatment can affect 
immunolocalisation results, as defined by component results criteria.
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fixation completion) in one respect:- the tissue was not pelleted and treated as a 
tissue block and it was washed after each treatment by centrifugation/ 
resuspension and not by aspiration.
Synaptosomes (Gray and Whittaker, 1962) were visible in both plates, 
characterized (Jones, 1975) as membrane bound particles of about 0,5 /xm 
diameter containing mitochondria, synaptic vesicles and synaptic junctions. An 
electron dense precipitate could be seen in both plates and some synaptosomes 
were damaged but clearly recognizable. The Hb preparation contained a variety 
of neuronal structures of different sizes: the P2b preparation was more 
homogeneous and contained a greater proportion of synaptosomes and more 
structures seemed to be damaged. Qualitative (by visual inspection) and 
quantitative (section 4.2.4) estimates of synaptosome abundance and damage 
indicated (table 4.3, figure 4.1) that:
a) recognizable synaptosomes were more than twice as abundant in P2b than Hb,
b) a greater proportion of recognizable synaptosomes were damaged in the P2b 
preparation
c) by implication and by observation, it seemed that there was a greater
proportion of synaptosomal debris in the P2b preparation.
Although other structures provide a useful immunostaining control and
synaptosome integrity is important, the P2b preparation was used in further
experiments, because of its greater synaptosome abundance.
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Table 4.3 The evaluation of synaptosome abundance and damage
plate number 1 2 3 4 5 6 7 8
Mitochondria,
detectable
74 66 49 71 74 21 46 50
Synaptosomes, 
detectable
22 37 27 22 25 16 37 46
Synaptosomes,
damaged
15 30 26 20 22 11 25 34
Synaptosomes, 
intact
7 7 1 2 3 5 12 12
Synaptosome
abundance
. 30 .56 .55 .31 . 34 .76 .80 .92
Intact
synaptosomes (%)
32 19 4 9 1 2 31 32 26
Table 4.3 displays synaptosomal integrity (intact/detected synaptosomes) and 
abundance (detected synaptosomes/mitochondria) for the entire analysis fields (eg 
plate la, volume 7.5 jim3) sampled by plates lb to 8 (see section 4.2.4).
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The results summarized in table 4.3 are graphically displayed in figure 4.1, for 
intact, damaged or detectable (ie recognizable) synaptosome populations:- 
synaptosome abundance = number of synaptosomes
total number of mitochondria
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4.3.1.2 C on sid eration  o f m echan ical dam age caused  bv 
centrifugation
Mechanical disruption was an inevitable consequence of centrifugation and 
resuspension during synaptosome preparation and prefixation immunostaining 
(Fleming et al, 1980), previous studies demonstrated that synaptosomal damage 
increased with increased centrifugal washing (Dunkley et al, 1988; Fleming et al, 
1980; appendix A.5). The effect of mechanical disruption upon synaptosome 
integrity was examined, to determine the degree of damage and to enable the 
evaluation of procedures to reduce damage. Plates 1, 2 and 3 represent three 
preparations, which required increasing amounts of washing by centrifugation: Hb, 
P2b and gold stained P2b respectively. The proportion of recognizable 
synaptosomes, which are intact falls from 32% to 4% with this increase in 
mechanical stress (Table 4.3, figure 4.1). Experiments were performed with the 
aim of reducing synaptosome damage by mechanical disruption.
al First developmental approach to reducing mechanical damage 
specimen preparation: encapsulating techniques
Encapsulation techniques are often employed to reduce damage to delicate 
structures during specimen preparation (Glauert, 1977). Two common embedding 
techniques were evaluated, both were performed, as described by Glauert (1977), 
at the earliest opportunity, ie immediately after glutaraldehyde fixation:-
i) The Ryter and Kellenberger method of agar encapsulation. The P2b pellet was 
rapidly resuspended in molten agar (50 °C) and the suspension rapidly cooled in
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the form of a thin layer. Plates 4 and 5 show the results of embedding in agar, 
they differ only in the buffer used, these micrographs are best compared to 
plate 8. Using this technique, the abundance and integrity of synaptosomes was 
very low, many were damaged beyond recognition (table 4.3, figure 4.1).
ii) The Shands method of BSA encapsulation. The P2b pellet was resuspended in 
PBS containing BSA (10% w/v, filtered) and a drop of 25% glutaraldehyde was 
added to form an encapsulating matrix of cross-linked protein. Plates 6 and 7 
show the results of BSA encapsulation of the P2b preparation as a pellet and a 
suspension respectively, they are best compared to plate 8. The proportion of 
intact synaptosomes and the levels of synaptosome abundance were high 
(table 4.3,figure 4.1). The background staining was high, some staining was of the 
same electron density and particle size as gold particles and some was of similar 
electron density and distribution to biological structures.
bl Second developmental approach to reducing mechanical damage 
during specimen preparation: the use of a tissue pellet
The concept of encapsulation was imitated, without any encapsulating matrix, 
instead a tissue pellet was treated as if it was a tissue block (Lentz and Chester, 
1977). The pellet was formed at the earliest possible stage, the washing stage after 
the glutaraldehyde fixation. It was gently treated in the same manor as a tissue 
block for the rest of the specimen preparation (plate 8). When this procedure was 
used, micrographs show that synaptosomes were far more abundant: plate 8 has 
three times as many as synaptosomes as Hb, plate 1. The reason for the increase 
in synaptosome abundance was the decrease in synaptosomal damage and so
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fewer synaptosomes were disrupted beyond recognition: 26% of recognizable 
synaptosomes were intact in plate 8 as compared to 19% in plate 2, (Table 4.3, 
figure 4.1).
cl In terpretation  o f developm ental attem pts to m inim ize  
mechanical damage and choice of protocol adjustments
Agar encapsulation (section 4.3.1.2.a.i)was an unsuccessful approach to reducing 
mechanical damage, probably the high temperature caused synaptosome lysis, it 
was not implemented. BSA encapsulation (section 4.3.1.2.a.ii) did reduce 
mechanical damage and provided excellent synaptosome preservation. However, 
it resulted in inconveniently high levels of non-specific staining and this 
background staining made interpretation far harder. This non-specific staining 
may have been the result of chemical reaction between the trapped PBS buffer 
and the positive stains (sections 4.3.1.3.dand 4.3.1.3.f.iii)or between the BSA 
itself and the positive stains. BSA encapsulation was only a partially success, only 
to be used if circumstances demanded, and it was not implemented.
The successful approach (section 4.3.1.2.b) reduced mechanical damage, but 
avoided the artifacts resulting from encapsulation. The pellets formed from this 
procedure were small, allowing easy penetration of acetone and resin 
(appendix A .10). Initially (section 4.3.1.2.b), pellets were formed after 
glutaraldehyde fixation (Lentz and Chester, 1977), in later experiments pellets 
were formed immediately after osmium fixation. Osmium tetroxide fixation caused 
a dramatic increase in specimen density and so a pellet can be formed very easily 
after this stage. The additional synaptosomal damage incurred by this change was
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expected to be minimal, indeed a far lower centrifugation speed could be used 
after glutaraldehyde fixation, because a less dense pellet was required at that 
stage. Pellet formation after osmium tetroxide fixation also allowed a change of 
vehicle prior to osmium fixation (section 4.3.1.3.e).These protocol adjustments 
which minimized mechanical damage were implemented for prefixation 
immunostaining experiments.
4.3.1.3 Vehicle composition during synaptosome preparation,
immunostaining and fixation
There is no universally appropriate vehicle for the artifact free preservation of 
cellular structure during fixation (Hayat, 1989a). In this particular case the 
selection of vehicle(s) was further complicated, as described in appendix A.6 and 
so an empirical evaluation of likely candidates was made.
a) Sucrose solution
Specimens prepared in unbuffered (pH adjusted to 7.4) 0.32M sucrose solution 
(plates 9 and 10) contain severely damaged synaptosomes. Tissue staining was 
good, it was better using uranyl acetate and lead citrate (plate 9) stains than lead 
citrate alone (plate 10). The low level of non-specific staining was unaffected by 
the use of uranyl acetate. This staining was a precipitation of electron dense 
particles which were 5 to 20 nm diameter, slightly irregular in shape and diffuse 
at the edges, with care it could be distinguished from gold particles.
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bl Tris buffer
Specimens prepared in Tris buffered saline, TBS (plate 11) have a very high level 
of synaptosome damage. Staining and background precipitation was similar to that 
seen when unbuffered sucrose was used.
cl Cacodylate buffer
Specimens prepared in cacodylate buffer (plates 12) have good synaptosome 
preservation. Staining was similar to unbuffered sucrose. Background precipitation 
was greater than in unbuffered sucrose, but levels were unaffected by using the 
uranyl acetate stain.
dl Phosphate buffers
Micrographs of specimens prepared using PBS (plate 4) were superior to 
equimolar phosphate buffer (plate 5), but there was no difference in synaptosome 
preservation or levels of background staining. The level of background 
precipitation was much higher than from other buffers, it was no different whether 
(plate 2) or not (plate 13) the uranyl acetate stain was used.
el P h o sp h a te  buffer u n til g lu taraldehyde fix a tio n , then
resuspension in unbuffered sucrose for osmium fixation
When the PBS/sucrose procedure was used for specimen preparation (see section 
4.2.1) the level of background precipitation was low (plate 3), it was between that 
found using cacodylate buffer (plate 12) and sucrose solution (plate 9).
NB the degree of synaptosome damage should not be considered in this case, as
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the preparation (PBS/sucrose, plate 3) was washed several times, by 
centrifugation, during immunogold staining. The level of synaptosomal damage 
using the PBS/sucrose approach was very similar to the damage level found when 
using PBS as the vehicle throughout.
f} Interpretation of the results of varying vehicle composition
Four factors were considered in the interpretation of results
i) The degree of synaptosome damage
ii) The effect on synaptosome visualization
iii) The degree of non-specific staining
iv) The viability of immunological recognition
il Synaptosomal damage
Certain vehicle components (Ca2+ and sucrose) tend to preserve tissue structure 
(Hayat, 1989a). Vehicle composition can also cause synaptosomal disruption, for 
example Hayat (1989a) recommends avoiding the use of Tris buffer prior to 
embedding. Synaptosomes immunostained and fixed using a TBS vehicle were 
heavily damaged (section 4.3.1.3.b), as expected. Surprisingly, synaptosomes 
immunostained and fixed using unbuffered sucrose were also damaged (section 
4.3.1.3.a).This may be due to pH changes during fixation (Hayat, 1989a), but it 
is more likely that the damage reflects the increased shear forces during 
centrifugation, due to the higher density of the medium (appendix A.5): when 
synaptosomes were treated as described in section 4.3.1.3.e,ie PBS buffer then 
sucrose after fixation, synaptosomal damage was similar to the damage found with 
PBS alone, indicating the synaptosomal disruption resulted from centrifugation.
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ill Synaptosomal visualization
The choice of treatment vehicle did not affect synaptosomal visualization directly: 
the clarity of synaptosomal images was the same for all vehicles. Staining with 
lead citrate and uranyl acetate always yielded clearer synaptosomal images than 
staining with lead citrate alone. The choice of treatment vehicle did not affect 
synaptosomal visualization indirectly, for example there was no cross reaction 
between the vehicle and positive stains which might have necessitated the 
avoidance of one of the positive stains.
HU Background staining
Uranyl acetate positive staining had no effect of the level of background staining 
(section 4.3.1.3) and so the precipitation was not due to chemical reactions 
between vehicle components (eg with PBS or cacodylate) and uranium ions 
(Hayat, 1989a). The electron dense precipitate found using unbuffered sucrose 
can only be attributed to chemical cross reaction between the glutaraldehyde and 
osmium tetroxide (Hopwood, 1970). In experienced hands, this osmium 
tetroxide/glutaraldehyde precipitation can be reduced further by careful 
manipulation of conditions (Hopwood, 1970). The TBS did not contribute to 
further precipitation, so although Tris is known to react with glutaraldehyde, this 
polyamine did not chemically react with the electron dense stains. Cocadylate and, 
to a greater extent, phosphate buffers did increase the level of background 
staining reflecting chemical reaction with osmium tetroxide (Hayat, 1989a). This 
deduction was confirmed by changing the vehicle from phosphate buffer to 
unbuffered sucrose prior to osmium fixation (section 4.3.1.3.e).
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iv) The effect of vehicle composition upon 
immunostaining
Antigen recognition is affected by vehicle composition, thus the ionic buffers TBS 
and PBS are recommended for immunological recognition (Priestly, 1987).
gl Optimal conditions
The optimal conditions derived from the results described in section 4.3.1 were
a) P2b preparation was suspended in PBS,
b) the suspension was immunostained, then fixed using glutaraldehyde in PBS,
c) the suspension was transferred into unbuffered sucrose solution for osmium 
tetroxide fixation and then precipitated by centrifugation to form a pellet, which 
was treated as a tissue block for dehydration (acetone) and embedding 
(epoxyresin).
4.3.1.4 An initial attempt at prefixation immunostaining 
a] Procedure
Plates 14 and 15 show the results of an initial attempt at prefixation 
immunostaining, strongly based on preliminary work by of B. Thome (person, 
comm.), specimen preparation was as described in section 4.2.1, with 4 minor 
differences
a) the specimen was washed once prior to glutaraldehyde fixation and thrice prior 
to osmium tetroxide fixation.
b) the specimen was kept as a suspension throughout all treatments and not 
treated in pellet form after fixation; it was washed by centrifugation/resuspension
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in the same way as the specimens seen in plates 1 and 2, section 4.3.1.1.
c) the specimen was embedded in LR White resin.
d) the primary probe was a cocktail of the Lindstrom monoclonal antibodies, the
secondary probe was gold conjugated anti-rat IgG antibodies.
bl Result
The image quality is noticeably poorer than in previous micrographs, reflecting 
the fact that LR White resin was used (appendix A. 10). No gold staining was seen 
in either plate.
cl Interpretation
The lack of any trace of gold staining could be ascribed to recognition failure or 
probe dissociation. The most likely explanation is the complete dissociation of the 
dense colloidal gold particle during the rather extensive centrifugation (appendix 
A.2, A.3). The recognition of monoclonal by secondary probe was confirmed in 
immunodetection (section 3) and immunoprecipitation experiments (section 5). 
Receptor recognition by the monoclonal antibodies could not be investigated fully 
until probe dissociation problems had been resolved. The optimized conditions 
described in section 4.3.1.3.gwere used for subsequent immunostaining attempts 
(section 4.3.2), because they involved far more gentle and infrequent 
centrifugation in order to reduce the loss of probe during washing.
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4.3.2 The result of prefixation immunostaining experiments
Micrographs from specimens prepared in PBS/sucrose and treated as pellets after 
osmium tetroxide fixation (section 4.3.1.3.g)were judged of sufficient quality, as 
defined by the criteria of table 4.2, to attempt immunogold staining. The protocol 
described in sections 4.2.1 to 4.2.4was fully implemented. Biotinylated mAbs were 
used as primary probes, they had been shown to recognize the nAChR under the 
same conditions as the unbiotinylated mAbs (section 5.3).Gold conjugated Avidin 
was used as a secondary probe, Avidin conjugates had been shown to recognize 
the biotinylated mAbs (sections 3.3 and 5.3). The Avidin-biotin system was used 
because of the specificity and high binding affinity of Avidin/biotin recognition 
(appendix A.3).
Gold particles could be seen in micrographs (plate 3), indicating the preparative 
procedure described in sections 4.2.1-4.2.4reduced dissociation relative to the 
initial attempt (section 4.3.1.4).Gold staining to P2b preparations was examined 
by performing 3 separate experiments, in each experiment P2b preparations were 
divided into portions, each representing 0.25g of original brain tissue, which were 
immunostained under different immunological conditions. The results of gold 
staining in 15 representative preparations are summarized in table 4.4a:-
a) Visual examination indicated that gold staining in all 15 preparations was 
randomly distributed in the regions of field where tissue was present, but largely 
absent in regions where tissue was absent. The tissue abundance was fairly 
constant in all micrographs of each prefixation immunostaining experiment, but 
the distribution varied.
b) The results of graphical analysis of micrographs are displayed in figure 4.2,
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Table 4.4 Pre-fixation gold staining, a summary of results
Table 4.4.a
Table 4.4.a displays representative results from 3 separate experiments (column 1), where P2b 
preparation was immunostained under a variety of immunological conditions (columns 2 to 4). 
Column 3 shows the /xl of biotinylated antibody cocktail (see figure 4.3), column 4 shows the /zl of 
Avidin-gold conjugate placed in 1ml of tissue suspension. The number of gold particles in 8 
quadrats, each of volume 0.94/xm3, were recorded and the sum, mean and standard deviation of the 




Number of gold particles 
(in 8 regions)
Exp Block [i°i [ 2° ] Total mean SEM
1 X 5 40 87 10.88 3.45
2 X 5 40 107 13.63 1 .82
1 X 0 40 90 11 .25 2.63
2 X 0 40 113 14.13 4.32
3 X 5 20 47 5.88 0.69
3 X 0.05 20 45 5. 63 2.27
3 X 5 2 2 0.25 0.16
3 X 0.05 2 4 0.5 0.27
1 y 5 40 36 4.5 1 .10
2 y 5 40 32 4.25 0.84
1 y 0 40 47 5.88 2.55
2 y 0 40 57 6. 50 1 .04
3 y 5 20 27 3.38 1 .27
3 y 0.05 20 N/D - -
3 y 5 2 3 0.38 0.37
3 y 0.05 2 5 0.63 0.33
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Table 4.4.b
The results of t-test analysis of gold distribution comparing each set of immunological conditions 
described in table 4.4. a are summarised in table 4.4b:- 
vs - t-test performed between 1st and 2nd sets 
+  - blocked
- not blocked 
both - sets pooled regardless of mAb exposure
diff - t-test shows sets differ at 0.05













40 - 0 vs 5 not 0.1399 0.8896
40 ■f 0 vs 5 not 1 .217 0.2330
20 - .05 vs 5 not 0.1055 0.9175
20 + .05 vs 5 — — —
2 - .05 vs 5 not 0.7977 0.4384
2 + .05 vs 5 not 0.5045 0.6217
40 - vs + both diff. 4.199 8. 7x1 0"5
20 - vs + both not 1 .279 0.2144
2 - vs + both not 0.4357 0.6661
40 vs 20 - both diff. 2.884 0.0060
40 vs 20 + both not 1 .167 0.2503
40 vs 2 - both diff. 5.522 1 .5x1 O'6
40 vs 2 + both diff. 4.426 5. 8x1 0'5
20 vs 2 - both diff. 4.649 6. 3x1 0-5
20 vs 2 + both diff. 3.056 0.0058
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Figure 4.2 Gold particle distribution curves
Quadrat data were primarily collected to compare immunostaining conditions: an accurate analysis 
of gold distribution would need a larger number of smaller quadrats. The distribution of gold 
particles in micrographs from experiments where blocking was not performed did not fit so well to 
a Poisson distribution (figures 4.2a, 4.2b, 4.2c). This was reflected in the value of chi squared (1 
degree of freedom) calculated for the fit of 4.2cto its distribution, 8.1217.This fit is poor and is not 
acceptable at the 5 % level. The distribution was skewed towards low gold distributions. On 
examination of this group of micrographs it was noted that the tissue density was low and uneven. 
The distribution of gold particles was not random, it matched the tissue distribution, ie gold particles 
were not washed off into regions which only contained resin. The only valid methods for avoiding 
this problem were to prepare a more evenly dispersed specimen or analyze at a different scale by 
taking more quadrats over a larger field. An invalid approach of ignoring quadrats which contain 
very low tissue densities produces a distribution of good fit to the Poisson distribution. As the tissue 
distribution was approximately equal in all of the micrographs where blocking was not performed, 
the conclusion that the level of staining was unaffected by mAb exposure is valid.
Despite the low quadrat numbers, the distribution of gold particles when blocking was performed 
matches the Poisson distribution well (figures 4.2d,4.2e,4.2f). A chi-squared goodness of fit test can 
only be applied at relatively high quadrat frequencies and so results of 4.2d and 4.2e were pooled 
to give 4 .2f.The value of chi squared (1 degree of freedom) for the distribution of 4.2fto a Poisson 
distribution of the same mean is 0.2889.This is a very good fit which is acceptable at the 5% level.
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they correlate with the observations described in (a). The distribution of gold 
particles is random and follows a Poisson distribution in regions where tissue is 
present. Gold staining is reduced in regions where tissue is absent, so the 
inclusion of quadrats covering non-tissue regions skews the distribution curves.
c) Visual inspection of micrographs indicated gold staining was entirely non­
specific: compare the level and distribution of gold staining in preparations 
exposed (plate 3) and not exposed (plate 16) to the monoclonal antibody cocktail.
d) Statistical analysis (table 4.4b), indicates that the concentration of monoclonal 
antibody has no effect upon the level of gold staining (figure 4.3)
e) The degree of gold staining varied with the concentration of Avidin-gold 
conjugate (table 4.4b), the former appeared to be proportional to the latter 
(figure 4.3)
f) Blocking caused a fall in gold staining (table 4.4a). The level of gold staining 
was approximately halved by blocking, but remained insensitive to monoclonal 
concentration and directly proportional to Avidin-gold concentration figure 4.3.
No analysis was performed to correlate the distribution of gold particles with 
biological structures, because it had been demonstrated (above) that all detectable 
gold staining was non-specific.
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n o t  b locked
N/Dnv o ui
mAb c o n c e n tr a t io n
cn
Avidin c o n c e n t r a t io n
The effect of altering blocking conditions, mAb concentration and Avidin-gold concentration is 
examined in figure 4.3.Standard error of the means (SEMs) are shown (n =  8). Table 4.4bdescribes 
the results of statistical analysis of these results.
1/xl of Avidin-gold contains 3.75 x 1010 gold particles
1/il of mAb cocktail in 1 ml contains 270 (40 pM), 290 (675 pM), 297 (7.5 pM), 299 (7.5 pM).
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4.3.3 O ptim ization o f post em bedding im m unoelectron  
microscopy
The second approach to immunoelectron microscopy was post-embedding 
immunostaining. This technique is more flexible, less sensitive and more 
commonly used, it also allows a general evaluation of immunostaining techniques 
for electron microscopy (appendix A.2).
4.3.3.1 Results of optimization experiments
The relationship between preparative conditions and results criteria for post­
embedding immunostaining is summarized in table 4.5.The important points are:-
a) immunological recognition must be balanced against image quality and clarity
b) immunostaining must be balanced against the non-specific precipitation of 
electron dense particles
c) synaptosome damage by centrifugation can be minimized
To summarise, this immunostaining approach involves a balance in the conditions 
of fixation, dehydration and embedding of synaptosomes to minimize denaturation 
and background staining, whilst maximizing image quality.
The image quality of micrographs of specimens embedded in LR White (plate 14) 
was inferior to those embedded in epoxyresin (plate 2), but subcellular structures 
such as synaptosomes could still be recognized (appendix A. 10). Micrographs of 
material fixed (section 4.2.5;appendix A.8, A.9) with aldehydes alone (plate 17) 
were  o f  c o n s i d e r a b l y  l o we r  q u a l i t y  t h a n  m a t e r i a l  f i xed  wi th  
glutaraldehyde/osmium tetroxide dual fixation (plate 14). Comparison of plates
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Table 4.5 Post-embedding immunostaining:- Which treatment 





















































































mechanical disruption during 
centrifugation
+
Buffer composition during 
immunostaining
- - - + + + - -
Triton X -1 0 0  usage during 
immunostaining
- - ? ? - - + -
Fixation regime + - - + + + - -
Dehydration + - u + - + - -
Resin type + + u + - + + -
This table summarises which conditions during specimen treatment can affect 
immunolocalisation results, as defined by component results criteria.
Kev






17 and 18 highlights the problem of LR White instability. Image quality and 
clarity was poorer and holes were rapidly burned when LR White sections were 
mounted without support on grids (plate 17). When sections were mounted on 
coated grids (appendix A. 11) as described in section 4.2.6there was some loss of 
image quality and clarity and higher levels of background staining, which made 
the identification of biological materials more difficult (plate 18). The 
interpretation of micrographs was made easier by using a higher accelerating 
voltage (plate 19 and 20).
4.3.3.2 Interpretation and evaluation of optimization experiments
Sections were stabilized by mounting on support films (appendix A. 11), because 
the LR White resin was unstable under the electron beam. The identification of 
synaptosomes and gold particles in film mounted sections was made harder by 
opaque markings resulting from variations in the coating. The coating contained 
atoms of low atomic mass, whilst the atoms used in positive stains (gold, uranium, 
lead) were of high atomic mass, so, by raising the accelerating voltage, it was 
possible to reduce the contrast of the markings, without affecting the biological 
staining.
The quality of the micrographs described in section 4.3.4 could have been 
improved further
a) In addition to marking caused by the support film staining was caused by the 
immunostaining vehicle. The PBS buffer used during immunostaining reacted with 
the positive stains to give produce a particular electron dense stain (Hayat, 
1989a), which was hard to distinguish from the colloidal gold (section 4.3.4). A
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more appropriate vehicle for immunostaining is TBS, which is appropriate for 
immunological recognition (section 4.3.1.3. f . ivPriestley, 1987), and reacts less 
with positive stains (section 4.3.1.3.f.iiifTayat 1989a). However the background 
staining due to the usage of the PBS buffer was negligible in comparison with the 
background staining resulting from the carbon coated piloform coat.
b) A significant proportion (about Vb to M) of potential synaptosomes could not be 
identified, because of the poor image quality. There are other fixatives and resins, 
which might have improved image quality with negligible denaturation increases 
(appendix A.8.2, A. 10; Hayat 1989a).
c) The proportion of available epitopes, which are immunostained, increases with 
decreasing gold particle size (appendix A.3). Smaller gold particles could be used, 
then visualized by either high magnifications or silver enhancement of the 
particles (Lackie et al 1985; pre-embedding van den Pol, 1986; appendix A.3). 
Neither option is desirable: small gold particles would be difficult to detect even 
at higher magnifications, and silver enhancement can involve nonspecific silver 
deposition.
The image quality of micrographs produced using postembedding techniques was 
poor, as anticipated from the choice of resin and fixatives (appendix A), but it was 
sufficient for synaptosom e and gold partic le  identification  and thus 
immunostaining was evaluated.
1 4 0
4.3.4 The results of postembedding immunogold electron 
microscopy
Plates 17 to 28 display the staining of Hb specimens embedded in hot and cold 
cured LR White resin in the presence and absence of Triton, under various 
blocking conditions, with and without primary probe. Specimens were fixed using 
the dual aldehyde method and embedded in LR White. Micrographs were made 
from gold stained sections which were mounted directly onto grids or coated grids. 
Table 4.6 summarizes these results.
a) The quality and clarity of images were poor. The image quality was at the limit 
necessary to recognize the features of synaptosomes, and sometimes synaptosome 
like structures could not be identified. The problems of synaptosome identification 
would have made immunolocalization difficult,
b) There was very little difference in image quality of micrographs of specimens 
prepared in hot (plates 18) and cold cured (plates 20) resin, when examined 
under identical conditions,
c) The level of gold staining, when primary probe was not present during 
immunostaining, was higher to sections of cold cured (plate 20) than hot cured 
resin (plate 18),
d) The level of gold staining, when primary probe was present during 
immunostaining, was higher to sections of hot cured (plate 22) than cold cured 
resin (plate 21),
e) The level of gold staining was higher in all cases when primary probe was 
present during immunostaining, than under corresponding conditions without the 
primary probe (eg consider +mAb in plate 22 compared no mAb in plate 18),
f) The level of gold staining was reduced in all cases when blocking conditions
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Table 4.6 The results of post-embedding immunostaining
experiments
Table 4.6 summarizes the results of preliminary post-embedding experiments. 
Cure type, the LR White resin was either by Hot or Cold cured. 
mAb, whether the Lindstrom mAb cocktail was used during immunostaining. 
Triton, whether Triton X-100 was used during immunostaining.
Block, 4 types of blocking were used during immunostaining 
A - 5% goat serum + 0.2% BSA + 5%  skimmed milk 
B - 5% goat serum + 0.2% BSA 
C - 5 % goat serum + 1 % BSA 
D - no protein block
Coated, whether sections were mounted upon grids coated with piloform plastic 
covered with a carbon layer (150nm).
Voltage, the accelerating voltage used to examine sections.
Gold, the number of gold particles in the analysis entire field (7.5 /xm3, 8 
quadrats).
c/c means "could not count" ie gold particles could not be counted either because 
the level of background staining was obstructively high or because the section or 
section and coating layer had detached or become otherwise lost.
Cure
type





C X X A y 80 c/c
C X X B y 80 c/c
C X X C y 120 82
C X V A y 80 c/c
C X y B y 80 33
C X y C y 120 c/c
C V X A y 80 c/c
C V X B y 80 328
C %/ X C y 120 94
C y y A y 80 29
C y y B y 80 284
C / y C y 120 c/c
H X X B X 80 15
H X X D X 80 5
H X X C y 120 1
H X y B X 80 c/c
H X V D X 80 33
H X V C y 120 90
H V X B X 80 980
H v/ X D X 80 «3600
H y X C y 120 1 46
H y y B X 80 1644
H y y D X 80 c/c
H y y C y 120 270
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during immunostaining were increased (consider no block plates 17 and 23 
compared to plates 18 and 24 respectively),
g) The effect of Triton upon gold staining was difficult to determine. Many 
specimens could not be viewed, because the detergent caused sections on 
uncoated grids to dislodge, and the coating of coated grids to fold and dislodge. 
In all cases Triton caused extensive background staining (plate 25). Occasionally, 
some regions with low background staining were found (plate 26), and in these 
cases the level of gold staining was slightly raised (compare plate 26 and 22),
h) An anti-neurofibillary serum (ANF 2F7F10 donated by A.Rogers) was used as 
primary probe for a positive control (plate 27 and 28). Unfortunately, background 
staining was too high to allow full quantification of gold particles, however, from 
analysis of the few regions of low background staining, primary probe dependent 
staining did seem to occur,
i) Visual inspection of micrographs indicated that gold staining appeared to be 
entirely non-specific. The distribution of the majority of gold particles was random 
and was not associated with the plasma membrane of any subcellular particles or 
with the contents of subcellular particles, no examples of specific staining were 
seen,
j) Quantitative analysis (table 4.7) of micrographs, from those specimens which 
were immunostained with both monoclonal antibodies and gold conjugated anti­
rat IgG, was performed to determine if any detectable immunostaining was 
specific nAChR recognition. The analysis strongly indicated that gold staining was 
entirely non-specific. The proportion of gold particles associated with subcellular 
structures mirrors the abundance of subcellular structures in the micrographs.
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C X A y 8 0 c / c - - - -
C X B y 8 0 3 2 8 5 1 2 6 5 1 5 1
c X C y 1 2 0 94 4 0 1 5 2 0
c V A y 8 0 2 9 - t / 1 t / 1 t / 1
c V B y 8 0 2 8 4 4 9 10 2 2 4 5
c y C y 1 2 0 c / c - - - -
H X B X 8 0 9 8 0 3 7 2 2 5 9 3 7
H X D X 8 0 3 6 0 0 4 2 6 3 1 4 6 4 3
H X C y 1 2 0 1 4 6 4 8 6 1 2 5 0
H V B X 8 0 1 6 4 4 4 8 4 1 8 5 4 8
H J D X 8 0 c / c - - - -
H V C y 1 2 0 2 7 0 4 9 4 8 5 0
Table 4.7 examines post-embedding immunogold staining in 12 micrographs, each representing 
different immunostaining conditions. For each section, 20 quadrats (total area 0.75 fim2) were 
quantitatively analyzed: the proportion of gold particles, which were associated with subcellular 
structures, was compared to the abundance of subcellular structures in quadrats. The abundance of 
subcellular structures (%) was calculated by measuring length of quadrats covering structures and 
dividing by the total quadrat length, then multiplying by 100% (NB quadrat width is the section 
thickness and is assumed to be a constant 90nm).
Key as table 4 .6 ,also: t/1 gold distribution too low to count in quadrats
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4.4 Discussion
4.4.1 I n te r p r e ta t io n  an d  e v a lu a t io n  o f  p r e - f ix a t io n  
immunostaining
The images produced in pre-fixation immunostaining experiments (section 4.3.2) 
had predictably good quality and clarity (section 4.3.1.3.g)Synaptosomes and gold 
particles could be identified and were quantified. There were 3 possible reasons 
for the lack of detectable specific binding:-
a) The nAChR abundance was too low to be detected
b) Probes recognized the nAChR, but dissociated during specimen treatment
c) Probes failed to recognize the nAChR
4.4.1.1 o4s2 abundance
On average each analysis micrograph was expected to contain 28.5 high affinity 
[3H]-nicotine binding sites or 14 o4£2 receptors (section 4.2.4).A correspondingly 
low level of non-specific binding must be achieved before this approach to 
immunolocalization could be considered viable. The estimation of a4£2 receptor 
content must be interpreted with some caution:-
a) Other nAChR subtypes containing the o;4 or the £2 subunits are probably 
present (section 1.2 and 1.4;Wada et al, 1989).
b) There is some evidence that a large proportion (90-95%) of the population of 
receptors containing the £2 subunit subtype are internal in soma or dendrites 
(Hill et al, 1993; Swanson et al, 1987). It is not clear what proportion of internal 
receptors can be detected by high affinity [3H]-nicotine binding of synaptosomal
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preparations, nor what proportion of synaptosomal &2-containing nAChRs are 
internal. As receptor synthesis and storage seems limited to the soma and 
dendrites (Hill et al, 1993; Swanson et al, 1987), it is reasonable to assume that 
internal receptor content is low (Jones, 1975) at nerve terminals, this reasoning 
was reinforced by immunoisolation experiments (section 5.4.3). Prefixation 
immunostaining, using the approach described in sections 4.2.1 to 4.2.4,could not 
be expected to detect internal receptors.
c) The distribution of the receptors is unknown, if receptors are highly 
concentrated on a few nerve terminals the probability of detecting a receptor rich 
terminal would be low. If the receptors are more dispersed, perhaps numbering 
10-30 receptors per terminal (Edwards et al, 1990), then detection would be far 
more likely in a small field.
The qj4S2 receptor subtype consists of 5 subunits (Anand et al, 1991; Cooper et 
al, 1991), each of which are probably a4 or £2 subtypes (Whiting et al, 1987a, b; 
Whiting and Lindstrom, 1986c, 1987, 1988). Labelling efficiency is fairly poor 
using colloidal gold particles, this is generally attributed to steric hinderance and 
labelling efficiency falls with increasing particle volume (Hayat, 1989a, b). Gold 
particles tend to dissociate easily and this tendency rises with increasing particle 
mass (Hayat, 1989a, b).
The low abundance of the nAChR means that an extensive study would be 
required in order to establish its distribution, even experiments to verify receptor 
recognition may require a very large field. The number of neurotransmitter 
receptors which are found at individual terminals varies enormously, from < 30
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to 1000’s of receptors per terminal (see Edwards et al, 1990). Receptor detection 
alone might require a field at least 10-50 times larger than the sample field used. 
However, the low dissociation of even non-specific binding coupled with the fact 
that the non-specific binding can be dramatically reduced using standard blocking 
procedures indicate that this approach to immunostaining nAChRs would be 
viable, if successful antigen recognition was achieved.
4.4.1.2 a4&2 detection
Pre-fixation immunostaining experiments were performed (section 4.3.2) under 
optimized conditions (appendix A; section 4.3.1.3.g), and so good quality 
micrographs were produced with manageable artifacts, and gold particles were 
found in all micrographs. There was no detectable additional gold staining to 
specimens which had been exposed to monoclonal antibodies (section 4.3.2),ie 
non-specific staining occurred, but no specific staining was detected. These 
experiments indicate that the lack of specific staining can be ascribed to low 
abundance and/or recognition failure, but not to probe dissociation:-
a) Gold particles were randomly distributed, but restricted to those areas where 
specimen tissue could been seen. The lack of gold staining in, or raised levels 
around, the specimen interstices implies that no gold had dissociated during 
centrifugation.
b) The level of gold staining was inversely related to the degree of protein 
blocking, demonstrating its non-specific character (Hayat, 1989b).
c) The level of gold staining mirrors the concentration of secondary probe (Table 
4.4).Calculations, based on the particle concentration (3.7xlO13 particles/ml), the 
protein concentration (6.25 mg protein) and the dimensions of the micrographs
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(section 4.4.1.1)indicate 1/xl of Avidin-gold particles would result in 3Vfe particles 
per micrograph. The low gold loss during specimen preparation (Table 4.8) after 
immunostaining under non-blocking conditions demonstrates the fact that virtually 
no probe dissociation occurred, despite the low affinity of the non-specific 
attachment, this low affinity is demonstrated by protein blocking which readily 
reduced staining (Table 4.8).
4.4.1.3 Controls for prefixation immunoelectron microscopy
Immunocytochemical light microscopy (Dechesne et al, 1990; Hill et al, 1993; 
Sargent et al, 1989) is often performed in parallel with immunoelectron 
microscopy studies, rapidly to verify antigen recognition. Synaptosomes are too 
small (0.5 fim diameter) to be seen using light microscopy and so variations in 
staining would not be seen. One approach to resolving this problem would be to 
immunostain tissue blocks for light microscopy (Sargent et al, 1989; Swanson et 
al, 1987), but a closer control was chosen:- directly to measure synaptosomal 
immunostaining (section 3.4.6and 3.4.7).
Probe dissociation and low receptor abundance were discarded as explanations 
for these immunoelectron microscopy results by performing immunostaining 
experiments (section 3.2.9) using 125I-labelled Avidin as a probe. This light 
molecule is much less likely to dissociate than the heavy gold conjugated probes 
(Hayat 1989a, b) and the sensitivity of the assay is very high so the receptor 
abundance was not a problem, thus the results (section 3.3.7) demonstrate 
recognition failure (section 3.4.7).
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Table 4.8 Analysis of the loss of Avidin-gold conjugates during 
specimen treatment after prefixation immunostaining
Avidin-gold (pi) 40 20 2
Gold particles per micrograph (no loss) 125 62.5 6.25
Gold particles per micrograph (no block) 99.3 46 3
Remaining gold (%) - (no block) 79 74 48
Gold particles per micrograph (block) 43 27 4
Remaining gold (%) - (block) 34 43 64
The theoretical number of gold particles, assuming no loss, and the actual number 
of gold particles found in micrographs (7.5/xm3) are compared in table 4.8. Very 
little gold is lost during treatment.
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4.4.2 Interpretation and evaluation of post-embedding
immunostaining
The low level of gold staining in the absence of mAb incubation may have 
represented non-specific association of the secondary probe to the resin (Hayat 
1989b) or merely inadequate washing. Non-specific association of the secondary 
probe is the more likely explanation because a decrease in blocking and/or the 
addition of Triton was associated with an increase in gold staining.
The high level of gold staining after mAb exposure might reflect specific binding, 
non-specific binding or inadequate washing:-
a) Inadequate washing can be discounted, because the same conditions applied 
for controls (no mAb, above).
b) Specific binding was not detected by visual inspection or distribution analysis 
(Section 4.3.4.ij). Specific recognition was unlikely because of the low abundance 
of the nAChR (section 4.4.1.1 and below), however it was possible that the 
nAChRs are widely dispersed, or that a nAChR rich terminal was present in the 
analysis field, in either case specific binding may have been possible. Visual 
inspection is an unreliable method, because patterns are so easily seen and gold 
particles sometimes clump together (over subcellular structures, resin or both), 
however even this approach produced very few examples of possible specific 
binding. Distribution analysis (Table 4.7) gave no indication that gold particles 
were preferentially associated with subcellular structures, ie no specific binding 
was detected. Figure 4.4 demonstrates that the quadrats taken for distribution 
analysis are representative of the entire field.
c) There was good evidence that immunogold staining was non-specific:- gold
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Table 4.7 examines post-embedding immunogold staining in 12 ihicrographs, each representing
different immunostaining conditions. For each micrograph (7.5 /xm3), 20 quadrats were analyzed
(total area 0.75 /xm2). Figure 4.4 demonstrates this method of sampling was appropriate, the
number of gold particles in the entire quadrat area was compared with the number of particles
present in the entire analysis micrograph. Linear regression indicates the two variables are
proportional to each other, 95% confidence lines are also shown.
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staining increased with decreased blocking and with the addition of Triton (Table 
4.6; 4.7). The non-specific gold staining might have been caused by:-
i) the recognition by mAbs of non-nAChR epitopes, which were revealed during 
specimen treatment.
ii) the use of inappropriately high concentrations of a probe, resulted in its 
binding to non-specific low affinity sites (Williams, 1977a). The concentration of 
the secondary probe was clearly appropriate (controls). The protein concentration 
of the primary probe was in the range which is generally appropriate (0.7,0.5-2.0 
mg/ml Williams, 1977b), however optimal protein concentrations for probes vary 
dramatically.
iii) non-specific adsorption of proteins by the resin due to non-covalent 
interactions (Hayat, 1989a).
The level of non-specific binding might have been further reduced, by altering the 
concentration of the primary probe and manipulation of blocking conditions.
The total lack of detectable specific binding in postembedding experiments was 
almost certainly due to the low abundance of epitopes, although it is quite 
possible that even if receptors were present in high enough concentrations for 
detection, the receptor conformation would have prevented epitope recognition. 
Gold particles cannot penetrate the resin (Beesley, 1989; Williams, 1977a) and so 
specific staining is limited to recognition of antigens present in the top lOnm 
(approximately 10 to 16%) of the resin (Hayat, 1989b). However, the population 
of £2 containing nAChRs present at the plasma membrane may (section 4.4.1.1) 
represent 5 to 10% of the total population (Hill eta l, 1993; Swanson eta l, 1987), 
unlike prefixation immunostaining, which would only detect plasma membrane
1 5 3
nAChRs, the postembedding immunostaining techniques would detect the total 
receptor population. This means the number of receptors which were available 
for recognition might be similar using both prefixation and postembedding 
techniques or might have been lower (approximately 10 fold) for the 
postembedding approach.
4.4.3 The viability of synaptosomal a4s2 detection using 
immunoelectron microscopy
The results interpreted in section 4.4.1.1 indicate that immunoelectron 
microscopic detection of synaptosomal a4£2 is probably viable using the 
prefixation approach providing a sufficiently large field is used and antigen 
recognition problems are resolved. A potential problem for prefixation 
immunostaining studies is gold particle dissociation, which can be avoided by 
immunostaining immobilized synaptosomes (Ratnam et al, 1986a; appendix A.2). 
However, the results interpreted in section 4.4.1.1 indicate gold particle 
dissociation was very low using the optimized conditions described in sections 
4.3.1.3.g-and 4.3 .2and immobilization procedures tend to reduce image quality 
and probe access, both factors are undesirable in this case.
The results interpreted in section 4.4.2indicate that the postembedding procedure 
might be viable using a large field and appropriate antibodies, however this 
approach to nAChR localization was inferior to the prefixation technique, because 
it produces poorer images and higher levels of nonspecific gold staining.
To pursue this work further, 2 obstacles must be overcome:-
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a) The abundance of the a4£2 nAChRs is low, so a study of nAChR distribution 
using immunoelectron microscopy of synaptosomes is potentially a very large task! 
It is possible that the only practical approaches to immunoelectron microscopy 
would be either to examine immunopurified synaptosomes (Richardson et al, 
1984), but this would omit a study of any synaptosomes which had low nAChR 
concentrations, or to examine tissue blocks (as Hill etal, 1993). In either case the 
original objective, of using immunoelectron microscopy of synaptosomes to 
examine the subcellular distribution of presynaptic nAChRs, would be 
compromised.
b) there is strong evidence that the Lindstrom mAbs which were used only bind 
to the high affinity [3H]-nicotine binding nAChRs in the presence of Triton 
(sections 4.4.2,3.4.7 and 5.4.3). Other antibodies are required, appendix B 
describes the suggested procedure for screening antibodies directed against 
extracellular sites of the a4£2.
Receptor recognition problems have been encountered by other groups using the 
Lindstrom antibodies (Clarke, person, comm.; Wonnacott, person, comm.) and the 
dependence on Triton of some Lindstrom antibodies for recognition has been 
mentioned (Deutch e ta l, 1987;Whiting and Lindstrom, 1986a) see section 5 .3for 
a full discussion. Recognition problems are not limited to the Lindstrom 
monoclonal antibodies. Hill et al (1993) failed to detect the £2 subtype at the 
synapse, using antibodies raised against fusion proteins, in both pre- and 
postembedding procedures. They proposed 2 explanations
a) The nAChRs containing the £2 subunit subtype are not expressed at the 
synapse, instead they subserve non-synaptic neurotransmission (Umbriaco et al,
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1991). This is a controversial explanation (section 1.4), the results of ligand 
binding to subcellular fractions (section 3.3.4) supports the opposing viewpoint 
that some o4£2 receptor is located at presynaptic terminals,
b) The antibodies were sterically hindered from reaching nAChRs containing the 
£2 subunit in the synaptic region by the subsynaptic density.
In fact, as receptor labelling was noticeably absent in Golgi saccules or vesicles, 
an alternative explanation related to (b) can be proposed: that the antigenic site 
is covered in the final stages of protein processing, ie only the internal receptor 
population was detected.
Recent advances in immunocytochemistry might assist imm unoelectron 
microscopy of the nAChR:-
a) Probes can be now conjugated to lnm diameter gold particles and visualized 
by silver enhancement techniques, which produce consistently shaped particles 
(Burry et al, 1993), these particles have far greater penetration, as well as the 
expected decrease in steric hinderance and dissociation and increase in labelling 
efficiency (appendix A. 3).
b) Guanidine hydrochloride has been shown to reveal certain masked antigens 
(Peranen et al, 1993).
Chapter 5 Immnnoisolation experiments
5.1 Introduction
The immunoprecipitation experiments described in section 5 were designed to 
immunoisolate subcellular particles bearing the nAChR, and to characterize those 
particles (as Docherty et al, 1987a, b, 1989; Richardson et al, 1984). Monoclonal 
antibodies were attached to a solid matrix and used to adsorb solubilized nAChRs 
or nAChR bearing subcellular particles from tissue preparations. It was hoped 
that release studies could be performed upon immunoisolated particles (Docherty 
et al, 1987a, Richardson et al, 1987). The aim of these experiments was to 
establish more clearly the role of nAChRs by developing methods to characterize 
those subcellular structures where they are located.
Preliminary experiments, performed in our laboratory, were promising (Irons et 
al, 1988, 1989), but, despite several attempts, they were difficult to repeat 
(Wonnacott person, comm.), thus at the beginning of this investigation it was 
decided to verify each stage of the immunoisolation procedure. The attachment 
of mAbs to beads was confirmed, and then the immunoisolation of detergent 
solubilized nAChRs onto mAb coated beads was successfully demonstrated using 
each of the 4 available mAbs. However, initial attempts to immunoisolate 
subcellular particles (synaptosomes) bearing the nAChRs onto mAb coated beads 
were unsuccessful. Immunoisolation was attempted using 5 approaches in an effort 
to understand the situation and so develop a successful synaptosome- 
immunoisolation procedure
a) The effect of Triton was examined. Immunoisolation of nAChRs from
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detergent extracts was measured at different Triton concentrations and 
immunoisolation of nAChRs from synaptosome preparations was measured in the 
presence of different concentrations of Triton.
b) Immunoisolation experiments were performed after exposure of the 
synaptosome preparation or the detergent extract to collagenase and exposure to 
collagenase with no bacterial inhibitors present. The 2 aims of this enzymic 
exposure were: to determine if the enzymes could interact with the nAChRs, 
because if the enzymes had access to the nAChRs then the mAbs should also 
have nAChR access; and to try to remove any proteins or parts of proteins which 
might mask the mAb binding sites, eg the extracellular matrix.
c) Immunoisolation experiments were performed after exposure of the 
synaptosome preparation to a glycosidase. The aim of this exposure was to 
eliminate the possibility that the mAb binding site was masked by carbohydrate 
residues which could easily be removed, this experiment was included for 
completion.
d) Some procedural variations were performed to increase the efficiency of 
immunoisolation, for example the synaptosome preparation was exposed to 
biotinylated mAbs and then exposed to Avidin coated beads, because precoating 
synaptosomes with mAbs often improves immunoisolation (Richardson and Luzio 
1986, 1888).
e) Glutaraldehyde cross-linking was performed after exposure of the synaptosome 
preparation to mAbs, this procedure would tend to reinforce the weakest link - 
the bond between mAb and nAChR.
If immunoadsorption experiments had been successful, they could have been
expanded to help determine the functional role of the isoform. Immunopurified 
subcellular particles could have been characterized for neurotransmitter content, 
by measuring the levels of the relevant neurotransmitter synthesizing enzymes 
(Irons et al, 1988, 1989), and possibly for the presence of other receptors.
5.2 Methods
5.2.1 T issue preparations used for im m unoadsorption  
experiments
Sections 3.2.land 3.2.2describe the production of Hb, P2 and P2b preparations. 
Detergent extracts of P2 and P2b (section 3.1.2) preparations (figure 5.1) were 
prepared using a method similar to that outlined in section 3.1.4. The 
preparations were washed once, by centrifugation, with 4 volumes of Tris/HEPES 
buffer (Sorval, 26,000g,30min), solubilized for 2 h in one volume of Tris/HEPES 
containing 0.5% v/v Triton X-100, and finally after centrifugation (Beckman, 
100,000g,30 min) the supernatant was collected. In some experiments, detergent 
extracts of tissue preparations were not made, but instead Triton was added to the 
tissue preparation, which was then solubilized for 2 hours, but no centrifugal 
extraction was performed, then immunoadsorption and ligand binding experiments 
were performed upon the detergent containing tissue.
5.2.2 Immunoadsorption onto beads
Antibodies may be directly or indirectly attached to beads (Richardson and Luzio, 
1986). Direct protein to bead attachment is via covalent bonding of the protein 
to activated beads. Indirect attachment of antibodies involves non-covalent 
binding to covalently attached linker proteins. Beads coated with linker proteins 
are sometimes commercially available, alternatively linker proteins may be 
attached. Unless otherwise stated in section 5.2.2:-all reactions were performed 
at room temperature; bead "washing"consisted of allowing them to settle, either
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Figure 5.1 summarizes the procedure for the detergent solubilization of P2 and 
P2b preparations using Triton X-100.
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by gravity or magnetism, removal of the old buffer by aspiration and resuspension 
in new buffer; all incubations proceeded under constant end-over-end rotation.
5.2.2.1 Direct attachment of proteins to cyanogen bromide 
activated beads
Direct protein attachment to (non-magnetic) cyanogen bromide activated beads 
was based on the protocol supplied. The activated gel was rehydrated (lh), 
without shaking, in swelling buffer (0.5% w/v, O.lmM hydrochloric acid). Beads 
were washed once with coupling buffer (beads 2.5% w/v in 0.1M sodium 
bicarbonate, NaHC03, 0.5M sodium chloride, NaCl) and then resuspended in 
fresh coupling buffer (beads 5% w/v) containing the protein for attachment 
(protein concentration up to 0.05% w/v). After protein coupling (18 h, 4°C) 
beads were washed twice with two volumes of coupling buffer and resuspended 
in one volume of deactivating buffer (ie beads 5% w/v 1M ethanolamine, pH 
8.0). After deactivation or capping of free activated sites (2h) the beads were 
washed for four washing cycles. Each cycle consisted of washing beads (5% w/v) 
in 0.1M acetic acid, 0.5M NaCl, pH 4.0, then (5% w/v) in 0.1M boric acid, 0.5M 
NaCl, pH 8.0. The beads were washed once (5% w/v) with, then resuspended 
(20% w/v) in, storage buffer (lOmM PBS, 0.01% sodium azide [NaN3], pH 7.4). 
Coated beads were stored at 4°C.
5.2.1.2 Direct attachment of proteins to tosylactivated beads
Direct protein attachment to (magnetic) tosylactivated Dynabeads was based on 
the protocol supplied. A uniform suspension of beads was mixed with an equal
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volume coupling buffer (0.5M sodium borate, pH 9.5) containing the protein for 
attachment (0.015% w/v, protein: bead ratio 1:200). After protein coupling (24h) 
beads were washed several times. Each wash consisted of resuspension in two 
volumes of PBS/BSA (10 mM PBS, 0.1% w/v BSA, 0.01% v/v NaN3, pH 7.4) and 
incubation before solvent removal. The beads were washed thrice for lOmin, then 
once for 30 min, and finally once (at 4°C) for 18 h. The coated beads were then 
stored at 4°C in fresh PBS/BSA buffer (3% w/v).
5.2.23  Indirect attachment of antibodies to beads
Free antibodies were indirectly attached to beads in three ways:-
a) antibodies were attached to antisera coated beads. When necessary, beads were 
blocked by 30 min incubation in (beads: 5% w/v) PBS containing 5% w/v Marvel 
milk powder, pH 7.4.
b) antibodies were attached to beads coated with immunoglobulin adsorbing 
proteins (Protein A or Protein G). Beads were blocked as above (a) when 
necessary.
c) biotinylated antibodies were attached to beads coated with biotin adsorbing 
proteins (Avidins). Blocking was not required.
In all cases, attachment was preceded by five washes with PBS and proceeded, 
either at room temperature (4h) or at 4°C (18h), in PBS (beads: 5% w/v 
Sepharose or 3% w/v Dynabeads) containing an excess of the anti-receptor 
antibodies (0.1% w/v unless otherwise stated). Unbound antibody was removed 
by washing the beads three times with fresh PBS (one volume, 10 min, 2% w/v).
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5.2.2.4 Confirmation of antibody attachment
Both peroxidase conjugated- and alkaline phosphatase conjugated- (anti-rat) sera 
were used to confirm the adsorption of Lindstrom mAbs onto beads. Control 
beads had received identical treatment, except that mAbs were omitted from the 
coupling buffer. Beads were incubated (2-4 h) in PBS containing the same 
concentration of conjugate which was recommended for western blots (generally 
0.1% v/v). A protein block (5% w/v milk powder) was not normally required. 
The beads were washed thrice (5 min) in PBS, before resuspension in substrate 
buffer.
The most visually striking substrate to use to confirm mAb attachment is one 
which produces an insoluble product. The insoluble product of the peroxidase 
catalyzed oxidation of DAB was precipitated onto beads as follows. Beads were 
incubated at room temperature for 10-120 sec in PBS containing hydrogen 
peroxide (H20 2, 0.6% v/v) and DAB (0.1% w/v), pH 7.4. Once the deposition was 
clearly visible, the reaction was stopped by washing the beads (1% v/v) in water. 
If the washing is not performed, even negative controls would have eventually 
become coated with the brown oxidation product.
Substrates which yielded soluble reaction products were used to confirm mAb 
attachment to beads, if the visualization of insoluble product was difficult because 
of bead colour, or when quantification was desired. If a peroxidase conjugated 
probe had been used, beads were incubated at room temperature in PBS 
containing 5AS, 0.2% w/v) and H20 2 (0.6% v/v), pH 7.4. The reaction was 
stopped after 30 min with 10% v/v 1M sodium hydroxide (NaOH). The soluble
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product was quantified by measuring the optical density of the liquid phase at 
450 nm.
When a phosphatase conjugated probe was used beads were incubated at room 
temperature in 50mM sodium bicarbonate [NaHC03] containing 0.1% w/v pnpp 
pH 9.6. The soluble product was quantified after 60 min by measuring the optical 
density of the liquid phase at 405 nm.
5.2.2.5 Enzyme assay
Only one enzyme assay was performed on tissue preparations, because the results 
of im m uno iso la tion  experim en ts p rec luded  the c h a rac te riza tio n  o f 
neurotransmitter synthesizing enzymes, which may have been performed (Irons 
et a l , 1988, 1989). L actate dehydrogenase (LDH = L -lactate: NAD 
oxidoreductase, EC 1.1.1.27) is a cytoplasmic marker which is released upon 
disruption of synaptosomal membranes (Johnson and Whittaker, 1963). It 
catalyses the reaction:-
Lactate + NAD+ ** pyruvate + NADH + H+
LDH was directly measured by a colorimetric determination of NADH depletion 
(at 340nm) with its back-reaction, described by Johnson (1960). A tissue 
preparation which contains mitochondria is likely to contain other dehydrogenases 
and so reaction components were added sequentially, to ensure that the substrate 
dependent activity could be measured. The degree of synaptosomal integrity could
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be assessed by the addition of Triton X-100, which ruptures synaptosomes and so 
allowing occluded LDH measurement (Marchbanks, 1967).
The substrate, co-substrate and detergent were prepared in 0.15 M Tris, pH 7.4 
and the rate of change of optical density at 340nm was measured, using a 
spectrophotometer and recorded on a chart recorder. The rate was measured for 
0.1 ml sample with 2.7ml buffer alone (0.15 M Tris, pH 7.4), and then with the 
addition of 0. lml substrate (lOmM sodium pyruvate [C3H30 3Na]), and then finally 
with the addition of 0.1ml co-substrate (2mM S-Nicotinamide adenine 
dinucleotide, reduced form [NADH]). The concentration of free LDH was 
calculated using the formula:-
Activity = A x cuvette vol x 1 x 103 mol. min"‘.(mg prot)"1 
E x vol of sample x p
A - change in adsorbance / min 
E - Molar absorption coefficient (6.22 x 103 M.cm'1)
1 - path length (1cm) 
p - protein concentration (mg.ml"1)
The total concentration of LDH was estimated after the addition of 0.1ml 
detergent (10% v/v Triton X-100). The concentration of occluded LDH was 
calculated:-
LDH™ = LDHFree + LDH,
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5.2.3 Immunoprecipitation of detergent solubilized nAChR 
using Lindstrom sera
Unless otherwise stated in this section all incubations were performed at 4°C, 
under gentle agitation using an end-over-end shaker. This method was loosely 
based on the protocol described by Whiting and Lindstrom (1986c). Two types of 
tissue were used: detergent extracts and preparations which had been exposed to 
the detergent, but which had not then been centrifuged to remove non-solubilized 
material.
Immunoprecipitation of nAChR from detergent extracts (section 5.2.1) or 
detergent exposed material using mAbs and beads (section 5.2.2) was performed 
in two ways:-either solubilized nAChR was incubated with mAb coated (directly 
or indirectly attached) beads for 18h; or solubilized nAChR was incubated with 
mAb for 18h, then the nAChR associated mAb was incubated with linker protein 
coated beads at 4°C (18h) or at room temperature (4h).
The immunoprecipitation of nAChR was detected in two ways:-
a) Ligand binding to beads was performed essentially as described by Flores et 
al (1992), except a different immunoadsorbant was used. Beads were dispensed 
into Eppendorf microfuge tubes (200/xl-1000/zl of 10% w/v bead suspension) and 
then the beads were allowed to settle by gravity or magnetically collected. The 
liquid removed by aspiration and the beads gently resuspended in 1ml 
Tris/HEPES buffer. Radiolabelled ± cold ligand were added to triplicate samples 
as described section 3.2.6:[3H]-nicotine plus water was added to determine total 
binding; [3H]-nicotine and (-)-nicotine were added to determine non-specific
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binding. After incubating the mixtures for 30 min at room temperature, then for 
18h at 4°C the bead bound nAChR was rapidly immunoprecipitated. The beads 
were collected either magnetically or by a centrifugation pulse in a microfuge and 
then the liquid was removed by aspiration. The beads in each tube were rapidly 
washed with 1ml of PBS. The total time for ligand removal and bead washing was 
less than 20 sec, it was performed at 4°C using chilled equipment and PBS. The 
beads were mixed (50% v/v) with 0.1 M NaOH containing sodium deoxycholate 
(3% w/v) and the whole transferred into a scintillation vial, containing 5ml 
scintillant. Tritium levels were measured with the 1600 TR. 
b) Ligand binding to bead exposed detergent extract. The detergent extract was 
carefully removed from the beads and diluted with Tris/HEPES until the Triton 
concentration was 0.25% v/v. Ligand binding (section 3.2.6)to the diluted extract 
was compared with controls prepared from the same detergent extract, but either 
not exposed to beads or exposed to beads which were not mAb coated. The 
degree of nAChR depletion relative to controls was calculated.
5.2.4 Immunoprecipitation of material bearing nAChR
The method for the immunoprecipitation of detergent solubilized nAChR (section 
5.2.3) was also used to precipitate nAChR containing tissue preparations which 
had not been  exposed to T riton at all. The only difference in the 
immunoprecipitation technique was that greater care was taken when handling the 
beads, in an effort to avoid dissociation of nAChR bearing material from the 
beads. Immunoprecipitation was analyzed either by ligand binding (section 5.2.3) 




5.3.1 Antibody immobilisation and detection
Table 5.1 summarizes the results of antibody immobilization by direct (section 
5.2.2.land 5.2.2.2)and indirect (section 5.2.2.3)attachment to beads and the 
detection of bead bound mAbs using enzyme linked probes and [3H]-nicotine 
binding, as described in section 5.2.2.4.The detection of mAb attachment using 
the phosphatase conjugated anti-(rat IgG) (0.1% v/v) was unsuccessfully 
attempted several times, in all cases the attachment was confirmed by peroxidase 
catalyzed DAB precipitation and immunoprecipitation of nAChRs. Figure 5.2 
shows a representative set of results.
Antibody detection using several batches of peroxidase linked probes was 
successful. The peroxidase conjugated anti-(rat IgG) antibody probes were used 
to confirm antibody attachment using 2 types of substrate
a) Plate 38 shows the result of monoclonal detection by the peroxidase catalyzed 
deposition of the insoluble product of DAB oxidation. The brown colour of the 
DAB oxidation product was very similar to the colour of Dynabeads and so
another method was required to confirm antibody attachment to them.
b) The soluble product of peroxidase catalyzed 5AS oxidation was measured 
antibody attachment. The results are summarized in 3 figures
i) Figure 5.3 demonstrates antibody attachment in a qualitative fashion, the 
attachment of all 4 Lindstrom mAbs can be confirmed in this way.
ii) Before quantification experiments were performed, steps were taken to
170
Table 5.1 Confirmation of antibody immobilisation
M a t r i x  L i n k e r s  mAb DAB 5 AS pnpp n i c
S e p h ----------------------------------------------290 Y Y N Y
S e p h ------- A R IgG ---------------------------270 Y Y N Y
S e p h ------- A R IgG ---------------------------290 Y Y N Y
S e p h ------- A R IgG ---------------------------29 7 Y Y N Y
S e p h ------- A R IgG ---------------------------299 Y Y N Y
S e p h ------- P r o t A -------- ARIgG------- a l l Y Y n / d Y
S e p h ------- P r o t G -------- ARIgG------- a l l Y Y n / d Y
S e p h ------- P r o t A --------------------------- a l l N N n / d N
S e p h ------- P r o t G --------------------------- a l l N N n / d N
D y n 4 ------- A R IgG ---------------------------a l l n / d Y n / d Y
D y n 4 ------- A v --------------------------------- a l l n / d n / d n / d Y
D y n 2 ------- A v --------------------------------- a l l n / d n / d n / d Y
Key
Seph - Sepharose 6MB
Dyn4 - Dynabeads M-450
Dyn2 - Dynabeads M-280
ARIgG - goat anti(rat IgG) antibodies
Av - Avidin
ProtG - Protein G
ProtA - Protein A
Lindstrom mAbs numbered as table 2.1 eg 270. all mAbs - all
DAB - Peroxidase linked probe, diaminobenzidine substrate
5AS - Peroxidase linked probe, 5 aminosalicylic acid substrate
Pnpp - Phosphatase linked probe, para nitrophenyl phosphate substrate
nic - [3H]-nicotine binding to immunoadsorbed nAChRs.
n/d - not done
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Figure 5.2 The use of a phosphatase conjugated anti-(rat IgG) probe 





















The mAb 290 was directly attached to Sepharose. The Sepharose (50/xl of 5%w/v) 
and Sepharose-290 (50/d of 5% w/v) were protein blocked, exposed to the probe 
and then incubated with substrate for lh. n=6, SEMs shown. The two populations 
are not significantly different at the 0.05 level (t-test, t=0.95).
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Figure 5.3 The use of a peroxidase conjugated anti-(rat IgG) probe 
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Figure 5.3 qualitatively demonstrates the detection of bead (50gl of 5%w/v) 
bound mAbs (0.4% v/v) by peroxidase conjugated anti-(rat IgG) (0.02% v/v). The 
peroxidase probe binds to each of the 4 mAbs and catalyses the oxidation of 5AS. 
The rate of 5AS oxidation was measured by determining the optical density (in 
absorbance units) at 450nm after 30 min. SEMs shown, n in brackets.
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minimize 5AS oxidation, which was not caused by the presence of mAbs. It had 
been noticed that significant quantities of peroxidase probes tended to adsorb to 
the vessel wall, the selection of a vessel which did not adsorb mAbs is 
summarized in figure 5.4. The result was dramatic and the negligible adsorption 
of the secondary probe was qualitatively confirmed in later experiments,
iii) Figure 5.5 demonstrates the saturation of anti-(rat IgG) binding sites with 
increasing mAb concentration, when the coating of beads with mAbs is required 
the mAbs are used in approximately 10 fold excess to ensure complete saturation.
5.3.2 Immunoisolation of detergent solubilised nAChRs
The attachment of mAbs might have caused conformational changes which 
prevented nAChR recognition. Before adsorption attempts were made the 
conditions for detection were characterized and where possible optimized.
5.3.2.1 Optimization of conditions
Detergent extracts of P2 membranes were prepared as described in section 5.2.1, 
the recovery of protein in extracts was 28% of the protein concentration of P2 
membranes (SEM=134%, n=5). Attempts were made to adsorb nAChRs to mAb 
coated beads, and to detect that adsorption. Section 3.3.1 describes optimization 
of the [3H]-nicotine binding assay. The binding measured by filtration of [3H]- 
nicotine to dilution series of detergent extracts of P2 membranes is summarized 
in figure 5.6. The level of detectable specific binding, expressed in fmol/mg 
protein, fell with increasing Triton concentration. Note the variance increases with 
decreasing Triton concentration, but this was expected (figure 5.6,section 5.4.2.1).
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Figure 5.4 Reduction in non-specific 5AS oxidation bv comparing the 

















Tube type  for b lank
A single experiment (n= 1) was performed to determine which vessel minimized wall adsorption of 
peroxidase probe (0.02%v/v) during the measurement of mAbs (0.4%v/v) adsorption onto 
Sepharose beads (50^1 of 5 %v/v). The rate of 5AS oxidation was measured (4 samples from each 
vessel, SEMs shown) by determining the optical density (in absorbance units) at 450nm after 30 
min:-
1) Lp4, white plastic tubes
2) Lp4, clear plastic tubes































0.0 0.5 1.0 1.5 2.0 2.5
Volume of mAb (299) a d d e d  
to  s e p h a r o s e  —an t i  —( r a t  IgG) (/xl)
The capacity of 30 /xl of Sepharose—anti-(rat IgG) (5%v/v) to bind the mAb 299 
is shown in figure 5.5 (n = 2 for all points, SEM shown).
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Figure 5.6 The effect of Triton concentration upon T3HI-nicotine
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Detergent extracts of P2 membranes were prepared and a dilution series made. The specific binding 
in cpm/mg protein verses Triton concentration is shown in figure 5.6, n= 3  for all points (SEM 
shown). Note the protein and Triton were diluted equally and so as the Triton concentration was 
decreased, the protein concentration was decreased and thus the error in the binding (cpm/mg 
protein) was increased.
1 7 7
5.3.2.2 Immunoisolation of detergent solubilised nAChRs 
experimental results
The adsorption of detergent solubilized nAChR onto Lindstrom antibody coated 
beads (section 5.2.3) was demonstrated in two ways:-
a) the measurement (section 5.2.3.b) of the decrease in specific high affinity 
ligand binding to detergent solubilized preparations after bead exposure (Whiting 
and Lindstrom, 1986a).
b) the measurement (section 5.2.3.a)of the increase in specific high affinity ligand 
binding to immunoisolated nAChRs after exposure to detergent solubilized 
material (Whiting and Lindstrom, 1986a).
Figures 5.7 and 5.8 summarize results using these approaches
a) Each of the Lindstrom mAbs could be used successfully to deplete a detergent 
extract of nAChRs (figure 5.7.a), various controls (preparations 1-4) were 
performed to confirm that the immunoadsorption of nAChRs was only possible 
when mAbs were immobilized onto beads, no depletion was observed in these 
controls. The degree of depletion of nAChR could be increased by increasing the 
temperature and decreasing the vigour of agitation during immunoadsorption 
(preparation 6).
b) The initial approach to measuring immunoisolated nAChRs directly was to 
attempt acid dissociation of the receptors from the beads and then to perform a 
filtration assay upon the resulting solution (section 3.2.6).When this approach was 
tried there was no detectable [3H]-nicotine binding protein, which had been 
dissociated from the beads (figure 5.7. b), furthermore after acid treatment there 
was no detectable [3H]-nicotine binding to beads. The second approach to 
measuring immunoisolated nAChRs was to measure the binding of [3H]-nicotine
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Figure 5.7.a:-nAChR immunoadsorption was performed at 0.5% v/v Triton, extracts were then 
diluted 10 fold, and the specific [3H]-nicotine binding was measured using the filtration assay. Beads 
50/il of 5%v/v. mAbs 0.1%v/v. The level of specific binding (fmol/mg protein) is displayed for:- 
Treatment n Detergent extract exposed to
1 6 no beads
2 2 Sepharose-anti-(rat IgG), no mAb
3 1 Sepharose + mAb cocktail
4 1 Sepharose-Protein G +  mAb cocktail
5 3 Sepharose-anti-(rat IgG) -I- 290
6 3 Sepharose-anti-(rat IgG) + 290 #2 - 18h, room temp
7 2 Sepharose-anti-(rat IgG) 4- 270
8 2 Sepharose-anti-(rat IgG) 4- 297
9 2 Sepharose-anti-(rat IgG) 4- 299
200  -
Figure 5.7.bdisplays the preliminary attempt to dissociate the nAChR from the beads by incubating 
them for lh with 0.1M HC1. The acid was then mixed with 9 volumes of Tris/HEPES, the pH 
adjusted to 7.4 and the concentration of [3H]-nicotine binding proteins in the mixture measured 
using the filtration assay
For beads from treatment (1), ie no exposure to extracts, n =  3.
For beads from treatment (5), n = 2 .
For the buffer alone, ie no beads, n = 1.
Note in these experiments 100 cpm represents approximately 2.1fmol/mg protein in the detergent 
extract. SEMs shown.
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Figure 5.8 The detection of the transfer of nAChRs from a detergent
extract of P2 membranes to mAh coated Dynabeads. the 
effect of Triton concentration
The transfer of nAChRs from a detergent extract of P2 membranes to mAb coated Dynabeads 
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Figure 5.8. a shows specific [3H]-nicotine binding to a detergent extract after exposure to beads or
controls in fmol/mg protein, after compensating for the effect of Triton concentration (see figure
5.6 and figure 5.11). A detergent extract was prepared at 0.5% Triton. Part of the extract (1 vol) was
diluted 10 fold with Tris/HEPES before bead exposure (treatment 4), or control (treatment l , no
beads), another part (1 vol) was diluted 10 fold with Tris/HEPES containing 0.5% Triton and then
exposed to Dynabeads (treatment 5), or control (treatment 2, no beads). A control (treatment 3)
was kept undiluted (0.5% Triton), then diluted to 0.05% Triton at the last minute to confirm that
there was no loss of activity in a detergent extract resulting from prolonged exposure to 0.5% Triton.
Binding to (4) was significantly different to combined [(1), (2) and (3)] (t-test, t=  14.2,P=7.6x 10-6)
Binding to (5) was significantly different to combined [(1), (2) and (3)] (t-test, t = 19.2,P=1.3x 10'6)
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b) Figure 5.8.b displays the specific binding to the beads and the mean of the sum of (bead 
associated specific binding plus extract associated specific binding) for both experiments. n=2.  
Binding to the beads was not different at the 0.05 level, but are different at the 0.1 level (t-test, 
t = 3.0, P = 0.095).Treatment 6 represents control Dynabeads (no mAbs) which were exposed to 
Detergent extracts containing 0.5% v/v Triton
Note when more nAChR was associated with the bead then less was associated with the extract, but 
the total bead + extract did not vary so much ie there was a different degree of immunoadsorption 
in the two experiments.
1 8 2
to beads as described in section 5.2.3.a. When this approach was used [3H]- 
nicotine binding proteins associated with beads could readily be detected (figure 
5.8.b), furthermore the quantity of nAChR recovered on the beads was only
slightly less than that lost from the extract (figure 5.8.b).
The results displayed in figure 5.8 show two other trends:-
i) The total recovery of nAChR seemed marginally better at the higher Triton
concentration
ii) The immunoadsorption of nAChR from extract to beads improved with 
increasing Triton concentration.
5.3.3 Immunoisolation of subcellular particles bearing nAChRs 
from svnaptosome preparations in the absence of Triton:- 
initial results
The immunoadsorption of particles bearing nAChRs was monitored in two ways:-
a) detection of LDH activity
b) detection of [3H]-nicotine binding proteins
a) The cytoplasmic enzyme LDH (LDH, E.C:1.1.1.27)is a cytoplasmic marker 
which is used to examine the degree of synaptosomal disruption:- LD H ^,^ 
activity reflects that synaptosome population which has not been damaged, whilst 
the external LDH activity (LDHfree) reflects damaged synaptosomes (Thome et al, 
1991). Figure 5.9 displays the results of LDH measurement upon fresh 
homogenate demonstrating that during homogenization some LDH was released
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Figure 5.9 The detection LDH activity to monitor of the adsorption
of subcellular particles bearing nAChRs
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Figure 5.9.ashows the LDH activity of 3 preparations in umol NADH produced/mg protein/min, 
n = 3 throughout, SEM shown:-
1) Homogenate
2) Hb after exposure to control beads ie Sepharose--anti-(rat IgG) without mAbs.
3) Hb after exposure to Sepharose-anti-(rat IgG)--mAbs (50/zl Sepharose, 20ptl mAb cocktail). 
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Figure 5.9.bshows the LDH activity of 3 preparations in nmol NADH produced/mg protein/min, 
n= 3  throughout, SEM shown:-
2) Sepharose--anti-(rat IgG) after exposure to the Hb referred to in (2) above.
3) Sepharose-anti-(rat IgG)-mAbs after exposure to the Hb referred to in (3) above.
(2) and (3) are not significantly different at the 0.05 level (t-test, t=0.265,P=0.804)
1 8 4
(LDHfree) and some LDH remained occluded (LDH^,^). Fresh Hb contained 
virtually no LDHfree, because it had been washed away. A single experiment was 
performed which indicated that occluded material was released with time: after 
storage for 36h at 4°C homogenate contained 29% occluded LDH and Hb 
contained 43% occluded LDH. In all experiments controls were performed, where 
the order of cosubstrate and Triton addition was altered, in all cases (± Triton) 
no enzyme activity was detected until both cosubstrates had been added. There 
was no depletion of LDH,^ or LD H ^,^ activity during exposure to mAb coated 
beads. There was very little activity associated with the beads after attempted 
immunoadsorption: the total LDH activity associated with the beads was
approximately 1000 fold less than with the LD H ^,^ activity present in Hb 
preparations and there was no difference in LDH activity associated with control 
beads than with mAb coated beads.
b) It was possible that immunoadsorption had occurred at level too low for 
detection with this assay and so the more sensitive [3H]-nicotine binding 
experiments were performed to investigate the distribution of nAChRs. The 
immunoadsorption of nAChRs from P2b preparations in the absence of Triton 
was monitored by measuring [3H]-nicotine binding. Figure 5.10displays the results 
of immunoadsorption experiments, neither depletion of nAChR from P2b 
preparations nor adsorption of nAChR to the beads occurred. Note the variance 
in specific binding to P2b preparations (figure 5 .lO.c)reflected vacuum problems 
which occurred during this series of experiments: two pumps were used, one of 
which produced an inconsistent vacuum. Whilst there was considerable variation 
between experiments, results were relatively consistent within experiments, thus
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Figure 5.10 The use of r3Hl-nicotine binding to monitor the 
immunoadsorption of nAChRs from P2b 
preparations in the absence of Triton
Throughout the experiments summarized in figures 5.10[3H]-nicotine binding to preparations was 
performed using the filtration assay, and [3H]-nicotine binding to beads was measured directly as 
described in section 5.2.3.SEMs are displayed and n values are shown in brackets. The numbers on 
the x-axis of figures 5.10.a,b and c refer to the following:-
1) P2b preparation after exposure to control beads ie Sepharose—anti-(rat IgG) without mAbs.
2) Sepharose-anti-(rat IgG) after exposure to the P2b preparation referred to in (1) above.
3) P2b preparation after exposure to Sepharose-anti-(rat IgG)-mAbs (50/il Sepharose, 20^1 mAb 
cocktail).
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Figure 5.10.acompares the P2b preparations which have and have not been exposed to mAb coated 
Sepharose, ie for each experiment:- P2b preparation (3) x 100% / P2b preparation (1)
Note this comparison compensates for variation between experiments, which was considerable, 
n =  14, mean = 103.5,SEM = 2.8.
Figure 5.10.bcompares the [3H]-nicotine binding to beads after exposure to P2b preparations. The 
specific binding is given in the raw data form of cpm/mg protein in the tissue preparation. Binding 




Figure 5.10.cdisplays the specific binding to both preparations and beads in fmol/mg of protein in 
the relevant P2b preparation.
Binding to preparations (1) and (3) are not significantly different at the 0.05 level (t-test, t=0.0536, 
P=0.958).
Binding to beads (2) and (4) are not significantly different at the 0.05 level (t-test, t=0.25,P=0.809)
1 8 7
the value of:-
P2b preparation exposed to mAb coated beads x 100%
P2b preparation exposed to control beads
provides a useful graphical method to compare the two preparations. Statistical 
analysis (t-test) indicates that there was no difference between exposed and 
control P2b preparations (see figure 5.10c).
5.3.4 Immunoisolation of material containing nAChRs from P2b
preparations containing Triton
Immunoisolation experiments which were performed in the presence of Triton 
could not be measured using LDH measurement, because the detergent would 
release LD H ^,^, and also [3H]-nicotine binding was a more sensitive approach 
for the detection of nAChR immunoadsorption.
5.3.4.1 Optimization of conditions
The effect of Triton concentration upon specific [3H]-nicotine binding was 
indicated by the results of binding to dilution series of detergent extracts (figure 
5.6, section 5.3.2.1).The effect of Triton concentration could be more readily 
investigated by measuring specific binding to nAChRs in the presence of Triton 
(figure 5.11). At concentrations of greater than 0.5% v/v Triton the solution 
viscosity was so great that its passage through the filter was retarded. The curve 
shown in figure 5 .ll.bprovided a guide to projecting true specific [3H]-nicotine
Figure 5.11
188
The effect of Triton concentration upon the level of
a) detectable specific binding to P2b preparation
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Figure 5.11. a displays the results of [3H]-nicotine binding (specific binding in fmol/mg protein) to 
P2b preparations in the presence of a range of Triton concentrations. SEMs shown, n displayed in 
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Figure 5.1 l.bdisplays the results of [3H]-nicotine binding to P2b preparations in the presence of a 
range of Triton concentrations expressed in each experiment as a percentage of the specific binding 
to the experimental control, ie the P2b preparation containing 0% Triton. SEMs shown, n’sas 4.11.a
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binding from the apparent binding in the presence of Triton, however where 
possible paired controls were used in immunoisolation experiments, or, if 
necessary, all filtration measurements in an experiment were performed at a 
constant Triton concentration (eg 0.25% v/v): these 2 approaches avoid problems 
due to inaccurate measurement of Triton or pump variation.
5.3.4.2 Immunoisolation experiments
The effect of Triton concentration upon immunoadsorption using the Lindstrom 
mAbs is shown in figure 5.12. In this figure the trend which was indicated in 
figure 5.8 (section 5.3.2.2) was reinforced, ie that immunoadsorption increases 
with increasing Triton concentration, at least up to 0.5% v/v Triton. The 
experiment displayed in figure 5.8 was repeated using P2b preparation containing 
Triton instead of detergent extracts, the immunoadsorption of nAChR (figure 
5.13) was very similar. The adsorption of nAChRs from detergent extracts (figure 
5.8) in the presence of 0.5% Triton was 1.85 times the immunoadsorption from 
detergent extracts in the presence of 0.05% Triton, immunoadsorption from P2b 
preparations in the presence of Triton (figure 5.13) at 0.5% was 2.25 times the 
level of immunoadsorption with 0.05% Triton.
Experiments were performed to examine the effect of collagenase upon 
immunoadsorption of nAChR bearing particles from P2b preparations in the 
presence of 0.5% v/v Triton (figure 5.14).These experiments acted as controls for 
parallel experiments in the absence of Triton (section 5.3.5). Collagenase was 
found to lower specific binding slightly, but once this was compensated for, no 
other effect of collagenase was apparent.
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Figure 5.12.adisplays the ratio of [3H]-nicotine binding to P2b preparations which had been exposed 
to mAb coated beads (50/xl of 3%w/v) to the binding to P2b preparations which had been exposed 
to control beads alone, in the presence of a range of Triton concentrations, ie specific binding to 
P2b preparations exposed to mAb coated Sepharose x 100%
P2b preparations exposed to control beads 
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Figure 5.12.bdisplays the loss of specific binding (fmol/mg protein, cd ) fr°m P2b preparations 
which have been exposed to Sepharose-anti-(rat IgG)—mAb relative to P2b preparations which have 
been exposed to Sepharose-anti-(rat IgG). The figure also displays the gain of specific binding 
(fmol/mg protein in relevant P2b preparation, m  ) by Sepharose-anti-(rat IgG)-mAb during 
exposure to the P2b preparation relative to Sepharose-anti-(rat IgG) controls during exposure to 
an identical P2b preparation. The transfer of nAChR from P2b preparation to mAb coated beads 
is shown at differing Triton concentrations. SEMs shown, n (brackets) is the same for loss from P2b 
preparations and gain by beads at any specific Triton concentration.
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Figure 5.13 The detection of the transfer of nAChRs from a P2b
preparation to mAb coated Dynabeads, the effect of 
Triton concentration
c 6 0 n
w 0% 0.005% 0.05% 0.5%
Triton c o n c e n t r a t i o n  (%v/v)
Figure 5.13 displays the results of a single experiment to compare with the results shown in 
figure 5 .8 .n = l.T h e  experimental procedure used was identical to that described for figure 5 .8 ,with 
the exception that the nAChR was depleted from a P2b preparation, in the presence of a range of 
Triton concentrations and not a detergent extract of P2 membranes. The specific binding to the 
mAb coated Dynabeads (50/xl of 3%w/v) is shown in fmol [3H]-nicotine binding/mg protein in the 
relevant P2b preparation.
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Figure 5.14 The effect of collagenase treatment upon the
immunoadsorption of nAChRs from P2b 
membranes in the presence of 0.5% Triton
The transfer of nAChR to mAb coated beads from P2b preparations containing 0.5% Triton which 
have been pretreated with 0% or 0.1% collagenase is displayed in figure 5 .14 .The loss of specific 
binding (fmol/mg protein) from P2b preparations, which have been exposed to mAb coated 
Dynabeads, relative to P2b preparations which have been exposed to control Dynabeads (no mAb), 
are displayed with □  . Note the reduction in specific binding caused by the presence of 0.5% 
Triton was compensated for, assuming 0.5% Triton causes a reduction of binding to 43% of the 
same preparation containing 0% Triton. The figure also displays the gain o f specific binding 
(fmol/mg protein in relevant P2b preparation, HI ) by mAb coated Dynabeads during exposure 
to the P2b preparation relative to control Dynabeads (no mAb) during exposure to an identical P2b 
preparation. The specific binding to Dynabeads was measured in Tris/HEPES without Triton.
The collagenase caused a reduction in specific binding (to 84.5%). Controls were used to measure 
the reduction and to compensate for that reduction separately for each experiment 
(n = 4 in all cases, SEM shown). Statistical analysis (t-test of all pairs) indicates (not shown) that 
there is no difference between:
lost nAChR in collagenase treated and control preparation at the 0.05 level (t=0.107,P=0.918). 
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5.3.5 Attempts to achieve immunoisolation of subcellular 
particles bearing nAChRs from synaptosome preparations 
in the absence of Triton
Triton could not be used to immunoisolate subcellular particles (eg synaptosomes) 
bearing nAChRs, because it disrupts membranes. Instead, 4 approaches to 
exploring probe access or probe dissociation were examined (see section 5.1 for 
rational)
a) The P2b preparation was pretreated with collagenase, sometimes in the 
absence of protease inhibitors, before immunoadsorption.
b) The P2b p re p a ra t io n  was p re tre a te d  w ith g lycosidase  b e fo re  
immunoadsorption.
c) The P2b preparation was exposed to biotinylated mAbs and then the mAb 
exposed synaptosomes were incubated with Avidin coated Dynabeads. Washing 
was performed by repeated addition of buffer in the absence of a magnetic field 
and buffer removal after bead collection in the magnetic field.
d) As (c) but cross-linking mAbs to nAChR by fixation using 1 % glutaraldehyde 
fixation (room temperature, lh). Immunoadsorption proceeded with very gentle 
agitation - every 15min the vial was turned end-over-end once. Washing was also 
very gentle washing, beads were held in a constant magnetic field and buffer 
added then removed, so that the passage of buffer over the surface of the beads 
washed material away. Note some of the P2b preparation was washed away using 
this method, washing proceeded for 20 minutes, during which time approximately 
2 thirds of the preparation was removed in all cases.
1 9 6
In all cases immunoisolation attempts were monitored by the more sensitive [3H]- 
nicotine binding assays.
a) Collagenase treatment caused a slight reduction in specific binding to 
preparation, but no immunoadsorption of subcellular particles (figure 5.15): there 
was no depletion by mAb coated beads of nAChRs from P2b preparations after 
treatment by a range of collagenase concentrations and no gain of nAChRs by 
beads.
b) There was no depletion by mAb coated beads of nAChRs from P2b 
preparations after pre-treatment with glycosidase and no gain of nAChRs by 
beads (figure 5.16). Glycosidase treatment seemed to have no effect upon ligand 
binding to P2b preparations.
c) Immunoisolation of subcellular particles bearing nAChRs was not improved by 
attempting to coat the synaptosomes with mAbs and then exposing those 
synaptosomes to beads (figure 5.16)
d) When glutaraldehyde fixation experiments were performed material bearing 
nAChRs was present with the Dynabeads (figure 5.16),however the precipitation 
was non-specific and not due to immunoadsorption.
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Figure 5.15 The effect of collagenase treatment upon the




















0 % 0 . 0 0 1 % 0 .0 1 % 0 . 1%
co l lagenase  (%)
( 4 )  ( 1 )  ( 1 )  ( 4 )
P2b preparations were pre-treated with a range of collagenase concentrations in PBS, for lh, at 
room temperature. Figure 5.15.a compares [3H]-nicotine binding of P2b preparations were then 
exposed to mAb coated Sepharose, with P2b preparation exposed to controls (no mAbs), ie:- 
P2b exposed to Sepharose-anti-(rat IgG)-mAb x 100%
P2b exposed to Sepharose-anti-(rat IgG)
Statistical analysis (t-test) indicates there is no difference between 0% and 0.1% collagenase 
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Figure 5.15.b compares the actual specific binding in fmol/mg protein in the relevant P2b 
preparation to:-
1) P2b preparation exposed to control beads, 0% collagenase
2) P2b preparation exposed to Sepharose--anti-(rat IgG)--mAb, 0% collagenase
3) Sepharose-anti-(rat IgG)-mAb after exposure to P2b preparation (2), 0% collagenase
4) P2b preparation exposed to control beads, 0.1% collagenase
5) P2b preparation exposed to Sepharose--anti-(rat IgG)--mAb, 0.1% collagenase
6) Sepharose--anti-(rat IgG)--mAb after exposure to P2b preparation (5), 0.1% collagenase
SEMs shown, n =4 throughout. Statistical analysis (t-test) indicates there is no difference between
(1) and (2) at the 0.05 level (t=0.0636,P=0.951)
(4) and (5) at the 0.05 level (t=0.207,P=0.843)
(3) and (6) at the 0.05 level (t=0.584,P=0.580)
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Figure 5.16 The effect of alternative approaches to the
immunoadsorption of nAChRs from P2b 
preparations in the absence of Triton
P2b preparations were pre-treated with or without glycopeptidase F in PBS, for 4h, at 37°C. Figure 
5.16compares the actual specific binding (SEMs shown, n’s in brackets) in fmol/mg protein of the 
relevant P2b preparation. Beads were used at 50/xl of 3%w/v.
1) P2b preparation exposed to control beads (2), after pretreatment with 0% glycosidase
2) Control Dynabeads (no mAb) after exposure to the P2b preparation (1), after pretreatment with 
0% glycosidase
3) P2b preparation exposed to control beads (2), after pretreatment with 0.5% v/v glycosidase (one 
unit/ml)
4) P2b preparation exposed to mAb coated Dynabeads (5), after pretreatment with 0.5% v/v 
glycosidase (one unit/ml)
5) Dynabeads coated with mAbs after exposure to P2b preparation (4), after pretreatment with 0.5% 
v/v glycosidase (one unit/ml)
6) Dynabead-Avidin after incubation with P2b preparation which had been pre-exposed to 
biotinylated mAbs
7) Dynabead-Avidin after incubation with P2b preparation which had been pre-exposed to 
biotinylated mAbs, then fixed with 1% v/v Glutaraldehyde. NB minimal agitation during incubation 
and minimal washing
8) Dynabead-Avidin after incubation with P2b preparation which had been not been pre-exposed 
to biotinylated mAbs, but then had been fixed with 1% v/v Glutaraldehyde. NB minimal agitation 
during incubation and minimal washing
Statistical analysis (t-test of all pairs) indicates (not shown) that there is no difference between:
(1), (3) and (4) at the 0.05 level
(2), (5) and (6) at the 0.05 level 
(7) and (8) at the 0.05 level
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5.4.1 Adsorption of antibodies to beads
The failure to detect bead bound mAbs with a phosphatase linked probe was not 
fully investigated, once the peroxidase linked system was established. The results, 
described in section 5.3.1,only indicate recognition failure using a single batch of 
phosphatase linked probe. Different batches of phosphatase linked probe would 
probably be suitable for mAb detection, because the same methods are used to 
raise antisera for both types of enzyme linked probe (Sigma technical 
information). The possible explanations for recognition failure for this batch are 
numerous, they range from accidental probe denaturation to a gap in the 
repertoire of epitopes presented to the immunological response.
The direct and indirect attachment of mAbs to beads could be detected, using 
several batches of peroxidase probe. The relative merits of direct and indirect 
attachment for the immunoadsorption of subcellular particles were explored by 
Richardson and Luzio (1986, 1988). Direct attachment has 2 advantages: secure 
attachment and specificity because there are no other species of probe present. 
Indirect attachment is favoured, it has the following advantages
i) the orientation of presentation is optimal, this dramatically increases the 
number of available recognition sites,
ii) steric problems are reduced by using a longer linkage between the beads and 
subcellular particles,
iii) conformational changes in the primary probe due to attachment are less likely.
2 0 2
The verification of the direct attachment of all 4 mAbs confirms that each mAb 
could be recognized when bound to the matrix using the peroxidase probe. 
Indirect attachment of mAbs via anti-rat IgG linkers and of biotinylated mAbs via 
Avidin linkers was verified confirming successful mAb recognition by the linker. 
Protein A (2 batches) and Protein G (1 batch) were used as linker proteins for 
indirect attachment, but neither could be used to adsorb any of the mAbs directly. 
The two linker proteins were functional, eg immunoadsorption was successfully 
performed using a triple sandwich consisting of Sepharose—Protein G--anti-(rat 
IgG)~mAb. The recognition of rat IgGs by both Protein A and Protein G is often 
poor or non-existent (Sigma and Pharmacia, technical information) and so 
recognition failure was not surprising. In the case of Protein G, the problem may 
have again been limited to the batch used.
Two types of bead were used in immunoadsorption experiments :-
a) Sepharose 6MB beads were used for preliminary experiments, they were easily 
handled and could readily be separated by gravity. The diameter of beads (Sigma, 
technical inform ation) was approximately 1000 times the diam eter of 
synaptosomes (0.5 /xm: Jones, 1975), when successful immunoadsorption occurs 
synaptosomes would be expected to coat the beads.
b) Dynabeads are 5-9 times the diameter of synaptosomes (M450 are 4.5 /xm and 
M280 are 2 .8 /xm diameter: Dynal, technical information) to synaptosomes. They 
were originally used in the hope that the reduced size would enable the formation 
of a matrix of Dynabeads and synaptosomes, where immunoadsorption might have 
been more efficient, because the number of sterically available attachment sites 
for synaptosomes bearing nAChRs would be far higher, and so the probability of
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detachment would be far lower (Richardson and Luzio 1986,1988). However this 
hypothesis was contradicted by empirical observations (Docherty et al, 1991) 
which indicate that Dynabeads are a less efficient immunoadsorbant of 
synaptosomes than larger magnetic beads (Magnogel, 60-140/mi diameter). 
Dynabeads can be collected very gently by magnetic separation or more vigorously 
by centrifugation (Docherty person, comm.; Dynal, technical information), the 
advantage of gentle separation was that fewer attachment bonds would be broken. 
Magnetic collection can suffer from washing problems, because the beads are not 
dense and could easily be washed away (Brennand D.,person, comm.), this meant 
that careful washing by magnetic collection was labour intensive, and controls 
were always performed. The attachment of biotinylated mAbs to Avidin-coated 
beads had potential advantages because of the specificity and affinity of the 
Avidin-biotin bond (appendix A.3).
5.4.2 Immunoadsorption of nAChRs from detergent extracts of 
P2 membranes
The mAbs were raised and selected by their ability to recognize nAChR in 0.5% 
v/v Triton extracts (Fraser and Lindstrom, 1984; Lindstrom, 1984, 1986; 
Lindstrom et al, 1981, 1987), thus in this investigation the activity of attached 
mAbs was confirmed by showing successful immunolocalization of nAChRs from 
detergent extracts (Whiting and Lindstrom 1986a, 1987). The detection of 
immunolocalization was aided by the fact that high affinity [3H]-nicotine binding 
sites detected in the filtration assay (section 3.2.6)correspond to the a4£2 subtype 
(section 1.3). The recovery of protein during detergent extraction was 
approximately 28%, this is comparable to previous studies (30-50%: Newby, 1984).
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5.4.2.1 Characterization of r3Hl-nicotine binding assay 
In the dilution experiments displayed in figure 5.6 both Triton and protein were 
diluted because there was no other method of rapidly and predictably altering the 
Triton concentration (Lindstrom, 1985): this means that the error in protein 
estimation increased, and the measured level of specific binding decreased, with 
decreasing Triton concentration. These two factors explain why the variance in 
specific binding (fmol/mg protein) was expected to increase with decreasing 
Triton concentration. The variance was too great realistically to apply statistical 
analysis to verify the trend seen in figure 5.6, ie that there was a decrease in 
detectable specific binding with increasing Triton concentration. However, the 
same trend was seen when Triton was added to P2 membranes (figure 5.11, 
section 5.3.4.1)and so there is no reason to believe that the trend implied in 
figure 5.6 does not occur.
Triton X-100 reversibly binds to Torpedo nAChRs and (Sudrez-Isla and Hucho, 
1977) non-competitively inhibits [3H]-nicotine binding (Heidmann et al, 1983). 
Triton X-100 does not seem to inhibit [3H]-nicotine binding to the a4S2 receptor, 
eg dialysis (Abood et al, 1980) and immunoprecipitation assays show no loss of 
[3H]-nicotine binding to Triton solubilized receptors (sections 3.3.3,3.3.4 and 
3.4.3;Whiting and Lindstrom 1986a). The deterioration in nAChR detection with 
increasing Triton concentration observed in sections 5.3.2 and 5.3.4.1 probably 
reflects an increase in the number of nAChRs which pass through the filter with 
increasing solubilization. This phenomenon is observed using the filtration assay 
for the measurement of the binding of ligands to many solubilized receptors and 
the loss for the [3H]-nicotine binding assay is relatively low (Bruns et al, 1983).
2 0 5
Care was taken throughout immunoadsorption experiments to measure [3H]- 
nicotine binding at reproducible and minimal Triton concentrations (eg Whiting 
and Lindstrom, 1986a), the concentration of Triton was reduced by dilution 
because of the predictability of this approach (see the start of this section).
5.4.2.2 The results of immunoisolation experiments aimed at the 
adsorption of nAChRs from detergent extracts of P2 
membranes
Each of the 4 mAbs were individually used to immunoadsorb nAChRs from a 
detergent extract of P2 membranes (section 5.3.2.2),essentially as described by 
Whiting and Lindstrom (1986a, 1987). The level of immunoadsorption was 
increased in one set of parallel experiments (Treatments 5 and 6), by increasing 
the temperature and decreasing the degree of agitation. After demonstrating that 
each mAb could immunoadsorb nAChRs separately, all further experiments were 
performed using a mAb cocktail to maximize recognition and affinity (Richardson 
and Luzio 1986, 1988).
Immunoadsorption could not be measured by the method described in section 
5.3.2.2.b,ie acid dissociation followed by the filtration assay. Acid dissociation 
may or may not cause receptor dissociation, but it does seem to alter receptor 
conformation such that specific [3H]-nicotine binding is no longer possible, as 
implied by Lunt (1987).
Immunoadsorption could be monitored directly as an increase in specific [3H]-
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nicotine binding associated with beads (Whiting and Lindstrom, 1986a), or 
indirectly by measuring the loss of specific [3H]-nicotine binding from extracts 
(Whiting and Lindstrom, 1986a). The importance of Triton for nAChR 
recognition was demonstrated by the observation that immunoadsorption 
increased with increasing Triton concentration. Very little of the nAChR was lost 
during transfer from detergent extracts onto the beads. The small quantities of 
nAChR which were not recovered probably reflect the dissociation of nAChRs 
from the beads during washing. This deduction was reinforced by the observation 
that there was more missing material from the beads which had been exposed to 
0.05% Triton than to 0.5% Triton, suggesting that the strength of attachment was 
reduced at the lower Triton concentration.
5.4.3 The immunoadsorption of nAChR bearing material from 
P2b preparations
Measurement of LDH activity in homogenate indicates some cytoplasm is 
released (36%) during homogenization, but considerable cytoplasm remained 
occluded in resealed vesicles. The concentration of non-occluded LDH in Hb 
preparations was negligible, reflecting the fact that little lysis of subcellular 
particles had occurred after all free LDH had been washed away; under 
appropriate conditions synaptosomes tend to be fairly stable (Bradford et al, 
1975). The controls indicated that no other dehydrogenases were measured in 
these experiments. The occluded LDH was gradually released with storage 
reflecting the disruption of subcellular particles. The low level of LDH activity 
associated with beads seems entirely due to inadequate washing, indicating that 
no immunoadsorption had occurred. It was possible that immunoadsorption had
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occurred at a level which was too low for detection, but the more sensitive 
[3H]-nicotine binding assay was capable of detecting very low levels of 
immunoisolation. The failure to detect immunoadsorption of subcellular particles 
bearing nAChRs from P2b preparations using [3H]-nicotine binding assays can be 
interpreted in a number of ways, which were addressed by the immunoisolation 
experiments described in sections 5.3.4and 5.3.5:-
Interpretation a) Immunoadsorption did occur, but remained undetected, for 
example this might reflect inhibition of [3H]-nicotine binding by the binding of 
mAbs, or immunoadsorption at a very low level. Neither possibility is likely. 
Immunoadsorption would have to be at a very low level not to be detected by the 
[3H]-nicotine binding assays. There is no indication in any Lindstrom literature 
that the 4 mAbs block [3H]-nicotine binding (Lindstrom et al, 1987), there was no 
depletion of nAChR from the P2b preparations due to mAb exposure (section 
5.3.3.b)and immunoadsorption of detergent solubilized receptors does not block 
binding (sections 5.3.2.2and 5.4.2.2).
Interpretation b) Immunoadsorption did not occur, because the nAChRs were 
blocked by other proteins, which were altered or removed during Triton exposure 
to allow antibody recognition. Blocking might be caused by the synaptic junctional 
matrix (Cotman and Taylor, 1972) or by the extracellular matrix (Froehner, 1993; 
Reichardt and Tomaselli, 1991). Blocking by the synaptic junctional matrix was 
evaluated by measuring [3H]-nicotine binding to the SJC (section 3.4.2),it does 
not account for the failure of antibodies to recognize all nAChRs. The P2b 
preparations were pre-treated with collagenase in the absence of protease
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inhibitors before immunoadsorption; this addresses the possibility of protection 
in 2 ways:-
i) The collective pool of proteases, including collagenase, might digest 
extracellular blocking proteins (Reichardt and Tomaselli, 1991) and allow 
immunoadsorption. No immunoadsorption was observed indicating either 
inadequate digestion or evidence against interpretation (b). Collagenase also had 
no effect upon immunoadsorption from P2b membranes in the presence of 0.5% 
v/v Triton (section 4.4.6.2), this observation contradicts the possibility that 
immunoadsorption failed because of inadequate digestion: if Triton and proteases 
both acted partially to remove masking proteins their effects would be additive 
and Triton would have more easily revealed nAChRs after the protease digestion, 
increasing immunoadsorption.
ii) Proteins which block antibody binding might be expected to prevent, or reduce, 
the protease digestion of the nAChR. The use of these proteases did result in the 
partial digestion of nAChRs, indicating at least partial access of enzymes to 
nAChRs. Furthermore, digestion did not increase when 0.5% v/v Triton was 
added to the P2b membranes (section 4.4.6.2), which would be expected to 
remove the antibody blocking protein according to this interpretation. If antibody 
blocking proteins were present they did not block protease activity.
Far stronger evidence against interpretation (b) has already been evaluated in 
section 5.3.2.2(see interpretation f)- The experiment to show immunoadsorption 
of nAChRs from detergent extracts to Dynabeads at different Triton 
concentration was performed using a single detergent extract, which was diluted 
ten fold with either Tris/HEPES buffer, or Tris/HEPES buffer containing 0.5%
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Triton. If interpretation (b) had been correct nAChR access would have been 
identical in both preparations, because the degree of blocking protein removal 
was the same.
Interpretation c) Immunoadsorption did not occur, because the method used 
tended to be too disruptive to linkage between beads and subcellular particles 
(Richardson and Luzio 1986; 1988): immunoadsorption did occur in the presence 
of Triton because the micelles which were produced were too light to cause 
dissociation. This is a difficult interpretation to disprove, even successful 
immunoadsorption experiments can have low yields (Richardson et al, 1984; 
Richardson and Luzio 1986)! Immunoadsorption was altered as follows
i) The temperature of immunoadsorption was increased to room temperature (2- 
4h).
ii) The P2b preparation was incubated with biotinylated mAbs (room 
temperature, 2-4h) before exposure to Avidin coated Dynabeads. This method of 
indirect attachment was recommended for the immunoisolation of subcellular 
particles (Richardson and Luzio 1986; 1988), because there is a greater 
probability of bead attachment to nAChR attached mAbs than to the nAChRs 
themselves. The high affinity of Avidin-biotin binding decreased the probability 
of loss of attachment.
iii) Immunoadsorption was favoured by gentle end-over-end agitation and 
magnetic collection (Docherty et al, 1987a; Richardson and Luzio 1986, 1988).
iv) The weakest linkage was the mAb to nAChR bond, this attachment was 
reinforced by glutaraldehyde fixation, before adsorption to Avidin coated beads.
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None of these changes allowed specific immunoprecipitation to occur (section
5.3.5).The high level of non-specific precipitation in the final experiments showed 
that conditions could not be made more gentle! Stronger evidence that 
dissociation was not responsible for the failure of immunoadsorption was provided 
by the results of the immunostaining experiments (section 3.4.7and 4.4).
Interpretation d) The nAChRs are internal (Hill et al, 1993; section 4.4.1.1,4.4.2) 
and are released by synaptosomal lysis due to Triton exposure (Docherty et al, 
1987a). This interpretation can be rejected for 2 reasons
i) The level of immunoadsorption differs from detergent solubilized material of 
2 different Triton concentrations, which were made from a common detergent 
extract. Any release of internal nAChRs would have been the same.
ii) Immunoadsorption from extracts at different Triton concentrations mirrors 
immunoadsorption from P2b preparations in the presence of those Triton 
concentrations, this does not disprove interpretation (d), but it does tend to 
contradict it.
Interpretation e) The nAChR are dispersed and very few receptors are present 
on each synaptosome, so that immunoadsorption does not occur, because the few 
attachments which are made are insufficient to prevent disruption. It is known 
that immunoadsorption is improved by increases in points of attachment 
(Richardson and Luzio 1986; 1988), however this cannot be the explanation for 
these results because immunostaining also failed (section 3.4.7).
Interpretation f) Triton causes a change in the protein conformation of the
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nAChR or possibly the mAbs, which allows the recognition of the nAChRs by the 
mAbs. In the 1970’s, Triton X-100 was shown to bind to Torpedo nAChRs and 
induce conformational changes, which are not caused by other detergents (Su&rez- 
Isla and Hucho, 1977): the Triton X-100 acts as a noncompetitive inhibitor of high 
affinity ligand binding (Heidmann et al, 1983). Perhaps the Triton X-100 has a 
similar effect upon a4£2 receptor, certainly solubilization often causes some 
conformational changes (Lindstrom, 1985). The experiments described in section 
5.3.4demonstrated the effect of Triton concentration upon immunoadsorption of 
nAChRs from P2b preparations. Immunoadsorption increased with increasing 
Triton concentration, as determined by depletion of the specific [3H]-nicotine 
binding from P2b preparations, and by the gain of specific [3H]-nicotine binding 
by beads (section 5.3.4.2). The experiments, which were performed to show 
immunoadsorption of nAChR from detergent extracts using Dynabeads (section
5.3.2.2),were repeated using P2b preparations containing Triton (section 5.3.4.2). 
The effect of Triton concentration upon immunoadsorption was the same in both 
experiments.
The evidence presented in this thesis strongly supports interpretation (f). Two 
methods were employed to try to induce conformational changes allowing 
receptor immunoadsorption in the absence of Triton (section 5.3.5):-
i) Protease exposure. Protease exposure can cause conformational changes 
resulting in loss of [3H]-nicotine binding (section 5.3.5, 5.3.4.2; Whiting and 
Lindstrom, 1986b, c), but conformational changes which aided immunoadsorption 
were not detectable. If digested receptors were attached to beads their 
concentration was low, because the level of undetected nAChR was low (section
5.3.5.5.3.4.2).
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ii) Glycosidase exposure. Experiments were performed to eliminate the possibility 
that the binding of mAbs to nAChRs in the absence of Triton was blocked by the 
nearby glycosylation sites (Anand etal, 1991; Gehle and Sumikawa, 1991;Nomoto 
et al, 1986). This hypothesis was unlikely, but it was investigated for completion. 
Exposure to glycopeptidase F was known to remove the carbohydrate component 
of the a4£2 receptor (Anand etal, 1991). Attempted deglycosylation had no effect 
upon immunoadsorption so this approach was not pursued.
5.4.4 The viability of Immunoadsorption of svnaptosomes 
bearing nAChRs
The experiments interpreted in section 5 demonstrate that immunoadsorption of 
synaptosomes bearing the nAChR was not possible using the 4 Lindstrom mAbs, 
this contradicts the preliminary results described by Irons e ta l (1988, 1989). The 
immunoadsorption results strongly indicate that receptor recognition by the 
monoclonal antibodies was dependent upon Triton concentration, the reason for 
this seems to be that Triton causes conformational changes in the nAChR or 
possibly the mAbs which are a prerequisite for recognition by the 4 mAbs. No 
alternative treatment was discovered which allowed nAChR immunoadsorption 
in the absence of Triton.
Immunoadsorption was measured by high affinity [3H]-nicotine binding to bead 
bound nAChR and non-adsorbed nAChR. This technique is superior to 
measurement in preliminary experiments (Irons et al, 1988, 1989), which were 
based on the measurement of cytoplasmic markers and neurotransmitter 
synthesizing enzymes (Docherty etal, 1987b; Richardson etal, 1984). High affinity
[3H]-nicotine binding is a sensitive technique, which measures a4£2 (section 1.3) 
directly and so, in this case, it was a far more accurate approach for investigating 
immunoadsorption. All available evidence indicates that the immunoadsorption 
of synaptosomes bearing nAChRs is a viable objective, using other antibodies.
Chapter 6 Conclusions
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6.1 Summary of results
Ligand binding to subcellular fractions (section 3) reinforced previous studies 
which demonstrated that o4£2 nAChRs are present in synaptosomes (section 
3.4.3),Preliminary ligand binding studies indicated that a large proportion of the 
o4&2 isoform are not present in the SJC itself, where they might be protected by 
the synaptic junctional matrix (section 3.4.2).Thus, a large proportion of receptors 
would appear to be accessible for immunoadsorption (section 5.4.3).
Attempts to immunoadsorb synaptosomes bearing the nAChR were unsuccessful, 
but various experiments were performed to determine the reason for this (section
5.3.5).There did seem to be a large proportion of receptors which were accessible 
for immunological recognition (5.4.3). Immunostaining techniques were 
unsuccessfu l (sec tion  4 and especially  3 .4.7), thus the reason  why 
immunoadsorption was not successful was not that the nAChRs were so widely 
dispersed that there were too few attachment sites on each synaptosome: if 
immunological recognition had occurred even widely dispersed nAChRs would 
have been detected by immunostaining (section 3.4.7).Sections 3.4.4,3.4.5,4 and
5.4.1 discuss how mAbs were shown to recognize the secondary probes; section
5.4.1 describes how mAbs were shown to attach to the bead matrix; section 5.4.2 
describes how the bead-bound mAbs were successfully used to immunoadsorb 
nAChRs from detergent extracts of synaptosome preparations. However, 
immunological recognition of the a4£2 isoform seemed to decrease with 
decreasing Triton concentration (sections 5.4.2.2 and 5.4.3). None of the 
treatments considered in section 5.4.3 altered immunological recognition; it is
2 1 6
possible that alternative treatments would be more successful. There are several 
possible explanations for the dependence of immunological recognition upon 
Triton: the explanation favoured by the author, based on the work presented in 
this thesis, is that Triton causes a conformational change in either the nAChR or 
the mAbs which enable immunological recognition (section 5.4.3). This 
explanation is proposed, because the mAbs were originally raised and screened 
against detergent solubilized nAChRs (section 1.4) and Triton X-100 has been 
shown to cause conformational changes in Torpedo nAChRs (section 5.4.3.f).No 
experiments have been performed to determine if this effect is limited to the rat 
a4S2 isoform: it is possible that these mAbs do not require Triton for the 
recognition of other isoforms or even of the a4£2 isoform of other species. No 
experiments were performed to determine if the dependence of immunological 
recognition upon Triton was caused by the storage conditions of the mAbs, which 
had been lyophilized for transport and were resuspended and frozen in aliquots 
for use within 6 months. The synaptosome immunolocalization experiments 
evaluated in section 5 are almost certainly viable, if antibodies which recognize 
the receptor in the absence of Triton X-100 can be found by the screening 
procedure derived from section 5 .2 in appendix B. Monitoring immunoadsorption 
would be considerably aided by using antibodies which do not block high affinity 
[3H]-nicotine binding. An alternative approach to correlating neurotransmitter 
content with nAChRs might be to perform [3H]-nicotine binding to synaptosomes 
which have been shown to be immunopurified on the basis of expressed 
neurotransmitter-synthesizing enzymes. This possibility was not investigated 
because of time constraints.
Immunoelectron microscopy of synaptosomes is probably best performed by 
prefixation immunostaining (appendix A, section 4.4.1 and 4.4.3). The 
concentration of the o4£2 nAChRs is so low (section 4.4.1) that detection in 
unpurified synaptosomes may not be possible; however, if this approach is viable, 
an extensive study is certainly required (section 4.4.3). Post-embedding 
immunoelectron microscopy is probably an inferior approach to the detection of 
the o4S2 isoform in synaptosomes, unless attempts were made to detect 
cytoplasmic nAChR sites (section 4.4.2 and 4.4.3). Immunostaining controls 
(section 3.4.7) indicated that immunological recognition was not possible using the 
mAbs without Triton and so a primary aim of further immunoelectron microscopy 
of synaptosomes would have to be to find antibodies which would bind to the 
nAChR with high affinity under conditions which do not damage or prevent the 
detection of synaptosomal ultrastructure. Immunoelectron microscopy has been 
performed upon tissue blocks, and this is clearly an appropriate approach because 
identification is far easier, alternatively immunopurified synaptosomes could be 
analyzed as they would bear far higher nAChR concentrations. Both these 
approaches were not attempted because they compromised the original objectives 
of the project (section 4.4.3).
6.2 The role of presynaptic AChRs
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This study reinforces previous studies which indicate a significant proportion of 
nAChRs are located at the presynaptic terminal (section 1.4), it also indicates that 
a significant proportion of those receptors are not found in SJCs. Metabotropic 
presynaptic receptors are thought to regulate the synaptic terminal and influence 
release (section 1.5) by controlling ion fluxes including calcium flow (Miller, 
1990). In many cases the role of LGICs is less clear (Papke, 1993). Some nAChRs 
are permeable to calcium (section 1.3) and are inwardly rectifying, it has been 
suggested that these nAChRs function as a "and not" logic gate (review Papke, 
1993), allowing Ca2+ flux when the cell is stimulated by ACh and not depolarized 
by other inputs. It is also possible that calcium permeable nAChRs induce calcium 
mediated responses in the same manor as metabotropic presynaptic receptors. To 
date calcium permeability has not been reported for the a4£2. The a4£2 isoform 
is rapidly desensitized (section 1.3, 1.5) and the presynaptic o4£2 is certainly 
involved in transiently increasing the probability of neurotransmitter release 
(section 1.3),but no other function seems to have been definitively demonstrated.
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Appendix A The choices available for immnnoelectron1 1  I I I
microscopy of synaptosomes
A .l Conditions for similar immnnoelectron 
microscopy studies
The optimal conditions for the examination of synaptosomes by electron 
microscopy were established in the late 1960’s (review: Jones, 1975). Briefly, 
synaptosome suspensions were fixed by dual fixation (glutaraldehyde, then osmium 
tetroxide, as Sabatini et al, 1963), dehydrated with acetone, embedded in 
expoxyresin (Glauert and Glauert, 1958) and positively stained using uranyl 
acetate (Silva et al, 1968) and lead citrate (Reynolds, 1963) salts.
Immunoelectron microscopy experiments, using neuronal tissue blocks, tend to 
follow a very similar pattern (eg: Barnes et al, 1988, 1992; Hill et al, 1993; 
Dechesne et al, 1990; Peng et al, 1991; Sargent et al, 1989; Somogyi et al, 1989) 
with only minor variations. Briefly, whole brains were fixed by perfusion and then 
dissected (Barnes et al, 1988), or sometimes dissected regions were fixed by 
submersion (Sargent et al, 1989). This primary fixation was aldehyde based with 
a phosphate buffer vehicle, the fixative(s) were either paraformaldehyde alone 
(Peng et al, 1991), 4% paraformaldehyde/0.1% glutaraldehyde (Barnes et al, 1988, 
1992; Dechesne et al, 1990; Matsas et al, 1986), paraformaldehyde/acrolein 
(Sargent et al, 1989), paraformaldehyde/picric acid (Hill et al, 1993) or 
paraformaldehyde/glutaraldehyde/picric acid (Somogyi et al, 1989). The tissue
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was then cryoprotected, with sucrose in phosphate buffer, frozen and sectioned 
(50/un). Mounted or "free floating" sections were immunostained, using a 
phosphate buffer vehicle, then fixed with osmium tetroxide (1% v/v). Sections 
were dehydrated, embedded, sectioned on an ultramicrotome (lOOnm) and 
positively stained essentially as described above.
One approach to immunostaining subcellular particles was described by Wray and 
Sealock (1984), La Rochelle et al (1985) and Ratman et al, (1986a): they were 
immobilized onto poly(vinyl chloride), lysed and immunostained before fixation 
(glutaraldehyde/tannic acid), dehydration (ethanol) and embedding (Epon). An 
alternative approach to immunostaining subcellular particles was to immunostain 
them in free suspension (Lentz and Chester, 1977) and then pelleted before 
fixation (glutaraldehyde), dehydration (ethanol) and embedding (Epon).
The following sections describe the available choices of preparative conditions 
and the reasons for using the two representative approaches described in 
section 4.
A.2 Immunostaining techniques
Immunostaining may be performed at virtually any stage in specimen treatment, 
but some stages tend to be more appropriate. As antibodies are often raised 
against native receptors an obvious stage to immunostain a specimen is before any 
chemical treatment whatsoever, this avoids epitope denaturation problems and so 
conditions of fixation, dehydration, embedding and positive staining can be chosen 
for optimal image quality. Despite this advantage prefixation immunostaining
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(Hayat, 1989a) is rarely used, because it produces optimal results only when 
epitopes are accessible without any pretreatment and very few epitopes fall into 
this category. Membrane permeabilization or lysis can be sometimes employed to 
allow immunological access (Ratnam, 1986a), but this approach can be 
unacceptable if a morphological identification is required which involves 
complicated membraneous structures, and also it causes antigen migration 
(Beesley, 1989). Fortunately, part of the nAChR is extracellular and some 
Lindstrom antibodies are directed against epitopes which are at that extracellular 
location (Ratnam et al, 1986b).
Cryoscopic preservation techniques (Hayat, 1989a) were inappropriate prior to 
prefixation immunostaining because:
a) the relevant equipment (and expertise) was not available
b) cryoscopic sections of synaptosomes can disperse, as they melt, during antigen 
exposure, or the synaptosome density can be high enough to prevent colloidal 
gold penetration.
Thus unfixed synaptosomes could have been immunostained in free suspension 
(Lentz and Chester, 1977) or immobilized against a matrix (Ratnam et al, 1986a). 
A potential advantage of immunostaining immobilized synaptosomes is the 
reduced probability of immunogold dissociation (Hayat, 1989b), but one 
dimension is lost.
Post-embedding immunostaining is performed immediately after sectioning. In 
most cases it is pointless to immunostain a specimen at any time between 
prefixation and post-embedding stages, because epitope access is constant until
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sectioning, but the chance of recognition falls with increasing denaturation during 
specimen treatment. After sectioning, access does not increase further, but 
positive stains alter biomolecule conformation. Post-embedding immunostaining 
is a common approach (Hayat, 1989a), it offers
a) equal access to all epitopes
b) virtually any immunostaining conditions can be used
c) no problems of dissociation
d) minimal damage to tissue morphology
This technique does have disadvantages
a) antigen denaturation is almost inevitable and so there is high chance of 
recognition failure
b) methods to increase the chance of recognition involve a decrease in image 
quality and clarity
c) probe penetration into resin is poor (Beesley, 1989) so that, at best, only 10% 
of epitopes are available for recognition
The choice of immunostaining techniques. Both prefixation and postembedding 
techniques were evaluated to determine the viability of immunostaining the a4S2 
receptor in subcellular fractions. The receptor is present at a low concentrations 
in subcellular fractions and the probability of detection was small, so prefixation 
immunostaining was performed on synaptosomes in free suspension, to optimise 
access and to maximise the number of synaptosomes/field. The possibility of 
probe dissociation was examined by performing controls (section 3). If 
immunolocalisation and immunostaining proved viable, then immunopurified
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synaptosomes would probably be best examined by matrix digestion (Richardson 
et al, 1984), synaptosome immobilization (Ratnam, 1986a), then prefixation 
immunogold staining.
A.3 The immunostain
Immunostaining is a natural extension of conventional chemical positive staining 
(A. 11), combining the specificity of biomolecules with the electron dense 
characteristics required for successful staining. Early immunocytochemistry 
employed ferritin coupled antibodies (Singer, 1959, Singer and Schick, 1961), later 
other markers including enzyme conjugated- (Deutch et al, 1987; Hill et al, 1993) 
and radiolabelled- (Swanson et al, 1987) antibody probes have been used. 
Colloidal particles have distinct profiles and offer superior localization and 
quantification to the radiolabelled and enzyme-linked probes (Williams, 1977b), 
but they suffer from reduced access (Williams, 1977a) and increased dissociation 
(Hayat, 1989b). Colloidal particles had to be used for this work, because the other 
two probe types could not localise an antigen to one side of the synapse (Hill et 
al, 1993).
Colloidal gold is classically considered the best colloidal particle for 
immunostaining (reviews: Beesley, 1989; Hayat, 1989a, b; Horisberger, 1981; 
Horisberger and Rosset, 1977; Polak and Van Noorden, 1984; Weakley, 1981). 
Gold labelling, initially using gold-tagged IgG (Faulk and Taylor, 1971), resolves 
the combination of problems found with the other probes:-
1) Colloidal gold particles are spherical, electron dense particles, which are 
readily detectable in electron micrographs.
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2) Nonspecific staining of the resin by the gold particles is extremely low.
3) The particles are discrete and bind with high affinity, allowing direct 
quantification.
4) Gold particles can be made from the reduction of gold chloride (Horisberger 
and Rosset, 1977) in a range of sizes (2.6nm to 150nm are available although 5 
to 20nm are generally used) by the manipulation of the preparative conditions (eg 
Horisberger, 1981; Slot and Geuze, 1985). The control of particle size, and the 
close proximity of the particle and recognition site means that localization is 
excellent.
5) Gold particles can be attached, via complex electrochemical interactions, to a 
variety of biomolecular probes, eg lectins, hormones, immunoglobulins, 
glycoproteins, lipoproteins, toxins, dextran, Avidin, Protein A or G and enzymes. 
The non-covalent attachment is generally not conformationally disruptive and so 
the probe retains its biological activity and specificity.
6) Multiple labelling can be routinely performed, using gold particles of two or 
more sizes.
7) Gold particles can be used as seeds for silver ion deposition (Holgate et al, 
1983; Hayat, 1989b; James, 1977) this improves gold particle visibility and silver 
staining is visible by light microscopy allowing comparative studies.
8) The technique is flexible:- pre- and post-embedding labelling may be 
performed, the latter is more common, and thin conventional sections, as well as 
thin cryosections, can be stained (as A.l).
Gold conjugated probes do have some disadvantages (Beesley, 1989; Hayat,
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1989a, b; Williams, 1977a):-
1) The particles are dense and can easily dissociate during centrifugation.
2) The particles are relatively large and so cannot penetrate resin.
3) The labelling efficiency is proportional to the inverse of the square root of 
particle diameter, but visibility decreases with particle size, this can be 
compensated by silver enlargement.
Initial studies were performed using lOnm diameter gold particles in order to 
determine an appropriate particle size and to avoid artifacts from silver 
enhancement. Once a successful immunostaining procedure had been derived, the 
particle size would be reduced to a minimum for immunostaining and silver 
enhancement used for visualisation. Avidin-gold probes (Hill et al, 1993) were 
used for prefixation immunostaining after specificity problems were encountered 
during postembedding experiments, the Avidin-biotin system combines high 
specificity with high affinity (Polak and Noorden, 1984) and so reduces the 
probability of dissociation.
A.4 The synaptosome preparation
The concentration of nAChRs vary throughout the brain (Clarke et al, 1985) and 
the neuronal distribution varies indifferent brain regions (sections 1.4,3.4.3),but 
estimates of the size of the presynaptic subpopulation for any particular region 
vary considerably. Synaptosomes were prepared from whole brains (each minus 
cerebellum), rather than homogenized brain regions, despite the reduced o4£2 
concentration, in order to avoid choosing a region with an untypical distribution 
or concentration of nAChRs. If brain region synaptosomes had been examined,
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the cortex would have been examined first (sections 1.4,3.4.3).
The choice of synaptosome preparation had to be made empirically, three obvious 
options were available
a) The Sl-Percoll method (section 3.2.4). A high proportion of the structures in 
fraction F4 are synaptosomes (Dunkley et al, 1988) and preliminary evidence 
indicates the F4 fraction contain high concentrations of the a4£2 (Barnes et al, 
1992; Thome et al, 1991).
b) The P2-sucrose gradient method (section 3.2.2).The P2b fraction contains a 
fairly high proportion of synaptosomes (Whittaker, 1969) and high concentrations 
of the o4£2 (Yoshida and Imura, 1979).
c) The H-sucrose gradient method (section 3.2.2). The Hb fraction contains a 
moderately high proportion of synaptosomes (Rapier et al, 1988) and high 
concentrations of the a4£2 (Rapier et al, 1990).
Options (a) and (c) do not involve synaptosomal precipitation (by centrifugation) 
and resuspension, which cause synaptosomal damage (Dunkley et al, 1988), but 
(a) does produce a low yield of synaptosomes (Dunkley et al, 1987) containing 
high concentrations of Percoll. This dense medium can be removed by centrifugal 
washing (Thome, 1990; section 3.3.3), but this causes synaptosomal damage. 
Prefixation immunostaining involves centrifugal washing which must be performed 
at higher, more destmctive, speeds if the Percoll is still present. Percoll associates 
with synaptosomal membranes (Wonnacott, person, comm.), and its effects upon 
post-embedding immunostaining are not known, and so removal is desirable. The 
efficiency of the Percoll preparative method raises 2 problems:-
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i) the high synaptosomal content of Percoll fractions (F4) means there are few 
other structures to act as controls to allow the interpretation of immunogold 
staining.
ii) synaptosomes are spread over all Percoll fractions, the morphology and 
neurotransmitter content of synaptosomes vary with each fraction so that each 
fraction, is unrepresentative of the entire synaptosome population (Harrison et al, 
1988), this is a more serious problem for an assessment of nAChR distribution.
The use of technique (a) was rejected, until immunostaining could be established. 
Experiments were performed to compare the synaptosome content and quality of 
the Hb and the P2b preparations (section 4.3.1.1).
A.5 Synaptosome damage
Synaptosomes are delicate structures and can be more easily damaged than 
synapses in a tissue block. Synaptosomal damage can be caused by:-
a) Mechanical disruption when a synaptosome suspension is washed by 
centrifugation and resuspension (Dunkley et al, 1988; Fleming et al, 1980). 
Mechanical damage is a major consideration because of the extensive centrifugal 
washing during prefixation im m unostaining described in section 4.2: 
postembedding immunostaining methods involve very little centrifugal washing 
before embedding, so mechanical damage was less of a problem.
b) The use of detergents, eg Triton, during immunostaining. Triton has no effect 
upon synaptosome damage during post-embedding immunostaining, as the 
synaptosomes have been fixed and embedded (section 4.3.4).The use of Triton 
for pre-fixation immunostaining is impractical, because synaptosomes are lysed
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and the damage to these delicate membraneous structures renders them 
unidentifiable.
c) The use of vehicles of inappropriate osmolarity, pH or chemical content 
(Hayat, 1989a, Weakley, 1981) can cause tissue damage:-
i) Tissue damage can be caused by the pH of vehicles, synaptosome disruption is 
least likely when buffers were made with physiological pH (7.4, Hayat, 1989a).
ii) Isotonic, or slightly hypertonic, vehicles are generally used to minimize tissue 
disruption, however the actual optimal osmotic strength of vehicle varies 
considerably depending on the specimen tissue (Hayat, 1989a) and so osmotic 
strength must be empirically defined. In this specific case, the strength of 
synaptosome membranes is low and so isotonic buffers are likely to be iso-osmotic 
with synaptosome content (320-350 mosmol: Dunkley et al, 1987). The osmotic 
strength of fixatives is quite high, but they penetrate structures slowly, an 
empirical rule (Hayat, 1989a) is to use vehicles isotonic to tissues.
iii) The chemical content of buffers can cause or reduce synaptosomal disruption. 
Some chemicals tend to help preserve tissue structure, eg sucrose (Burdett and 
Rogers, 1970) and calcium chloride (Morel et al, 1971). Calcium chloride was 
avoided, because it reacts with several chemicals to give insoluble electron dense 
precipitates (Hayat, 1989a). The use of dense media (eg 0.32M sucrose) tends 
increase mechanical disruption during centrifugation as high forces must be used 
(Dunkley et al, 1988).
A.6 Vehicle choice
Vehicle usage affects immunostaining and synaptosome integrity, but it can also 
affect image quality, and chemical cross-reaction can cause the precipitation of
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electron dense particles during staining (A. 11). Several buffers are routinely used, 
they have differing effects on fixation and extraction. The commonly used buffers 
are based on the following salts: cacodylate, collidine, HEPES, MOPES (3-[N- 
morpholino] propanesulphonic acid), phosphate, PIPES (piperazine-N,N’-bis[2- 
ethanesulphonic acid]), Tris and veronal acetate. A variety of chemicals are added
to stabilize tissue, such as sucrose and calcium chloride, or to alter osmolarity,
such as sodium chloride. A full discussion of the relative merits of vehicle 
components is given elsewhere (Hayat, 1989a; Lewis and Knight, 1977), the 
relevant points are detailed, as appropriate, in other sections. It is generally 
recommended that optimal buffer conditions are established empirically (section 
4.3.1.3).
A.7 Fixation method
There are four methods of chemical fixation:
a) vascular perfusion (Barnes et al, 1988)
b) immersion (Sargent et al, 1989)
c) dripping onto the surface of the organ (Hayat, 1989a)
d) injection into the organ (Koelle et al, 1974)
Method (a) is the best option and method (b) the worst option for most cases, 
because of the difficulty of access (Hayat, 1989a). In this project, the specimen is 
a suspension of small particles and the situation is reversed, because the distance
the fixative must penetrate is so short (Reith et al, 1984). The immersion method




Different fixatives were chosen for prefixation and postembedding immunostaining 
experiments.
A.8.1 Prefixation immunostaining
Pre-fixation immunostaining is unaffected by receptor denaturation, thus the 
criteria for fixation must be image quality. The dual fixation technique (Sabatini 
et al, 1963) consists of primary fixation with glutaraldehyde then secondary 
fixation using osmium tetroxide. Glutaraldehyde is the most effective aldehyde for 
preserving fine structure (Sabatini et al 1963,). Fixation chemistry is not 
completely understood because commercial glutaraldehyde is highly impure and 
mainly consists of polymerised condensation derivatives (reviews Hayat 1986a, 
1989a; Sabatini et al 1963). Glutaraldehyde reacts mainly with proteins, some 
secondary structure (especially a. helical arrangements) is lost during cross-linkage, 
but tertiary or quaternary structure are usually unaffected, thus denaturation is 
limited and often biological function and conformation are maintained.
Extraction, during osmium tetroxide, is reduced by the glutaraldehyde fixation. 
Osmium tetroxide acts as a fixative and an electron dense positive stain. It is a 
reactive chemical which primarily cross-links the C=C double bonds of lipids and 
lipoproteins (Dreher et al, 1967), but also reacts with proteins, polypeptides 
(Hake, 1965), nucleic acids (Chang et al, 1977) and a variety of other compounds 
including phenols and alkaloids (review Hayat, 1989a).
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A.8.2 Post-embedding immunostaining
Osmium tetroxide causes considerable conformational distortion and chemical 
modification of proteins (Lenard and Singer, 1968; Hayat, 1989a), this 
denaturation often results in the loss of antigenic sites. It can sometimes be used 
prior to immunostaining (Bendayan and Zollinger, 1982), but generally this gives 
poor or negative results (Beesley, 1989, Polak and Van Noorden, 1984). 
Permanganates cause extensive extraction, which results in clear membranes by 
a dramatic reduction of non-lipid components (Hayat, 1989a). As the 
concentration of nAChRs is low anyway, increased extraction was inappropriate.
Aldehydes are effective for the maintenance of fine structure of proteins and 
proteinaceous structures (Hayat, 1989a). Fixation is by condensation reactions 
between the aldehyde and amino groups yield alpha-hydroxyamines, which then 
cross link with other amino groups by further condensation reactions. The first 
aldehyde to be used was the monoaldehyde acrolein. In the early 1960’sBarmett 
and colleagues (Sabatini et al, 1963) published extensive studies with aldehydes 
and began their general usage. Acrolein cannot be used with sucrose (Hayat, 
1989a) and so it was avoided. Glutaraldehyde is described in section A.8.1. 
Formaldehyde (methanal) is a far weaker and less specific cross-linking agent 
than glutaraldehyde. The colourless gas readily dissolves in water to give formalin, 
which contains contaminants, such as methanol and methanoic acid (Walker, 
1964), that inhibit cross-linking, so formaldehyde solutions are best prepared from 
the polymer paraformaldehyde, by hydrolysis, under mild alkaline conditions. 
Formaldehyde reversibly cross-links proteins and nucleic acids, and seems to 
encourage the extraction of lipids during subsequent dehydration.
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The mixed aldehyde fixation technique minimizes denaturation, whilst maximizing 
tissue preservation, and so it is often used prior to immunostaining (Barnes et al, 
1988, 1992; Dechesne et al, 1990; Matsas et al, 1986). Formaldehyde and 
glutaraldehyde (Kamovsky, 1965) seem to act in concert, to give a far greater 
fixation than would be expected from the individual aldehydes. The classical 
rationale for this effect is that the former rapidly penetrates the material, causing 
partial fixation until the slower glutaraldehyde arrives, to cause irreversible cross- 
linkage, but it seems increasingly likely that the two aldehyde react with each 
other to catalyze cross-linkage (Kirkeby and Moe, 1986).
Other fixatives (Hayat, 1981, 1986b), including tannic acid (Chaplin, 1985) and 
picric acid (Somogyi et al, 1989), can be used in combination with aldehyde 
fixation to improve membrane visualization, but for initial experiments it was 
important to minimise the use of potentially denaturating chemicals.
A.9 Fixation conditions
In order to minimise artifacts, the following fixation conditions have been 
established empirically (Hayat, 1989a):-temperature, duration, and method of 
fixation, and buffer composition, concentration, pH and osmolarity. A major 
factor to consider was the degree biomolecule extraction (leeching). Fixation 
reduces extraction, but the fixatives themselves cause extraction.
The rate of extraction during glutaraldehyde exposure is very low, it is increased 
at higher temperatures, longer durations and high fixative concentrations, but 
there is a wide window for these parameters and penetration is affected by the
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same variables. Minimal artifacts are generally achieved by using 1-4% 
glutaraldehyde (optimum 2%), for 1-18 h (optimum 2h) at 0°C to room 
temperature (optimum 4°C). The pH for fixation is optimal at 7.0-7.4:-as pH 
increases cross-linking improves, but at pH’s greater than 7.5 the aldehyde tends 
to polymerize, also a physiological pH tends to minimize artifacts from tissue 
damage.
Osmium tetroxide fixation causes extensive extraction, especially of unfixed 
material. The molecule is large and non-polar, it penetrates slowly (0.7mm per 
hour), but is unimpeded by layers of charged material. Minimal artifacts are 
generally achieved by using 0.5% and 2% osmium tetroxide (optimum 1%), for 
30-120 minutes (optimum 30-45 min for particular material) and physiological 
pH’s (7.2-7.4).Fixation is best begun at 4°C, although the temperature can then 
be allowed to rise to room temperature.
A .10 The resin and dehydration conditions
Electron beams are rapidly attenuated, furthermore stereological information 
deteriorates with section thickness (Holmes Effect, 1921, see Williams, 1977b), 
thus image quality and clarity increase with decreasing section thickness providing 
sufficient contrast can be achieved by staining. Section thickness can be reduced 
by using a sharper knife and mechanical cutting (A. 11), and by making the 
specimen harder and more rigid. Embedding is defined as the complete and 
uniform impregnation of the interstices of a specimen with a medium and its 
subsequent solidification, resulting in a large and uniform increase in specimen 
rigidity. This is often achieved by monomer infiltration, ie the gradual and
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continuous replacement the original solvent (water), then polymerization. 
Infiltration is accelerated by limiting specimen size and by continuous agitation. 
Various embedding materials are available (Hayat, 1989a).
Epoxyresin was a suitable resin for prefixation immunostaining where 
denaturation is unimportant, but image quality was desired. Epoxyresin (araldite) 
is a glycerol-based aromatic resin (Glauert and Glauert, 1958; Hayat, 1989a), 
which is relatively hard and stable to electron beams and so sections have 
negligible cutting artifacts and can be mounted directly on grids, therefore 
specimens can be viewed with good image quality and negligible artifacts to a 
high resolution. The disadvantages of araldite are mainly related to its 
hydophobicity and immiscibility with water:-
1) All free water must be replaced by a resin-miscible solvent before resin 
infiltration. The best solvent for this extensive dehydration in terms of: resin 
miscibility, minimization of structural changes, rapidity of dehydration and hence 
minimal extraction, and finally low chemical reactivity is acetone. A series of 
acetone washes result in gradual, even and complete dehydration. The 
hydrophobic conditions contribute to protein denaturation and loss of antigenicity
2) The fixation must be more severe to minimize the extraction during full 
dehydration, this increases protein denaturation and loss of antigenicity.
3) Polymerization is achieved using a "heat cure" procedure whereby the resin- 
impregnated specimen is heated to 60°C, for 48 hours, this increases protein 
denaturation and loss of antigenicity.
4) The density of the resin and hydrophobic character of the resin does not favour 
immunological staining. This problem may be bypassed by etching sections, but
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this process of breaking bonds risks specimen damage and also results in loss of 
the positive resin characteristics of strength and stability so, for example, electron 
beam damage is more likely. Etching is pointless if the antigen has been 
denatured to a degree where epitope recognition is impossible.
Epoxyresin was of doubtful value for post-embedding immunostaining because of 
protein denaturation. Previous work, using Lindstrom monoclonal antibodies 
(Thorne, 1990, personal comm.), failed to show specific post-embedding 
immunogold staining of o4£2 nAChRs in epoxyresin embedded P2b preparations. 
A far more appropriate resin was LR White (Newman et al, 1983, 1989; Hayat, 
1989a), which is a polar resin, because the monomer is a polyhydroxylated 
aromatic acrylic. LR White is miscible with water (if H20  < 1 2 %  v/v), so 
dehydration can be rapid, incomplete and use the milder solvent ethanol. 
Infiltration is rapid because of the acrylic resin’s low viscosity. Thus, extraction 
and denaturat ion are minimized during dehydrat ion and embedding.  
Immunocytochemicals can penetrate sections without etching as the resin is 
hydrophillic and has a relatively open structure (Newman, 1987). The resin has 
very low toxicity and during immunostaining the resin itself is negligibly stained. 
LR White polymerization requires the absence of oxygen, but can be achieved in 
three ways:-
a) Heat curing. Full (60°C) or partial (55 °C) curing takes about 24 hours, so 
denaturation is high, but less than attained when curing epoxyresin.
b) Chemical curing. Chemical catalysts and modifiers can be used to polymerize 
the resin, but they cause denaturation both chemically and by virtue of high local 
temperatures from highly exothermic polymerization reactions.
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c) Light curing. The use of UV radiation to cure LR White is by far the least 
damaging curing procedure.
The resin could not be cured using UV-light for practical reasons, but the other 
two curing methods were assessed. The disadvantages of LR White are related 
to its low density:- it is soft and difficult to cut so images are less clear; beam 
stability is poor, so sections tend to need to be mounted on coated grids; both the 
lower resin density and use of coated grids decrease image quality.
A .l l  Sectioning and positive staining
Sections were produced, at a range of section thickness, using an ultramicrotome 
with both mechanical and thermal feed. Two types of knife were available 
(review: Hayat, 1989a):
a) Diamond knives are very sharp and cut very clear sections down to a thickness 
of 5-10nm, they are very wear resistant, but they are expensive and only 
moderately tough.
b) Glass knives are cheap and disposable, but they are not wear resistant and are 
less sharp, they produce inferior images. Glass knives were considered adequate 
and for financial reasons they were used for this project.
When sections have insufficient strength, either to withstand the electron beam 
or to self support when mounted directly onto grids, a support film is required. 
The film must have high electron transparency to reduce artifacts, whilst providing 
strength and electron stability. As artifacts are always introduced, support films 
are only used when necessary. Preliminary experiments (section 4.3.3) showed that 
LR White resin had insufficient electron stability. LR White sections were
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mounted on carbon coated piloform support films. Piloform is a good physical 
support, but has little electron stability, the carbon coating provides beam stability 
(Hayat, 1989a).
All sections were positively stained, after all other treatments, by standard 
techniques (Reid, 1974), using standard stains (Lewis and Knight, 1977): lead 
citrate (Reynold, 1963) and uranyl acetate (Weakley, 1981). When osmium 
tetroxide fixation was performed it also acted as a positive stain (Hayat, 1989a). 
A positive stain improves image contrast for the structure of interest by making 
some biomolecules more electron dense. Image opacity increases with electron 
density, caused by the degree of electron scatter, which is determined by atomic 
weight, section thickness and density, and by microscope parameters such as 
accelerating voltage and aperture size. Staining helps image contrast and 
resolution, facilitates focusing and also acts to stabilize stained components so 
that they are less prone to sublimation by the electron beam, this latter factor 
leads to even greater contrast. Staining tends to be additive and so both stains 
were employed. Chemical cross-reactions between positive stain and any vehicles 
is possible (Hayat, 1989a; Lewis and Knight, 1977), but this is only a consideration 
when washing is inadequate (section 4.3.1,4.3.3).
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Appendix B A screening protocol to find antihndies 
fnrtfieimmiinoadsorptinn and immiino- 
electrnn microscopy of synaptosomes
Future antibodies should be screened to verify receptor recognition before 
attempting immunoadsorption and immunoelectron microscopy experiments. The 
following procedure is suggested:-
1) If the antibody is raised in the same species as the preparation bearing the 
nAChR, then the antibody should be biotinylated to avoid specificity problems.
2) Confirm the secondary probe will recognize the antibody, first by dot-blot 
recognition (section 3.3.5.2),then by using the secondary probe to attach the 
antibody to the bead (section 5.3.1)
3) Confirm that the antibody can be used to immunoprecipitate detergent 
solubilized receptor (section 5.3.2)
4) Confirm that the antibody can be used to immunostain the receptor in the 
absence of Triton (section 3.3.7)using an ,25I-labelled secondary probe.
Any further problems in immunoadsorption or immunoelectron microscopy 




Prefixation immunostaining: plates 1 to 16
Postembedding immunostaining: plates 17 to 28
Immunological staining: plates 29 to 39
Plate la  Micrograph of Hb demonstrating analysis field
Plates lb and la  show a representative field at the magnification used for analysis 
(30k) and the total analysis field at a slightly lower magnification respectively. The 
scale bar in la  shows l,000nm. For specimen and treatment details see plate lb 
legend.
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Plate lb
Plates lb shows a representative field at the magnification used for analysis (30k) of plate la. 
Specimen:- Hb. Immunostaining:- none (prefixation procedure). Immunostaining vehicle:- PBS. 
Concentration of mAb:- none. Secondary probe:- none. Blocking (immunostain):- none. 
Fixation:- Glutaraldehyde (o/n, 4°C), then osmium tetroxide (lh, 4°C). Fixation vehicle:- PBS. 
Encapsulation:- None. Dehydration:- Acetone. Embedding medium:- Epoxyresin.
Mould:- Eppendorf. Positive stains:- Uranyl acetate/ lead citrate 
Results:-
Synaptosomes (s) were visible as plasma membrane (pm) enclosed structures of approximately 0.5 
ixm diameter, containing synaptic junctions (j), mitochondria (m) and synaptic vesicles (sv). 
Background staining (b) was visible. A variety of non-synaptosomal structures were also seen in 
micrographs of Hb preparations.
Plate 2
Plates 2 shows a representative field at the magnification used for analysis (30k).
Specimen:- P2b. Immunostaining:- none (prefixation procedure). Immunostaining vehicle:- PBS. 
Concentration of mAb:- none. Secondary probe:- none. Blocking (immunostain):- none. 
Fixation:- Glutaraldehyde (16h, 4°C) then osmium tetroxide (lh, 4°C). Fixation vehicle:- PBS. 
Encapsulation:- None. Dehydration:- Acetone. Embedding medium:- Epoxyresin.
Mould:- Eppendorf. Positive stains:- Uranyl acetate/lead citrate.
Results:-
Synaptosomal damage is greater than in Hb (plate 1), but the number of identifiable synaptosomes 
is greater and the number of non-synaptosomal structures is far lower in the P2b preparation 
(plate 2).
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Plate 3
Plates 3 shows a representative field at the magnification used for analysis (30k).
Specimen:- P2b. Immunostaining:- prefixation. Immunostaining vehicle:- PBS 
Concentration of mAb:- 270 (200 pM), 290 (3375 pM), 297 (38 pM), 299 (38 pM) in 1ml 
Secondary probe:- Avidin-lOnm gold (1.5 x 1012 particles, 1ml). Blocking (immunostain):- none 
Fixation:-Glutaraldehyde (lh , 4°C) then osmium tetroxide (lh, 4°C).
Fixation vehicle:- PBS then sucrose for Os04. Encapsulation:- Pellet after osmium fixation 
Dehydration:- Acetone. Embedding medium:- Epoxyresin. Mould:- Eppendorf 
Positive stains: - Uranyl acetate/ lead citrate
Results:-
Synaptosomal damage is greater than in P2b (plate 2), reflecting greater centrifugation. Gold 
staining (g) could be distinguished from background staining (b) with care.
Plate 4
Plates 4 shows a representative field at the magnification used for analysis (30k).
Specimen:- P2b. Immunostaining:- none (prefixation procedure). Immunostaining vehicle:- PBS. 
Concentration of mAb:- none. Secondary probe:- none. Blocking (immunostain):- none. 
Fixation:- Glutaraldehyde (16h, 4°C) then osmium tetroxide (lh , 4°C). Fixation vehicle:- PBS. 
Encapsulation:- Agar. Dehydration:- Acetone. Embedding medium:- Epoxyresin.
Mould:- Eppendorf. Positive stains:- Uranyl acetate/ lead citrate.
Results:-
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Plates 5 shows a representative field at the magnification used for analysis (30k).
Specimen:- P2b. Immunostaining:- none (prefixation procedure). Immunostaining vehicle:- PBS. 
Concentration of mAb:- none. Secondary probe:- none. Blocking (immunostain):- none. 
Fixation:- Glutaraldehyde (16h, 4°C) then osmium tetroxide (lh , 4°C).
Fixation vehicle:- lOOmM phosphate (pH 7.4). Encapsulation:- Agar. Dehydration:- Acetone. 
Embedding medium:- Epoxyresin. Mould:- Eppendorf. Positive stains:- Uranyl acetate/ lead citrate 
Results:-
All synaptosomes were damaged, this was thought to be due to the high temperature (50°C) of the 
agar (see plate 4).
Plate 6
Plates 6 shows a representative field at the magnification used for analysis (30k).
Specimen:- P2b. Immunostaining:- none (prefixation procedure). Immunostaining vehicle:- PBS. 
Concentration of mAb:- none. Secondary probe:- none. Blocking (immunostain):- none. 
Fixation:- Glutaraldehyde (16h, 4°C) then osmium tetroxide (lh , 4°C). Fixation vehicle:- PBS. 
Encapsulation:- BSA of suspension after glutaraldehyde fixation. Dehydration:- Acetone. 
Embedding medium:-Epoxy resin. Mould:-Eppendorf. Positive stains:-Uranyl acetate/lead citrate. 
Results:-
Synaptosomes were not damaged, but the background staining was very high.
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Plates 7 shows a representative field at the magnification used for analysis (30k).
Specimen:- P2b. Immunostaining:- none (prefixation procedure). Immunostaining vehicle:- PBS. 
Concentration of mAb:- none. Secondary probe:- none. Blocking (immunostain):- none. 
Fixation:- Glutaraldehyde (16h, 4°C) then osmium tetroxide (lh , 4°C). Fixation vehicle:- PBS. 
Encapsulation:- BSA of pellet after glutaraldehyde fixation. Dehydration:- Acetone 
Embedding medium:-Epoxyresin. Mould:-Eppendorf. Positive stains:-Uranyl acetate/lead citrate. 
Results:-
Synaptosomes were not damaged, but the background staining was very high.
Plate 8
Plates 8 shows a representative field at the magnification used for analysis (30k).
Specimen:- P2b. Immunostaining:- none (prefixation procedure). Immunostaining vehicle:- PBS. 
Concentration of mAb:- none. Secondary probe:- none. Blocking (immunostain):- none. 
Fixation:- Glutaraldehyde (16h, 4°C) then osmium tetroxide (lh, 4°C). Fixation vehicle:- PBS. 
Encapsulation:- Pellet after osmium fixation. Dehydration:- Acetone.
Embedding medium:- Epoxyresin. Mould:- Eppendorf. Positive stains:- Uranyl acetate/lead citrate. 
Results:-
Synaptosomal damage was reduced by forming a pellet after osmium fixation, then treating the pellet 






Plates 9 shows a representative field at the magnification used for analysis (30k).
Specimen:- P2b. Immunostaining:- none (prefixation procedure). Immunostaining vehicle:-sucrose. 
Concentration of mAb:- none. Secondary probe:- none. Blocking (immunostain):- none. 
Fixation:-Glutaraldehyde (16h,4°C) then osmium tetroxide (lh , 4°C). Fixation vehicle:-sucrose. 
Encapsulation:- Pellet after osmium fixation. Dehydration:- Acetone.
Embedding medium:-Epoxy resin. Mould:-Eppendorf. Positive stains:-Uranyl acetate/lead citrate. 
Results:-
Synaptosomes were damaged due to centrifugation. The level of background staining was very low. 
Plate 10
Plates 10 shows a representative field at the magnification used for analysis (30k).
Specimen:- P2b. Immunostaining:- none (prefixation procedure). Immunostaining vehicle:-sucrose. 
Concentration of mAb:- none. Secondary probe:- none. Blocking (immunostain):- none 
Fixation:- Glutaraldehyde (16h, 4°C) then osmium tetroxide (lh , 4°C). Fixation vehicle:- sucrose. 
Encapsulation:- Pellet after osmium fixation. Dehydration:- Acetone.
Embedding medium:- Epoxyresin. Mould:- Eppendorf. Positive stains:- lead citrate.
Results:-
Synaptosomes were damaged as plate 9. The level of background staining was at the same low level 
as plate 9, showing the staining was due to osmium tetroxide/ glutaraldehyde cross reaction.
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Plates 11 shows a representative field at the magnification used for analysis (30k).
Specimen:- P2b. Immunostaining:- none (prefixation procedure). Immunostaining vehicle:- TBS. 
Concentration of mAb:- none. Secondary probe:- none. Blocking (immunostain):- none. 
Fixation:- Glutaraldehyde (16h, 4°C) then osmium tetroxide (lh , 4°C). Fixation vehicle:- TBS. 
Encapsulation:- Pellet after osmium fixation. Dehydration:- Acetone.
Embedding medium:-Epoxyresin. Mould:-Eppendorf. Positive stains:-Uranyl acetate/lead citrate. 
Results:-
Synaptosomes were damaged. The level of background staining was very low, at a similar level 
plate 9.
Plate 12
Plates 12 shows a representative field at the magnification used for analysis (30k).
Specimen:- P2b. Immunostaining:- none (prefixation procedure).
Immunostaining vehicle:- cacodylate. Concentration of mAb:- none. Secondary probe:- none. 
Blocking (immunostain):- none.
Fixation:-Glutaraldehyde (16h, 4°C) then osmium tetroxide (lh , 4°C).
Fixation vehicle:-cacodylate. Encapsulation:- Pellet after osmium fixation. Dehydration:- Acetone. 
Embedding medium:- Epoxyresin. Mould:- Eppendorf. Positive stains:-uranyl acetate/lead citrate 
Results:-
Synaptosomal damage was low, background staining was greater than plate 9.







Plates 13 shows a representative field at the magnification used for analysis (30k).
Specimen:- P2b. Immunostaining:- none (prefixation procedure). Immunostaining vehicle:- PBS. 
Concentration of mAb:- none. Secondary probe:- none. Blocking (immunostain):- none. 
Fixation:- Glutaraldehyde (16h, 4°C) then osmium tetroxide (lh , 4°C). Fixation vehicle:- PBS. 
Encapsulation:- Pellet after osmium fixation. Dehydration:- Acetone.
Embedding medium:- Epoxyresin. Mould:- Eppendorf. Positive stains:- lead citrate.
Results:-
Synaptosomal damage was low. The level of background staining was greater than that found in 
plate 9. This staining does not reflect chemical cross reaction between uranyl acetate and phosphate, 
as the level does not differ from plate 2.
Plate 14
Plates 14 shows a representative field at the magnification used for analysis (30k).
Specimen:- P2b. Immunostaining:- prefixation. Immunostaining vehicle:- PBS.
Concentration of mAb:- none. Blocking (immunostain):- none.
Secondary probe:- Gold conjugated goat anti-(rat IgG) (2 x 1012 particles, 1ml)
Fixation:- Glutaraldehyde (16h, 4°C) then osmium tetroxide (lh , 4°C). Fixation vehicle:- PBS. 
Encapsulation:- none. Dehydration:- Ethanol. Embedding medium:- LR White. Mould: Eppendorf. 
Positive stains:- uranyl acetate/lead citrate 
Results:-
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Plate 15
Plates 15 shows a representative field at the magnification used for analysis (30k).
Specimen:- P2b. Immunostaining:- prefixation. Immunostaining vehicle:-PBS.
Concentration of mAb:- 270 (160 pM), 290 (675 pM), 297 (150 pM), 299 (150 pM). 1ml 
Secondary probe:- Gold conjugated goat anti-(rat IgG) (2 x 1012 particles, 1ml).
Blocking (immunostain):- none.
Fixation:- Glutaraldehyde (16h, 4°C) then osmium tetroxide (lh , 4°C). Fixation vehicle:- PBS. 
Encapsulation:- none. Dehydration:- Ethanol. Embedding medium:- LR White.
Mould:- Eppendorf. Positive stains:- uranyl acetate/lead citrate 
Results:-
Gold staining was not seen reflecting lack of gold binding or gold dissociation.
Fate 16
Plates 16 shows a representative field at the magnification used for analysis (30k).
Specimen:- P2b. Immunostaining:- prefixation. Immunostaining vehicle:- PBS.
Concentration of mAb:- none. Secondary probe:- Avidin-lOnm gold (1.5 x 1012 particles, 1ml). 
Blocking (immunostain):- none.
Fixation:-Glutaraldehyde (16h, 4°C) then osmium tetroxide (lh , 4°C)
Fixation vehicle:- PBS then sucrose for Os04. Encapsulation:- Pellet after osmium fixation 
Dehydration:- Acetone. Embedding medium:- Epoxyresin. Mould:- Eppendorf.
Positive stains:- uranyl acetate/lead citrate 
Results:-


















Plates 17 shows a representative field at the magnification used for analysis (30k).
Specimen:- Hb. Immunostaining:- post embedding. Immunostaining vehicle:- TBS, no Triton. 
Concentration of mAb:- none. Blocking (immunostain):- none.
Secondary probe:- Gold conjugated goat anti-(rat IgG) (1 x 1012 particles, 0.2ml)
Fixation:-Glutaraldehyde (0.1%) and formaldehyde (2%) (lh , 4°C). Fixation vehicle:-PBS. 
Dehydration:- Ethanol. Embedding medium:- LR White. Cure:- Hot. Mould:- gelatine capsule 
Positive stains: - uranyl acetate/lead citrate. Coat:- none. Accelerating voltage:- 80kV.
Plate 18
Plates 18 shows a representative field at the magnification used for analysis (30k).
Specimen:- Hb. Immunostaining:- post embedding. Immunostaining vehicle:- TBS, no Triton. 
Concentration of mAb:- none. Blocking (immunostain):- 1% BSA, 5% goat serum.
Secondary probe:- Gold conjugated goat anti-(rat IgG) (1 x 1012 particles, 0.2ml).
Fixation:-Glutaraldehyde (0.1%) and formaldehyde (2%) (lh , 4°C). Fixation vehicle:-PBS. 
Dehydration:- Ethanol. Embedding medium:- LR White. Cure:- Hot. Mould:- gelatine capsule. 









Plates 19 shows a representative field at the magnification used for analysis (30k).
Specimen:- Hb. Immunostaining:- post embedding. Immunostaining vehicle:- PBS, no Triton 
Concentration of mAb:- none. Blocking (immunostain):- 0.2% BSA, 5% goat serum.
Secondary probe:- Gold conjugated goat anti-(rat IgG) (1 x 1012 particles, 0.2ml).
Fixation:-Glutaraldehyde (0.1%) and formaldehyde (2%) (lh , 4°C). Fixation vehicle:-PBS 
Dehydration:- Ethanol. Embedding medium:- LR White. Cure:- cold. Mould:- gelatine capsule. 
Positive stains:-uranyl acetate/lead citrate. Coat:-piloform/carbon. Accelerating voltage:-80 kV.
Plate 20
Plates 20 shows a representative field at the magnification used for analysis (30k).
Specimen:- Hb. Immunostaining:- post embedding. Immunostaining vehicle:- TBS, no Triton. 
Concentration of mAb:- none. Blocking (immunostain):- 1% BSA, 5% goat serum.
Secondary probe:- Gold conjugated goat anti-(rat IgG) (1 x 1012 particles, 0.2ml).
Fixation:-Glutaraldehyde (0.1%) and formaldehyde (2%) (lh , 4°C). Fixation vehicle:-PBS. 
Dehydration:- Ethanol. Embedding medium:- LR White. Cure:- Cold. Mould:- gelatine capsule. 






Plates 21 shows a representative field at the magnification used for analysis (30k).
Specimen:- Hb. Immunostaining:- post embedding. Immunostaining vehicle:- TBS, no Triton. 
Concentration of mAb:- 270 (800 pM), 290 (13500 pM), 297 (150 pM), 299 (150 pM). 0.25ml 
Secondary probe:- Gold conjugated goat anti-(rat IgG) (1 x 1012 particles, 0.2ml).
Blocking (immunostain):- 1% BSA, 5% goat serum.
Fixation:-Glutaraldehyde (0.1%) and formaldehyde (2%) (lh, 4°C).
Fixation vehicle:- PBS. Dehydration:- Ethanol. Embedding medium:- LR White. Cure:- cold. 
Mould:- gelatine capsule. Positive stains:- uranyl acetate/lead citrate. Coat:- piloform/carbon. 
Accelerating voltage:- 120 kV
Plate 22
Plates 22 shows a representative field at the magnification used for analysis (30k).
Specimen:- Hb. Immunostaining:- post embedding. Immunostaining vehicle:- TBS, no Triton. 
Concentration of mAb:- 270 (800 pM), 290 (13500 pM), 297 (150 pM), 299 (150 pM). 0.25ml 
Secondary probe:- Gold conjugated goat anti-(rat IgG) (1 x 1012 particles, 0.2ml)
Blocking (immunostain):- 1% BSA, 5% goat serum.
Fixation:-Glutaraldehyde (0.1%) and formaldehyde (2%) (lh, 4°C). Fixation vehicle:-PBS. 
Dehydration:- Ethanol. Embedding medium:- LR White. Cure:- hot. Mould:- gelatine capsule. 





Plates 23 shows a representative field at the magnification used for analysis (30k).
Specimen:- Hb. Immunostaining:- post embedding. Immunostaining vehicle:- TBS, no Triton. 
Concentration of mAb:- 270 (800 pM), 290 (13500 pM), 297 (150 pM), 299 (150 pM). 0.25ml 
Secondary probe:- Gold conjugated goat anti-(rat IgG) (1 x 1012 particles, 0.2ml).
Blocking (immunostain):- none.
Fixation:-Glutaraldehyde (0.1%) and formaldehyde (2%) (lh , 4°C). Fixation vehicle:-PBS 
Dehydration:- Ethanol. Embedding medium:- LR White. Cure:- hot. Mould:- gelatine capsule. 
Positive stains:- uranyl acetate/lead citrate. Coat:- none. Accelerating voltage:- 80 kV.
Plate 24
Plates 24 shows a representative field at the magnification used for analysis (30k).
Specimen:- Hb. Immunostaining:- post embedding. Immunostaining vehicle:- PBS, no Triton. 
Concentration of mAb:- 270 (800 pM), 290 (13500 pM), 297 (150 pM), 299 (150 pM). 0.25ml 
Secondary probe:- Gold conjugated goat anti-(rat IgG) (1 x 1012 particles, 0.2ml).
Blocking (immunostain):- 0.2% BSA, 5% goat serum.
Fixation:-Glutaraldehyde (0.1%) and formaldehyde (2%) (lh , 4°C). Fixation vehicle:-PBS. 
Dehydration:- Ethanol. Embedding medium:- LR White. Cure:- hot. Mould:- gelatine capsule. 






Plates 25 shows a representative field at the magnification used for analysis (30k).
Specimen:- Hb. Immunostaining:- post embedding. Immunostaining vehicle:- TBS, Triton. 
Concentration of mAb:- 270 (800 pM), 290 (13500 pM), 297 (150 pM), 299 (150 pM). 0.25ml 
Secondary probe:- Gold conjugated goat anti-(rat IgG) (1 x 1012 particles, 0.2ml).
Blocking (immunostain):- 1% BSA, 5% goat serum.
Fixation:-Glutaraldehyde (0.1%) and formaldehyde (2%) (lh, 4°C). Fixation vehicle:-PBS. 
Dehydration:- Ethanol. Embedding medium:- LR White. Cure:- cold. Mould:- gelatine capsule. 
Positive stains:-uranyl acetate/lead citrate. Coat:-piloform/carbon. Accelerating voltage:-120 kV.
Plate 26
Plates 26 shows a representative field at the magnification used for analysis (30k).
Specimen:- Hb. Immunostaining:- post embedding. Immunostaining vehicle:- TBS, Triton. 
Concentration of mAb: 270 (800 pM), 290 (13500 pM), 297 (150 pM), 299 (150 pM). 0.25ml. 
Secondary probe:- Gold conjugated goat anti-(rat IgG) (1 x 1012 particles, 0.2ml).
Blocking (immunostain):- 1% BSA, 5% goat serum
Fixation:-Glutaraldehyde (0.1 %) and formaldehyde (2%) (lh , 4°C). Fixation vehicle:-PBS. 
Dehydration:- Ethanol. Embedding medium:- LR White. Cure:- hot. Mould:- gelatine capsule. 
Positive stains:-uranyl acetate/lead citrate. Coat:-piloform/carbon. Accelerating voltage:-120 kV.
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Plate 27
Plates 27 shows a representative field at the magnification used for analysis (30k).
Specimen:- Hb. Immunostaining:- post embedding. Immunostaining vehicle:- PBS, no Triton. 
Concentration of mAb:- ANF 2F7F10(20% v/v).
Secondary probe:- Gold conjugated goat anti-(mouse IgG) (1 x 1012 particles, 0.2ml).
Blocking (immunostain):- 0.2% BSA, 5% goat serum.
Fixation:-Glutaraldehyde (0.1%) and formaldehyde (2%) (lh, 4°C). Fixation vehicle:-PBS. 
Dehydration:- Ethanol. Embedding medium:- LR White. Cure:- cold Mould:- gelatine capsule. 
Positive stains:- uranyl acetate/lead citrate. Coat:- piloform/carbon. Accelerating voltage:- 80 kV.
Plate 28
Plates 28 shows a representative field at the magnification used for analysis (30k).
Specimen:- Hb. Immunostaining:- post embedding. Immunostaining vehicle:- PBS, no Triton. 
Concentration of mAb:- ANF 2F7F10(20% v/v).
Secondary probe:- Gold conjugated goat anti-(mouse IgG) (1 x 1012 particles, 0.2ml).
Blocking (immunostain):- 0.2% BSA, 5% goat serum.
Fixation:-Glutaraldehyde (0.1%) and formaldehyde (2%) (lh, 4°C). Fixation vehicle:- PBS. 
Dehydration:- Ethanol. Embedding medium:- LR White. Cure:- cold. Mould:- gelatine capsule. 
Positive stains:-uranyl acetate/lead citrate. Coat:-piloform/carbon. Accelerating voltage:-80 kV.
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Plate 29 Demonstration of protein estimation bv PAGE analysis
Plate 29 demonstrates the general approach to protein estimation by Phast-PAGE analysis of 
dilution series. The vanishing point were the light (1) or heavy (h) immunoglobulin chain cannot be 
seen should be constant for all IgG molecules. This approach avoids protein estimation problems 
which arise due to stabilizing proteins of different molecular weights (eg BSA).
Plate 30 The determination of an appropriate concentration for the PAGE 
analysis of P2 membranes
Each PAGE system must be characterized to determine the maximum sample concentration which 
can be used without overloading. At excessively high concentrations (in this case ;>2mg/ml) the 
passage of component polypeptides is retarded. The optimal concentration for PAGE analysis, using 
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Plate 31 Immunoblotting using peroxidase conjugated goat anti-rat IgG
antibodies: and
Plate 32 Immunoblotting using peroxidase conjugated Avidin
Plates 31 and 32 demonstrate immunoblotting to combined dot blots (figure 4.4a) and PAGE 
separated P2 membranes. Antibody exposure was performed in 4ml of PBS/Tween, washing was 
performed in 50 ml of PBS/Tween. Secondary probe concentration is expressed as a percentage of 
the recommended concentration, the recommended concentration of goat anti-rat IgG was 1/5000. 
A cocktail of all 4 mAbs was used that 4 fil cocktail contained:-
antibody volume final titre (pM) sufficient to detect
270 0.1/xl 40 160 fmol nAChR
290 0.1 fil 675 2700 fmol nAChR
297 0.1 fil 7.5 30 fmol nAChR
299 0.1/zl 7.5 30 fmol nAChR
lane Immunoblotting Plate 31 Plate 32
Primary probe Secondary probe Block in PBS/Tween
1 16/xl cocktail 500% 5% w/v milk none
2 16/xl cocktail 100% 5% w/v milk none
3 16/il cocktail 20% 5% w/v milk none
4 80/d cocktail 100% 5% w/v milk none
5 16/d cocktail 100% 5% w/v milk none
6 3.2/xl cocktail 100% 5% w/v milk none
7 16/d cocktail 100% none Avidin/biotin block
8 Protein stain
9 Molecular weight markers (Sigma MW-SDS-200)
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Plate 33 Immunoblotting using r125I1-Avidin
Plate 33 demonstrates immunoblotting to combined dot blots (figure 4.4b) and PAGE separated P2 
membranes. Antibody exposure was performed in 4ml of PBS/Tween, washing was performed in 
50 ml of PBS/Tween. A cocktail of all 4 biotinylated mAbs was used such that overall titres (of the 
more dilute antibodies) were the same as plate 311-
lane Immunoblotting
Primary probe Secondary probe Block in PBS/Tween
1 16/xl cocktail 11 pM (44 fmol) None
2 16/xl cocktail 44 pM (176 fmol) None
3 16/xl cocktail 176 pM (704 fmol) None
4 80/xl cocktail 44 pM (176 fmol) None
5 16/xl cocktail 44 pM (176 fmol) None
6 3.2/xl cocktail 44 pM (176 fmol) None
7 16/xl cocktail 44 pM (176 fmol) Avidin/biotin block
8 Protein stain
9 Molecular weight markers (Sigma MW-SDS-200)
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Plate 34 Immunoblotting using peroxidase conjugated goat anti-rat IgG
antibodies
Plate 34 demonstrates immunoblotting of PAGE separated material is unaffected by the presence 
or absence of mAbs. Antibody exposure was performed in 4ml of PBS/Tween, washing was 
performed in 50 ml of PBS/Tween. The secondary probe was used at the recommended 
concentration (1/5000). The primary probe was 16/xl of a cocktail of all 4 mAbs was used such that 
overall titres were the same as plate 31:- 
lane Immunoblotting
Primary probe Block in PBS/Tween Preparation
1 No 5% w/v milk P2
2 No 5% w/v milk P2b
3 Molecular weight markers (Sigma MW-SDS-7B)
4 Yes 5% w/v milk P2
5 Yes 5% w/v milk P2b
Plate 35 Immunoblotting using r125Il-Avidin
Plate 35 demonstrates immunoblotting of PAGE separated material is unaffected by the presence 
or absence of mAbs. Antibody exposure was performed in 4ml of PBS/Tween, washing was 
performed in 50 ml of PBS/Tween. The secondary probe was used at 44 pM (176 fmol). The 
primary probe was 16/xl of a cocktail of all 4 biotinylated mAbs was used such that overall titres 
were the same as plate 31. 
lane Immunoblotting
Primary probe Block in PBS/Tween Preparation
1 Yes Biotin/Avidin P2
2 Yes None P2
3 No Biotin/Avidin P2
4 No None P2
Molecular weight markers (Sigma MW-SDS-200) were used throughout.
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Plate 36 Immunoblotting using peroxidase conjugated goat anti-rat IgG 
antibodies and mAb 270 alone
Plate 36 demonstrates immunoblotting of PAGE separated material using mAb 270 alone. Antibody 
exposure was performed in 4ml of PBS/Tween, washing was performed in 50 ml of PBS/Tween. 
The nitrocellulose was blocked using 5% w/v milk in PBS/Tween. The primary probe was 0.4/d of 
mAb 270 (titre 160 pM), which was sufficient to detect 640fmol nAChR. The secondary probe was 
used at the recommended concentration (1/5000).
lane 1 2 3 4 5 6 7 8
Preparation Homogenate SI P2 FI F2 F3 F4 F5
Plate 37 Immunoblotting using peroxidase conjugated goat anti-rat IgG
antibodies and mAb 297 alone
Plate 37 demonstrates immunoblotting of PAGE separated material using mAb 297 alone (0.4/d 
of mAb 297, titre 30 pM, which was sufficient to detect 120fmol nAChR). The procedure and lanes 
were as described for plate 36.
Plate 38 Immunoblotting using peroxidase conjugated goat anti rat IgG
antibodies and mAb 299 alone
Plate 38 demonstrates immunoblotting of PAGE separated material using mAb 299 alone (0.4/d 
of mAb 299, titre 30 pM, which was sufficient to detect 120fmol nAChR). The procedure and lanes 
were as described for plate 36.
Plate 39 Verification of mAb attachment
The procedure described in section 3.2.4was used to confirm the attachment of mAbs to beads. In 
this case, mAb 290 (40/d) had been attached directly to cyanogen bromide activated sepharose (150 
mg). The beads had been blocked by incubation in 5% w/v milk in PBS/Tween, then incubated with 
peroxidase conjugated anti-(rat IgG) antibodies (1/5000), before oxidative DAB deposition. The 
difference was very clear between mAb coated (2) and control (1) beads.
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